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SUMMARY
This study of flavivirus genomes was facilitated by the amplification method developed in 
the thesis. The envelope (E) gene and non-structural protein five (NS5) were analysed for 
the existence of homologous nucleotide sequences in thirteen flaviviruses by reverse 
transcription/polymerase chain reaction from virus infected-cell RNA extracts. A 
homologous fragment of the NS5 gene was amplified from all the extracts. Subsequently 
homologous fragments from eighteen flavivirus infected-cell extracts, representative of 
every group of flaviviruses, were produced.
The nucleotide sequences of the fragments were determined from a tick-borne virus, a 
mosquito-borne virus and a non-vector-borne virus. Two of these viruses (Banzi and 
Modoc) are classified into serocomplexes from which no viral genome sequence has 
previously been reported. The NS5 gene sequence of Banzi (BAN) virus and 90% of the 
gene sequence of Modoc (MOD) virus was subsequently determined. Comparison of the 
deduced amino-acid sequences with those of other reported flavivirus sequences 
confirmed the existence of functionally conserved motifs, which may be involved in RNA 
polymerase activities of the NS5 protein. A method of classification of flaviviruses on the 
basis of phylogenetic analysis of NS5 gene sequence was examined. The relationships 
between central european encephalitis (CEE), BAN, MOD and other flaviviruses were 
confirmed to be similar to those obtained from serological studies.
Other nucleotide sequences determined, from regions flanking the NS5 gene showed the 
NS4B genes and 3’ NC regions of BAN virus and yellow fever (YF) virus were highly 
similar. While the 3’ NC region of MOD virus is not similar to that of any flavivirus 
previously sequenced
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1 INTRODUCTION
1.1 General Introduction
Flaviviruses are a large and diverse group, many cause potentially fatal or disabilitating 
disease in man and animals. Some viruses in the group are widely studied mainly due to 
the severity of disease they cause, many viruses are poorly characterised. Despite the fact 
that a flavivirus (yellow fever virus) was the first virus infecting humans to be identified, 
details of the virus transmission, life-cycle and replication have not yet been fully 
elucidated. The classification of flaviviruses has traditionally been based on serology, 
however some viruses have proved difficult to classify. Study of the molecular biology of 
flaviviruses should lead to improved methods of classification. In recent years the 
nucleotide sequence of the entire genome of several flaviviruses has been determined. 
Much has been gained concerning the structure of the genome, protein translation and 
processing and the determinants of virulence. Comparison of nucleotide and amino acid 
sequence data with other proteins of known function has lead to functions for some of the 
viral proteins being proposed. On the basis of the nucleotide sequence data from 
flaviviruses (wild type, vaccine strains and escape mutants) conserved regions of the 
genome possibly important for virus function were identified. However, the function of only 
one flavivirus encoded protein has been demonstrated definitively. Infectious cDNA 
clones are currently being studied and will be important in identifying the function of the 
proteins and protein domains. Molecular biology will no doubt play a large role in aiding 
our knowledge of flaviviruses.
This project is an investigation of the nucleotide sequence of flavivirus genomes to 
examine the function of the viral proteins and the relationships between the viruses.
1.2 Flaviviridae
The family Flaviviridae contains three genera, the flaviviruses, the Pestiviruses and 
Hepatitis C viruses (Collett et al., 1988; Collett, 1992; Heinz, 1992). Previously these 
viruses had been classified as genera in the Toqaviridae family based on morphological, 
physicochemical or serological characteristics. The elucidation of the nucleotide 
sequences, predicted amino acid sequence and genome structure of these viruses led 
to firstly the flaviviruses being placed as the only genus in the family Flaviviridae. later the 
Pestiviruses and hepatitis C viruses were reclassified into the Flaviviridae family (Collett
1
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et al., 1988; Heinz, 1992). Study of one of these groups of viruses may yield information 
concerning other viruses in the Flaviviridae.
1.3 Flaviviruses
The flavivirus genus contains at least 70 viruses. These viruses are serologically related, 
maintaining a similar morphology and genome structure but are diverse in the diseases 
they cause. Most are arthropod-borne and are transmitted by infected mosquitoes or 
ticks.
1.3.1 Historical Perspective
Yellow fever (YF) virus was the first filterable agent known to cause disease of man. In 
1901 Reed et al.. showed that the agent was transmitted by mosquitoes (Reed, 1902). 
The virus was first isolated in 1927 and grown in-vivo in 1932. However it had been 
recognised as a disease for many centuries before this and there is a debate among 
historians as to whether Christopher Columbus and his crew encountered YF (Siler et al.. 
1926). Dengue (DEN) virus was shown to be a filterable agent in the early part of the 
twentieth century but was not isolated until 1943. In 1930 outbreaks of encephalitis in 
human populations focused attention on what was believed to be a new group of viruses, 
many of which were identified as arboviruses (arthropod-borne viruses) and later classified 
as flaviviruses. Many other encephalitic diseases had been observed throughout history 
that were later shown to be caused by flavivirus infections.
One of the most important events in flavivirus research has been the development of 
insect and vertebrate cell lines for virus propagation and isolation. The study of viruses 
in cell culture has given an insight to viral infections in-vivo (Koblet. 1993).
1.3.2 Physical and Chemical Properties
Flaviviruses observed under negative contrast electron microscopy are small spherical 
particles of approximately 50nm in diameter. They appear to have a membranous 
envelope and small surface projections (Murphy, 1980). The core contains the RNA 
genome within a spherical capsid composed of single molecules of C or capsid protein. 
The exact organisation of the core is unresolved. This core is surrounded by a viral
2
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envelope containing E and M (envelope and membrane associated) proteins. The E 
protein is found in the envelope as an complex of E protein dimers (Heinz et al.. 1991: 
Heinz & Kunz, 1980) or a hetero-oligomeric complex of E and prM (Wengler, 1989; Heinz 
et al.. 1994a). Intracellular virions contain prM protein, the precursor of the M protein, 
extracellular virions contain M protein (Shapiro et al.. 1972; Wengler, 1989).
Flaviviruses are inactivated by heat; following incubation at 50°C for 10 mins 50% of virus 
activity is inactivated. They are also sensitive to ultraviolet light, gamma-irradiation and 
various disinfectants. The tick-borne viruses are more resistant to physical and chemical 
inactivation than the mosquito-borne viruses (Monath, 1990).
1.3.3 Antigenic Classification
Flaviviruses have been divided into a number of antigenic complexes based on cross­
neutralisation in cell culture tests (table 1.1) (Calisher et al.. 1989). This analysis has 
indicated there are eight serocomplexes containing 49 viruses plus 17 viruses which could 
not be assigned to any serocomplex. Several potential flaviviruses were omitted from this 
study in particular some strains of central European encephalitis (CEE) virus and cell- 
fusing agent (CFA). The serocomplexes also reflect the vector involved in virus 
transmission. However this classification system leaves at least 15% of the flaviviruses, 
including YF virus, unassigned. Since the classification of flaviviruses on the basis of 
serology at least one more potential flavivirus has been discovered (Coimbra etal.. 1993). 
Serology suggests this new virus, Igape, is related to the currently known flaviviruses. The 
limitations of the current classification system suggests that future reclassification of 
flaviviruses is likely to be based on nucleotide and protein sequence data (Gao et al.. 
1993b; Gao et al.. 1993a).
1.4 Flaviviruses and Disease
Flaviviruses cause disease in a range of animals from humans to birds and rodents. 
Approximately half of the known flaviviruses have been associated with disease in 
humans. Three different types of illness are caused by flaviviruses, encephalitis, fever-rash 
and haemorrhagic fever. The severity of the disease is dependent on the virus infection, 
previous history of flavivirus infection or vaccination and the general health of the 
individual, often the severity increases with age.
3
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Table 1.1 : Antigenic Classification of Flaviviruses.
Vector Antigenic
Complex
Viruses
Tick Tick-borne
encephalitis
(central European encephalitis, Russian spring- 
summer encephalitis), Omsk haemorrhagic fever, 
louping ill, Kyasanur forest disease, (Langat, Phnom- 
Penh bat, Carey Island), Negishi, Powassan, Karshi, 
Royal Farm
Tick Tyuleniy Tyuleniy, Saumaurez Reef, Meaban
Mosquito Japanese
encephalitis
Japanese encephalitis, St Louis encephalitis, Murray 
Valley encephalitis, West Nile, Kunjin, Usutu, 
Kokobera, Stratford, Alfuy, Koutango
Mosquito Ntaya Ntaya, (Tembusu, Yokose), (Israel turkey 
meningoencephalitis, Bagaza)
Mosquito Uganda S Uganda S, Banzi, Bouboui, Edge Hill
Mosquito Dengue dengue 1, 2, 3 and 4
None Rio Bravo Rio Bravo, Entebbe bat, Dakar bat, Bukalusa bat, 
Apoi, Saboya
None Modoc Modoc, Cowbone Ridge, Jutiapa, Sal Vieja, San 
Perlita
Viruses in brackets are most closely serologically related. The following viruses could not 
be assigned to a serocomplex: Aroa, Bussuquara, Cacipacore, Gadget’s Gulley, Ileus, 
Jugra, Kadam, Montana myotis Leukoencephalitis, Naranjal, Rocio, Sepik, Sokuluk, 
Spondweni, Tamana bat, Wesselbron, Yellow Fever, Zika.
4
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The flaviviruses most frequently associated with encephalitis are Japanese encephalitis 
(JE), St. Louis encephalitis (SLE) Murray Valley encephalitis (MVE), CEE, Russian spring- 
summer encephalitis (RSSE), Powassan (POW), Negishi (NEG) and Rocio. Louping ill (LI) 
causes encephalitis in sheep. Viruses associated with fever and arthralgic rash include all 
four DEN viruses and West Nile (WN) virus. The major flavivirus recognised as causing 
haemorrhagic fever is YF though cases of haemorrhagic fever caused by DEN virus are 
increasing. Two members of the TBE serocomplex, Kyasanur forest disease (KFD) and 
Omsk haemorrhagic fever (OHF) viruses also cause this severe disease.
There is no specific treatment for any flavivirus infection however good supportive care 
including hospitalisation can reduce fatalities considerably. The main problem being that 
traditionally this type of care is not available in areas of the tropical world affected by 
flavivirus disease.
The data in the sections 1.5 to 1.13 are reviewed by Monath (1990) and by the sub­
committee on information exchange of the American committee on arthropod-borne 
viruses (1985) unless otherwise referenced.
1.5 Viruses of the Tick-Borne Encephalitis Serocomplex
Viruses in this serocomplex are transmitted by ticks with the exception of Phnom-Penh 
and Carey Island viruses which have never been isolated from any arthropod and may be 
transmitted directly between animal hosts.
OHF and KFD viruses cause haemorrhagic fever in infected humans which is 
characterised by fever, headache, cough and haemorrhages. Only OHF has frequent but 
mild sequelae. These two viruses are limited to specific areas of the world, OHF virus is 
found only in certain areas of Russia and KFD virus is restricted to areas around the 
Kynasanur forest in India. The nucleotide sequence of the structural genes of KFD virus 
(Venugopal etal., 1994a) and the envelope gene of OHF virus (Gritsun etal.. 1993b) have 
been determined.
POW virus has been isolated from man, deer, foxes, many small mammals, ticks and 
mosquitoes. The major route of transmission is probably the tick. POW is found mainly 
in western USA/Canada and USSR. It rarely causes disease in humans with the number
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of reported cases being in the twenties, with one fatality. POW is thought to naturally infect 
wild mammals. The entire genome of the virus has been nucleotide sequenced (Mandl 
et al.. 1993). The results confirmed serological data that POW was the most divergent 
member of the TBE serocomplex. Significant differences between tick and mosquito 
transmitted flaviviruses were also characterised.
Louping ill (LI) is primarily an infection of sheep, however humans may contract the 
disease following tick bites or from direct contact with infected sheep. The disease in 
humans is relatively mild and similar to the disease caused by CEE virus as described in 
section 1.5.1. The NS1 and E genes have been nucleotide sequenced (Venugopal et al.. 
1994b; Shiu et al.. 1991). Comparison of the E gene nucleotide sequence of LI with other 
flavivirus E gene sequences showed NEG virus was highly related to LI and that NEG may 
of a strain of LI (Venugopal et al.. 1992). NEG has only ever been isolated from man 
where it causes a more severe form of disease than LI.
The viruses Langat (LGT), Phnom-Penh bat and Carey Island are all serologically highly 
related. These viruses have never been associated with human disease but may infect 
bats and rodents. LGT which is a naturally attenuated member of the TBE serocomplex 
(Mayer, 1975) has been extensively studied because it is closely antigenically similar to 
highly pathogenic RSSE virus. The nucleotide sequence of the entire genome of LGT has 
been determined (lacono Connors & Schmaljohn, 1992; Mandl etal.. 1991a). The natural 
attenuation can therefore be compared highly pathogenic flaviviruses. Kararishi and 
Royal Farm were isolated from arthropods and they are not associated with any disease 
in man or animals.
1.5.1 CEE Virus Kumlinge
CEE and RSSE viruses are a members of the TBE serocomplex (Clarke, 1964). As the 
name suggests these viruses are transmitted by ticks.
CEE viruses (eg. strains Neudoerfl, Kumlinge Hypr) and RSSE (eg. Sofjin, 205) viruses are 
antigenically similar. However the two viruses differ in their clinical manifestations. CEE 
tends to be less severe with minor post-infection sequelae. Fatality rates are 1-2%. In 
comparison RSSE virus infections induce post-infection neurological sequelae in 30-60%, 
including partial paralysis and the fatality rate is 20% of patients. The current vaccine,
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which offers good protection against both viruses, is an inactivated cell culture grown 
virus. Also natural infection offers life-long immunity.
In 1962 a serological study showed that a range of farm and wild animals had antibodies 
to TBE viruses (Brummer-Korvenkontio et al.. 1962). The virus was first isolated from 
various mammals, birds and ticks from samples taken on Kumlinge island in the 
Southwest archipelago, Finland (Brummer-Korvenkontio et al.. 1973). In the same study 
virus was also isolated from early blood samples from humans with a feverish illness. 
Two of these were laboratory workers. This virus was identified as a CEE virus and called 
Kumlinge.
The nucleotide sequence of the E gene from Kumlinge has been determined (Whitby et 
al., 1993a). This gene showed variation in only one amino acid from Neudorfl, a previously 
recognised strain of CEE virus. The similarity between the genes of two viruses isolated 
from different locations suggests there is a strong selective pressure to maintain the E 
protein amino acid sequence.
1.6 Viruses of the Tyuleniy Serocomplex
The viruses in this serocomplex have not been widely studied. All the viruses in this 
complex, Tyuleniy (TYL), Saumaurez Reef encephalitis (SRE) and Meaban were isolated 
from ticks. They have been associated with sea birds and are not known to cause disease 
in humans, though two individuals from Commodore Island, USSR have been shown 
by a haemagglutination inhibition assay to have antibodies against TYL virus.
1.7 Viruses of the JE Serocomplex
The viruses in this serocomplex are transmitted by mosquitoes. Many of the viruses in this 
complex are pathogenic for man, and are therefore widely studied.
JE virus is probably the most important flavivirus in terms of severity of disease and 
mortality. It mainly affects areas in Asia. Recently a case of JE was identified in Leeds, UK, 
the individual had briefly travelled to an affected area (Burdon et al.. 1994). The onset of 
the disease may result in a febrile headache, aseptic meningitis or encephalitis. This is 
followed by neurological disorders. Neurological sequelae occur in up to 70% of
7
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survivors. There are both live attenuated and formalin-inactivated vaccines available. The 
nucleotide sequence of the entire genome of several strains of JE virus have been 
determined, these include virulent and vaccine strains (Sumioshi et al.. 1987; Nitayaphan 
et al.. 1990). This lead to an infectious clone of the virus being produced to study in detail 
the molecular biology of the virus (Sumiyoshi et al.. 1992). The mechanism of replication 
of this virus has also been studied (Edward & Takegami, 1993; Konishi & Mason, 1993; 
Haseqawa et al.. 1992; Gupta et al.. 1991).
SLE virus is the most important cause of mosquito-borne encephalitis in the USA and 
Canada, it is found in many regions of the western hemisphere. The disease is similar to 
that of JE though slightly less severe with an increase in severity with age (Calisher, 1994). 
There is currently no vaccine available. Nucleotide sequence data for the NS1, NS2A and 
NS2B genes has been determined for this virus (Trent et al.. 1987).
MVE virus is found in the southern hemisphere in southern and western Australia and New 
Guinea. There are three categories of disease 1) mild with neurological sequelae in 40% 
of cases, 2) severe with severe neurological sequelae in all cases, 3) fatal resulting from 
extreme neurological damage. Again there is no vaccine against this disease. The 
nucleotide sequence of the genome of MVE virus has been reported (Lee et al.. 1990; 
Dalqarno et al.. 1986). The mechanism of virus-cell fusion (Guirakhoo et al.. 1992) and of 
protein processing (Lobigs, 1992) have been studied.
WN virus infection normally results in a mild fever and rash for up to a week followed by 
rapid recovery. There are few reported cases of complications following infection. Very 
mild cases are common. This virus has been extensively studied perhaps because of its 
similarity to highly pathogenic viruses of the JE serocomplex. The processing of the 
polyprotein (Wengler et al.. 1991; Nowak et al.. 1989) and capsid protein (Yamshchikov 
&Compans, 1994), virus replication (Sreenivasan etal.. 1993: Grun &Brinton, 1987; Grun 
& Brinton, 1988) and virus fusion (Wengler, 1989) have been investigated. Again 
nucleotide sequence data have been published for the entire genome of this virus. 
(Wengler et al.. 1985; Castle et al.. 1985; Castle et al.. 1986; Castle & Wengler, 1987).
Kunjin (KUN) virus is highly similar to MVE virus both in terms of nucleotide sequence and 
disease caused in humans. Some KUN infections may have been mis-diagnosed as MVE, 
however this virus rarely infects humans, its main hosts are other mammals and birds. The
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nucleotide sequence of the whole genome has been published and an infectious clone 
of this virus has been established (Khromykh & Westaway, 1994; Coia et al.. 1988). KUN 
virus infection and in particular replication has been studied in detail (Chu et al., 1992; 
Chu & Westaway, 1992; Ng & Hong, 1989; Chu & Westaway, 1987).
There are five more viruses classified into this serocomplex. Kokebera, Stratford, Alfuy and 
Koutango were isolated in Australia, Usutu was isolated in Africa. Alfuy was isolated from 
a bird while all the others were originally isolated from mosquitoes. Although most of 
these viruses do not infect man, one natural infection of Usutu and one laboratory 
infection of Koutango have been reported, in both cases viruses were isolated from blood. 
The natural host for these viruses is birds, mammals and marsupials.
1.8 Viruses of the Ntaya Serocomplex
Israel Turkey Meningoencephalitis virus has been isolated from diseased turkeys in Israel 
and South Africa. The other viruses of this serocomplex were isolated from mosquitoes, 
Tembusu has also been found in chickens. These viruses are not associated with disease 
in man however, antibodies against Ntaya are prevalent in the inhabitants of many 
countries of Asia and Africa. These results may not indicate past infection with Ntaya but 
antibody cross-reaction with JE virus, which also affects these regions . One individual 
also showed antibodies to Tembusu. None of the viruses in this serocomplex have been 
widely studied.
1.9 Viruses of the Uganda S Serocomplex
Two of the viruses from this serocomplex BAN and Uganda S are the highly serologically 
related to YF virus. However, the only virus in this serocomplex to be associated with 
disease in humans is BAN. Uganda S. virus appears to affect monkeys and birds. Edge 
Hill virus affects marsupials and mammals. Bouboui virus has been isolated from a 
baboon. Uganda S virus is serologically closely related to BAN virus and like BAN virus, 
antibodies to Uganda S virus are found in many individuals in Africa, Uganda S virus may 
also have been isolated from these some of these individuals.
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1.9.1 BAN virus
BAN was first identified and isolated from a nine year old boy with a mild febrile illness 
in Tongaland South Africa (Smithburn et al., 1959). It may also have been isolated from 
a human in Tanzania (Williams & Woodall, 1964). Neutralising antibodies against BAN 
virus have been found in sheep, cattle (Kokernot et al.. 1961) and human residents of 
Tongaland, Mozambique and Angola (Kokernot et al.. 1965). The virus has also been 
isolated from, and is capable of being transmitted by, mosquitoes (McIntosh et al.. 1976; 
Metslaaret al.. 1974). Its natural host is probably rodents (McIntosh, 1961). Little is known 
about BAN virus but it has been used as a model to study the pathogenesis of 
flaviviruses. Jacoby and Bhatt (1976) showed that genetic resistance to BAN virus lethal 
encephalitis in adult C3H/RV mice was not solely due to limited viral replication. The 
structure of the BAN virus virion has also been studied both in-vitro and in-vivo 
(Calberg-Bacq et al.. 1975). It was shown to be spherical with fuzzy projections.
1.10 Viruses of the DEN Serocomplex
DEN is a world-wide health problem and is found in Asia, Africa and America, particularly 
in tropical regions. The disease is caused by four serologically related viruses known as 
DEN 1-4. The disease begins with a general malaise with rash and high fever. There may 
be an apparent recovery period before the onset of more severe symptoms and 
secondary rash prior to full recovery. Occasionally infection with a DEN virus may cause 
a more severe and fatal disease. All four types of DEN can cause haemorrhagic fever and 
DEN shock syndrome, it is unclear why the viruses of the DEN serocomplex which 
normally causes a milder disease, as previously described above, sometimes causes this 
potentially fatal disease. There are two possible explanations. Firstly that some strains of 
DEN viruses have evolved to be highly virulent. At present there is no evidence to support 
this theory. The second explanation is that some type of antibody dependent 
enhancement of the disease occurs. This has been demonstrated in-vitro for a number 
of flaviviruses (Halstead, 1982). Infection with one serotypes of DEN induces immunity to 
that serotype but very limited cross protection against other serotypes so subsequent 
infections are possible where there are circulating antibodies against the original DEN 
infection. The disease initially appears similar to normal DEN infection but after 2-5 days 
the symptoms become severe with haemorrhaging. The fatality rate can be as high as
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50%. Vaccine development against DEN is hindered by the probability that vaccination 
may aid in causing haemorrhagic fever as it will induce sub-neutralising concentrations 
of antibody. Much effort has been expended in designing vaccines which will not cause 
such problems because it protects against all four DEN viruses (Becker, 1990). Methods 
of surveillance and results of surveillance have been important for monitoring DEN 
infection particularly in the light of the increasing incidence of DEN haemorrhagic fever 
(Lucia & Kangwanpong, 1994; Vorndam et al.. 1994; Chow et al.. 1993; Deubel et al.. 
1993; Lam, 1993; Lewis et al.. 1993; Wang et al.. 1993). The genomes of all four DEN 
serotypes have been nucleotide sequenced (Blok et al.. 1992; Fu et al.. 1992; Osatomi 
&Sumiyoshi, 1990; Irie et al.. 1989; Deubel et al.. 1988; Hahn et al.. 1988; Mackow et al.. 
1987; Mason et al.. 1987; Deubel et al.. 1986; Zhao et al.. 1986). Other workers have 
investigated the processing of the DEN polyprotein and the viral encoded proteins (Arias 
eta!., 1993; Bartholomeusz & Wright, 1993) and DEN virus neurovirulence (Kawano et al.. 
1993).
1.11 Viruses of the Rio Bravo Serocomplex
These viruses do not appear to have an arthropod vector, though Saboya may be 
transmitted by sand flies (Fontenille et al.. 1994). They were all isolated from bats or 
rodents and rarely infect man. A few cases of natural infection with Rio Bravo and two of 
Dakar bat have been reported in Africa and one case of Apoi in Japan. Due to their lack 
of pathogenicity for man these viruses are not well studied.
1.12 Viruses of the MOD Serocomplex
There has been very little investigation into viruses in this serocomplex beyond their initial 
isolation. Their is no known arthropod vector for these viruses, they seem to mainly infect 
rodents and no symptomatic infections of humans have ever been reported.
1.12.1 MOD virus
MOD virus was first isolated from a mouse, during a study being carried out to identify the 
causative agent of Colorado tick fever. The MOD virus was shown to belong to the group 
B arboviruses (Casals, 1960). Several experiments to identify an arthropod vector for the
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virus failed. However limited experiments showed that the virus could be passed from one 
mouse to another by ingestion of infected material. The virus has never been isolated from 
an arthropod and MOD virus can not be propagated in the mosquito cell line C6/36 
(Varelas-Wesley & Calisher, 1982). The mode of dissemination of this virus is thought to 
be through direct contact with excreta. Since the virus can be isolated from mammary 
glands there is a possibility it is transmitted in infected milk.
Early studies on cross-protection of mice showed that MOD virus was related to Rio-Bravo 
virus. Prior infection with MOD virus protected mice against subsequent challenge with 
Rio-Bravo virus (Johnson, 1967). However, Rio-Bravo offers only slight protection against 
MOD suggesting MOD has additional unique antigens. More recent studies show no 
cross-reaction with Rio-Bravo in neutralization tests and places MOD in a serocomplex 
with Cowbone Ridge, Jutiapa, Sal Viejaand San Perlita viruses. The virus has the potential 
to become latent in hamster kidneys (Johnson, 1970). MOD virus probably causes 
unapparent infection in humans, only laboratory acquired infections have been noted (The 
subcommittee on arbovirus laboratory safety of the American committee on 
arthropod-borne viruses, 1980).
1.13 Viruses Unassiqned to a Serocomplex
Seven of the remaining seventeen unclassified flaviviruses cause disease in humans. The 
remainder are associated with birds, bats, and other mammals. YF is probably the most 
widely studied flavivirus. It causes disease mainly in America and Africa. Onset of YF is 
usually sudden and lasts for a few days, this is followed by a remission period for up to 
a day. The symptoms then become more severe with bleeding, 20-50% of cases are fatal. 
Two live vaccines have been developed, however the French neurotropic vaccine is no 
longer produced as it resulted in vaccine induced symptoms in 20% of vaccinees. The 
17D vaccine is prepared from infected chick embryos and is highly effective and safe as 
extensive studies have shown (Theiler & Smith, 1937). The nucleotide sequence of the 
whole genome has been determined 1985 (Rice et al.. 1985; Dupuy et al.. 1989). 
Research has also been carried out on YF protein processing (Rice et al.. 1985; Amberg 
et al.. 1994; Chambers et al.. 1993; Lin et al.. 1993a; Lin et al.. 1993b; Chambers et al.. 
1990b) and function (Warrener et al.. 1993).
Rocio was identified in 1975 from human fatal cases in Brazil. Infection is clinically similar
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to JE virus and SLE virus however long term neurological effects only occur in 20% of 
cases.
Wesselsbron mainly infects sheep causing abortion and death of new-borne lambs. 
Natural human infections do occur and virus has been isolated from blood in these cases.
The remaining unassigned viruses occasionally infect humans but their main hosts are 
other primates, bats, birds and rodents. Spondweni and Zika viruses are serologically 
similar. They are both similar to YF virus and viruses from the Uganda S serocomplex. 
Spondweni and Zika viruses have been isolated from humans with mild febrile illness and 
a rash in the case of Zika. The incidence of these infections is very small and mainly 
laboratory acquired. The nucleotide sequence of 300 bases of the NS5 gene and part of 
the 3’ NC region of Zika virus has been determined (Pierre et al.. 1994). Several human 
infections of Ileus have been reported and one infection of Bussuquara.
A virus called cell fusing agent (CFA) may also be a flavivirus, though there is evidence 
it may be a member of a separate genera of the Flaviviridae. It was isolated as a 
contaminant of a mosquito-cell line. The nucleotide sequence of the virus has been 
determined and though its genome organisation is the same as other flaviviruses the 
individual genes do not show a high degree of identity with the genes of other flaviviruses 
(Cammisa-Parks et al.. 1992).
1.14 Transmission Cycle
Most flaviviruses are transmitted between vertebrate hosts by arthropod vectors. The 
transmission cycle can be simple or complex depending on the host, vector and virus. 
The environmental pressures on host and vector will also affect the cycle. Man tends to 
be a dead-end host for flaviviruses and rarely have a primary role in virus transmission. 
Viruses from the serocomplexes JE, Ntaya, Uganda S and DEN are transmitted by 
mosquitoes. Those from TBE and Tyuleniy serocomplexes are transmitted by ticks. No 
insect vector is known for viruses from Rio-Bravo and MOD serocomplexes.
Replication of virus in the insect host does not seem to result in any significant 
pathological effect suggesting that virus and vector co-evolved. Some flaviviruses exhibit 
a high degree of vector specificity while others do not. This is due to the susceptibility of
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the mid-gut epithelia which is infected following ingestion of blood containing virus. 
Vertical transmission of some flaviviruses has been shown to be important for survival 
overwinter. Horizontal transmission may also occur.
Vertebrate hosts are infected when a female mosquito or tick penetrates the skin for a 
blood meal. It is only female mosquitoes that are blood feeders, occasionally males are 
infected with flaviviruses obtained transovarially or venereally from the female. Humans 
may also be infected by digestion of raw dairy products from infected animals.
Recently a flavivirus (Saboya) was isolated from sand flies in West Africa, this virus had 
previously been isolated from rodents (Fontenille et al.. 1994). The authors suggest a 
transmission cycle with the rodent as a primary host and the sand fly as a vector. This 
virus was previously thought to have no arthropod vector.
Two serocomplexes of flaviviruses contain viruses which mainly infect rodents, bats and 
birds (Varelas-Wesley & Calisher, 1982) and do not appear to be transmitted by 
arthropods, these are possible spread by direct contact of infected animals. The virus CFA 
may be a flavivirus which has lost the ability to replicate in the animal host but has 
adapted to infecting the arthropod vector only.
1.15 Virus Entry
The first steps of virus entry into a cell involve attachment and fusion. Little is known 
about the initial interaction of the flavivirus virus with the host cell, though it is thought to 
be via a virus-receptor interaction. Viral fusion however has been studied extensively. 
TBE virus replication is inhibited when vacuolar type H+-ATPase inhibitors are present 
during the early stages of virus infection, indicating that the virus is taken up by receptor- 
mediated endocytosis. The acid pH of the endosome then causes the viral membrane to 
fuse with the endosomal membrane releasing the nucleocapsid into the cytoplasm. The 
fusion process is controlled by the envelope (E) protein. Mutations in the E gene of a JE 
virus showed reduced virulence in mice because of altered early virus-cell interaction/viral 
replication was not affected (Hasegawa et al.. 1992). The exact location of these mutants 
has been mapped. Monoclonal antibodies mapped to antigenic domains of the E protein 
of TBE virus also inhibited viral fusion (Guirakhoo et al.. 1991). The regions of E that 
undergo conformational changes at acid pH and are presumably involved in fusion have
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been mapped using monoclonal antibodies (Heinz & Mandl, 1993).
1.16 Virion Assembly and budding
Studies with WN virus indicated that the virus-host interaction is important for correct virus 
assembly. In Vero cells virus maturation but not replication was markedly reduced by 
brefeldin A, a chemical which is known to affect functions of the endoplasmic reticulum 
and golgi apparatus. In C6/36 cells no such effect was seen, indicating either the 
mosquito cell line is resistant to brefeldin A or that the virus-host interactions are different 
in the two different cell types (Sreenivasan et al.. 1993).
Events in virion maturation have been studied and show that the cleavage of membrane 
associated intracellular core protein to the virion type core protein is also essential for 
virus release. The putative viral protease NS2-NS3 was implicated in this cleavage 
(Yamshchikov & Compans, 1993).
Virion assembly is thought to begin with nucleocapsid formation involving interaction of 
vRNA with the capsid protein. The immature intracellular virion contains prM protein but 
the mature secreted virions contain M protein. Thus it is thought that cleavage of prM to 
M is involved in virus maturation. When the pH of intracellular vesicles is raised immature 
virions with prM are secreted. Thus it is assumed that acidic pH vesicles are involved in 
the late events of flavivirus maturation. Immature virions containing prM do not exhibit acid 
induced fusion described previously. Virions containing prM can be secreted but are 
unlikely to be able to infect cells because the virus cannot fuse with the cell membrane 
(Guirakhoo et al.. 1991). At acid pH, E protein is shown to go through conformational 
change. Recent studies show the existence of prM-E protein complexes. The close 
association of prM with the E protein may prevent the conformational change in the E 
protein at acid pH. Perhaps the late processing of prM protects the virus from pH induced 
fusion within vesicle membranes as it is secreted from the cell. Then during or before 
budding the prM may be cleaved. (Guirakhoo et al.. 1992; Heinz et al.. 1994b).
1.17 Genome
All flaviviruses contain a single stranded, positive sense RNA genome of approximately 
11 kb in length (Figure 1.1). The full length RNA is infectious and only full length mRNA
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molecules are found in infected cells. The genomic RNA has a type 1 cap (m7GpppAmp) 
at its 5’ end (Cleaves & Dubin, 1979). The cap is followed by two conserved nucleotides 
AG in all flaviviruses nucleotide sequenced to-date. The 3’ end of the genomic RNA is not 
necessarily polyadenylated. To date the only flavivirus thought to contain a 3’ poly(A) tract 
is the CEE virus strain Neudoerfl (Mandl et al.. 1991b).
The nucleotide sequence of the whole genome of several flaviviruses has been 
determined. These data showed that the flavivirus genome contains one open reading 
frame of over 10kb. The structural proteins C(capsid protein), prM and E are found in the 
5’ quarter of the genome. The non-structural proteins NS1 to NS5 are found in the 
remainder of the genome (Figure 1.1). The proteins are coded on the open reading frame 
as follows 5’-C-prM(M)-E-NS1-NS2A-NS2B-NS3-NS4A-NS4B-NS5-3’ (Rice et al.. 1985; 
Speight &Westaway, 1989b; Schrader & Westaway, 1988).
The open reading frame is flanked by short non-coding (NC) regions. The 5’ NC region 
is approximately 100 nucleotides long and there is nucleotide sequence conservation 
between the viruses of a single serocomplex but less between viruses of different 
serocomplexes (Coelen & MacKenzie, 1980). Howeverthis region has the potential to form 
secondary structures which may be conserved in many flaviviruses (Brinton & Dispoto,
1988).
There is little nucleotide sequence homology between the 3’ NC region of flaviviruses, 
however distinct features have been identified for groups of viruses. Mandl et al... (1991 b) 
suggested that the viruses of the TBE serocomplex could be separated into two groups, 
those having a short 3’ NC region followed by a 3’ terminal poly(A) structure (eg. 
Neudoerfl) and those having a longer 3’ NC region with the absence of a poly(A) structure 
(eg. Hypr). Both viruses contain two sequences in the 3’ end of the NS5 gene which are 
repeated or inversely repeated in the 3’ NC region.
Mosquito-borne flaviviruses sequenced to date possess a 3’ NC region of 385 to 585 
nucleotides in length. Highly conserved repeated nucleotide sequences known as CS1 
and CS2 are found in the 3’ NC region of mosquito-borne flaviviruses. CS1 has identity 
with a conserved region near the 5’ end of the C gene known as 5’ CS. In addition the 
viruses of the DEN and JE serocomplexes have a second repeat of CS2. Viruses of the 
JE serocomplex also contain a third conserved repeated sequence. YF virus contains a
17
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different sequence repeated three times (Chambers et al.. 1990a).
All the flavivirus 3’ NC regions have the potential to form stable secondary structures 
(loops or stems) (Mohan & Padmanabhan, 1991; Takegami et al.. 1986; Brinton et al.. 
1986). There is evidence, from RNAse protection studies, for secondary structure 
formation of the 3’ terminus of DEN-2 (Mohan & Padmanabhan, 1991).
1.18 Protein translation/processing
Amino acid sequencing of N-termini of proteins from CEE, YF, WN and SLE viruses 
demonstrated that the translation begins with the first AUG in the ORF. Mosquito-borne 
flaviviruses have second AUG codon 12 to 14 nucleotides down-stream, translation may 
also occur from this second codon (Castle et al.. 1985).
A single large polyprotein is translated from the genomic RNA and terminates at the a 
stop codon in the RNA. There appears to be no strong termination codon preference as 
all three are used : UAA (DEN 3, DEN-4, KUN, MVE, WN, CEE, RSSE and POW viruses), 
UAG (JE and DEN-2 viruses) and UGA (DEN 1 and YF viruses). Individual proteins are 
then produced by cleavage of the polyprotein by either viral or host encoded enzymes 
(figure 1.1). Amino-acid sequences tend to be conserved at the N and C termini of 
flavivirus proteins. Comparison of these conserved sequences and experimentation 
showed that proteolytic processing is similar in all flaviviruses studied to date (Chambers 
et al.. 1990a). The first type of cleavage generates the N terminus of prM, E, NS1 and 
NS4B. This is mediated by a signal peptidase found in association with the endoplasmic 
reticulum membrane. The second type of cleavage generates the N terminus of NS2B, 
NS3, NS4A and NS5. This cleavage follows two basic amino acids (eg Lys or Arg), it is 
followed by a small amino acid such as Gly, Ser or Ala. The viral encoded NS2B-NS3 
protease is thought to be responsible for cleavage at these sites (Chambers eta]., 1990b; 
Cahour et al.. 1992; Chambers et al.. 1991; Falgout etal., 1991; Chambers et al.. 1993; 
Falgout et al.. 1993). The processing of NS1/NS2A does not involve either of the above 
mechanisms. The amino-acids important for protease recognition and cleavage have been 
identified in a number of flaviviruses. In DEN-4 the amino acids important for recognition 
of the cleavage site in NS1/NS2A processing and N terminus cleavage of NS2B, NS3, 
NS4A, NS5 have been shown (Lai et al.. 1994). Amino acids important in YF NS3/4A and 
NS4B/5 processing have also been identified (Lin et al.. 1993b).
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Some of the flavivirus proteins are subject to further processing. The capsid protein is 
known to exist in several forms. The N-terminal initiation methionine is removed during 
virus maturation (Chambers et al.. 1990a) , also a region of 18 amino acids is cleaved 
from the C-terminus of capsid protein (Speight, Westaway, 1989a). Some WN capsid 
protein begins at the second in frame methionine residue . Differences in the 
electrophoretic mobilities of intracellular and virion-associated capsid have been noted for 
KUN, WN, TBE virus (Chambers et al.. 1990a). In all flaviviruses studied the prM 
glycoprotein found in intracellular virions, is the cleaved to produce the M protein which 
found in extracellular mature virions. The N terminus of the M protein follows two basic 
amino acids thought to be the cleavage site for either a viral or host encoded enzyme. 
The locations of potential glycosylation sites of the M protein have been identified 
(Chambers et al.. 1990a). The E protein is glycosylated in some flaviviruses. Potential 
glycosylation sites are not so highly conserved for E as for the prM/M proteins (Chambers 
et al.. 1990a). Multiple forms of NS1 exist between flaviviruses however, potential 
glycosylation sites are conserved (Chambers etal.. 1990a). NS2A, NS2B, NS4Aand NS4B 
are small proteins, no post-translational modifications of these protein are known. The two 
largest flavivirus proteins NS3 and NS5 also seem to have no further modifications.
1.19 Flaviviral RNA Replication
The mechanism of flavivirus replication is as yet not well defined, comparison of the 
structure of the flavivirus genome and the encoded proteins with other RNA viruses has 
aided the elucidation of steps in flavivirus replication.
The un-coated viral RNA is used as a template for the synthesis of minus stranded RNA 
molecules. These molecules can then be used to synthesise positive strand molecules 
which serve as a template for translation of virus proteins, for further minus strand 
synthesis or to be incorporated into the virion.
Double stranded replicative forms and single stranded replicative intermediates have been 
identified (Chu & Westaway, 1987; Cleaves et al.. 1981). The flaviviruses are thought to 
replicate by a semi-conservative mechanism. The conserved sequences found in both 
the 3’ and 5’ NC regions may play a role in replication and could allow circularisation of 
the virus genome (Hah et al.. 1987). Bartholomeusz and Wright showed that KUN 
replicative form template could be a substrate for DEN-2 polymerase and vice versa.
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They suggested that this was in part due to recognition of conserved secondary structures 
at the termini of the RNA (Bartholomeusz & Wright, 1993). There is thought to be a 
mechanism to regulate the synthesis of minus strand molecules because the ratio of plus 
to minus strands of 10:1 has been noted at peak RNA synthesis in DEN virus. Several 
flavivirus non-structural proteins may have a role in viral RNA synthesis. In particular NS3, 
which contains RNA helicase motifs (Lain et al.. 1989) and NS5 which is proposed to be 
an RNA-dependent RNA polymerase. There is some debate as to where the replication 
complex is localised with it being identified in cytoplasmic extracts (Chu etal., 1992; Chu 
& Westaway, 1992) and also at the perinuclear site (Buckley et al.. 1992; Edward & 
Takegami, 1993). The later group identified NS3 and NS5 in the replication complex and 
showed antibodies to these proteins inhibited viral replication. Other workers have 
suggested that the nucleus is essential for some stage of flavivirus replication (Lad et al.. 
1993). The small protein NS2B has also been implicated in viral replication (Chambers et 
ah, 1993). NS2B and possibly NS4 proteins may be associated with the viral replication 
complex (Chambers et_aj., 1990a).
Studies on the susceptibility of mice to flaviviruses have identified a host allele that can 
confer resistance to flaviviruses (Sangster et al.. 1993). This allele has been mapped to 
the murine chromosome 5 (Sangster etal., 1994). Reduced virus replication with low viral 
RNA synthesis which does not seem to be related to the host immune system occurred 
in resistant mice. Thus it would seem that host genes play an important role in virus 
replication.
1.20 E Gene
The E protein is the most extensively studied flavivirus protein and is highly conserved. 
It is the major protein of the virus envelope and has a role in mediating virus entry into the 
cell probably both by interacting with cell receptors and inducing fusion. Antibodies 
against the E protein are capable of neutralising virus replication in cell culture. The 
current flavivirus classification into serocomplexes is based on cross-neutralisation of 
polyclonal sera against the outer virus membrane. In 1990 Heinz et al.. published a model 
for the E protein of TBE virus based on predicted protein sequence homology between 
flaviviruses, epitopes elucidated in antibody binding/ inhibition studies and monoclonal 
antibody escape mutants (Heinz et al.. 1990). The protein contains a hydrophobic region
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thought to be the membrane anchor. Further E gene sequences , including those from 
viruses of the TBE serocomplex, Omsk haemorrhagic fever, the CEE viruses Vasilchenko 
strain (Gritsun et al.. 1993a), Turkish isolate (Whitby et al.. 1993b) and Kumlinge (Whitby 
et al.. 1993a), Kyasanur Forest disease virus (Venugopal et al.. 1994a) , Negishi 
(Venugopal et al.. 1992) and isolates of DEN-1 and 2 ,have been elucidated in more 
recent studies. The predicted protein sequences lent confirmation to the original model ( 
such as the structural role of the conserved cysteine residues, three N-glycosylation sites 
and the predicted fusion peptide. Extensive analysis of the predicted amino acid 
sequence has lead to identification of amino acid sequence genetic markers unique for 
different virus types. Dendrograms produced from sequence data appear to reflect the 
results of serological testing, this will be discussed further in chapter 3. Work to identify 
the function of some of these unique and conserved regions using infectious clones 
should lead to a better understanding of the role of the E gene and determinants of 
virulence.
1.21 NS5 Gene
The NS5 gene encodes the largest and most highly conserved flavivirus protein (Mandl 
et al.. 1989b; Blok et al.. 1992). It is a basic protein. The C-terminus of the protein extends 
to the end of the virus poly-protein and the N-terminus is formed by cleavage as 
described above.
A number of conserved amino acid sequences are found in the NS5 protein. Comparison 
of these sequences with other proteins indicated that NS5 protein is a flavivirus RNA 
polymerase. All flavivirus NS5 proteins contain the conserved GDD motif, thought to be 
conserved in all RNA polymerases (Ishihama & Barbier, 1994). In flaviviruses this motif 
is surrounded by hydrophobic amino acids, this hydrophobic region is also generally 
conserved. Further comparison of the flavivirus NS5 proteins with other RNA polymerases 
identifies other highly conserved regions. Poch et al... have identified four conserved 
amino-acid motifs in RNA polymerases, one of these is the GDD region (Poch et al..
1989). Koonin et al.. (1991) identified eight motifs which included the four motifs 
previously identified by Poch et al.. (1989) . This high degree of conservation reflects an 
essential role of these regions in the function of the NS5 protein. The regions strictly 
conserved are probably involved directly in enzymic activity, those regions conservatively 
maintained could be involved in protein structure.
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Experimental work substantiates the role of the NS5 gene as an RNA polymerase. 
Recently studies have shown anti-sera against NS3 or NS5 will inhibit both RNA synthesis 
in JE virus and the conversion of replicative form to replicative intermediate in-vitro in DEN 
virus.(Bartholomeusz & Wright, 1993; Edward & Takegami, 1993). NS3 contains 
conserved helicase sequence motifs and may also be involved in viral replication. Other 
work on characterising the RNA dependent RNA polymerase activity of KUN and WN 
(Grun & Brinton, 1987; Chu & Westaway, 1992) suggests that NS5 is not essential for all 
RNA dependent RNA polymerase activity. These worker suggest NS5 may be involved 
only in minus strand synthesis or that very small amounts of NS5 could be present in the 
RNA dependent RNA polymerase complex. The function of the NS5 protein as an RNA 
polymerase is therefore still under debate.
A second activity for the NS5 protein has been predicted (Koonin, 1993). A conserved 
sequence motif was identified in the N-terminal of the NS5 protein of a number of 
flaviviruses which corresponds to that of S-adenosylmethionine utilizing 
methyltransferases. No reported work has investigated this possibility.
The determination of the function(s) of the NS5 gene should lead to a greater 
understanding of virus replication and the interaction with the host.
1.22 Current Diagnostics
Diagnosis of a flavivirus infection is initially based on the recent history of the individual 
and the symptoms described. Local knowledge of other cases in the region or of travel 
to an infected region is an important indicator. With tick-borne infection the individual may 
have a history of a tick bite or consuming unpasteurised dairy products. Other non- 
flavivirus infections must also be ruled out. Flavivirus infection could be misdiagnosed as 
a number of other things eg influenza, common cold or other causes of encephalitis such 
as bacterial infections.
Specific diagnosis depends on virus isolation from brain tissue of fatal encephalitis cases 
or from the blood of individuals. In most cases however isolation from blood is either 
impossible or difficult. DEN, YF, WN and TBE viruses can be isolated, with a varying 
degree of success, if blood samples are taken at the correct time, when the viraemia is 
at the highest level.
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Most flavivirus infections will be diagnosed by serological testing either in 
haemagglutination inhibition tests, complement fixation tests or IgM capture ELISA. These 
methods are currently the most reliable, however because of the serological relatedness 
of the flaviviruses there are problems with cross-reactions. Previous flavivirus infection or 
vaccination may also complicate the diagnosis.
1.23 Reverse Transcription/Polymerase Chain Reaction
The polymerase chain reaction (PCR) has become an essential tool for molecular 
biologists. It allows sensitive and specific amplification of a target DNA fragment. PCR has 
many potential applications and recently many new methods have been developed using 
this technique eg. cycle sequencing, cloning and mutagenesis.
Denatured template DNA is incubated with two appropriately designed primers. These 
primers anneal to the DNA template. Extension from the 3’ of the annealed primer is then 
catalysed by a DNA polymerase in the presence of the four deoxynucleotide 
triphosphates. The temperature is then raised to denature the synthesised double 
stranded DNA and the cycle is repeated. In theory after n cycles there should be 2n 
copies of the original template. The first experimenters with PCRs used the Klenow 
fragment of E.coli DNA polymerase 1 which was added to the reaction after each 
denaturation step. The discovery of thermostable DNA polymerases allowed automation 
of the reaction in modern thermocyclers. The most commonly used enzyme is Tag DNA 
polymerase which has optimal enzymic activity at 72°C. However, other polymerases with 
different properties are available eg. Vent DNA polymerase which also has 3’-> 5’ 
proofreading exonuclease activity.
Reverse transcription (RT) is the process by which a DNA copy (cDNA) is made from a 
single stranded RNA molecule. The reaction is catalysed by a reverse transcriptase in the 
presence of the four deoxynucleotide triphosphates and a 3’OH group provided by 
binding of a short oligonucleotide. cDNA can be used as template DNA for PCR.
1.23.1 Applications of RT/PCR to Flavivirus Research
Reverse transcription/polymerase chain reaction (RT/PCR) can be used to study RNA. It 
has advantages over other RNA molecular biology methods because it will sensitively and
23
Chapter 1 Introduction
specifically detect RNA at very low levels and methods have been developed for 
quantitative RT/PCR. This method has been employed in analysis of transcriptional 
activity, expression and intron studies. It has also been used to amplify viral RNA to study 
the viral genome and is used where more traditional methods have failed or are not 
sufficiently sensitive.
The RT/PCR has been shown to be useful for amplification of cDNA derived from some 
common flaviviruses and in particular viruses causing disabilitating disease in humans. 
The range of flaviviruses amplified will vary depending on the specificity reflected by the 
nucleotide sequence of the primers and the stringency of the reaction conditions.
Methods for amplification of a single type of flavivirus have been developed, this usually 
relies on previously elucidated nucleotide sequence data. Many such methods have been 
developed.
The evolution and geographical distribution of YF virus were studied using RT/PCR and 
YF virus specific primers. A pre-determined region of the YF virus E gene was amplified 
using either one of two downstream primers and a single upstream primer. The resulting 
products were nucleotide sequenced. The analysis showed variation between isolates 
confirming the existence of four groups of geographical variants of YF virus and new sub 
divisions within these groups. This type of RT/PCR followed by direct nucleotide 
sequencing could be employed to study the spread of different strains of YF virus and in 
conjunction with vaccination may aid in prevention of the disease (Lepiniec et al.. 1994).
PCR was used to develop a rapid identification technique for WN virus. Two primers were 
designed from the NS3 gene and the down stream primer used to produce the initial 
single stranded cDNA, both primers were used in the subsequent PCR. Different isolates 
from both antigenic groups of WN virus were detected by this method, nucleotide 
sequence analysis elucidated some sequence variation between the isolates. Other 
isolates of related viruses were subjected to the same test and KUN virus isolates 
constantly produced DNA fragments of the predicted size. This is not unexpected as KUN 
and WN viruses are known to be highly related by amino acid and nucleotide sequences. 
This method may have uses in clinical diagnostics, characterisation of different strains of 
WN virus and studying WN virus epidemiology (Porter et al.. 1993).
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The four serotypes of DEN virus have been extensively studied using RT/PCR. Much of 
this work has been the study of why viruses from the DEN serocomplex cause 
haemorrhagic fever, by attempting to identify differences in the nucleotide sequences 
between flaviviruses that could be responsible for the increased degree of virulence, or 
surveying incidence of infection with different serotypes that could be responsible for 
immune enhancement. Two different approaches have been followed. Either development 
of RT/PCR with primers designed to amplify viruses from only a single DEN serocomplex 
or methods where the primers were designed so they would amplify any virus from the 
DEN serocomplex. Vorndam et al.. developed a method of differentiating strains of DEN-2 
and DEN-3 by restriction mapping of amplified DNA (Vorndam et al.. 1994). The primers 
used in this study had previously been developed by Lewis et al. (1992). These primers 
were designed to be identical to the published nucleotide sequence of DEN-2 Jamaica 
strain but had high identity with the published nucleotide sequence of the other DEN 
serotypes. Thus an RT/PCR product was produced when a variety of DEN virus RNAs 
were used as templates. The RT/PCR conditions were unusual in this method with a high 
temperature (56°C) of RT, high annealing temp (65°C) and a long extension time at 72°C 
(10 minutes). This was presumably to combat vRNA secondary structure formation and 
to obtain the large amplified products. In an attempt to study DEN virus target cells in-vivo 
an in-situ RTPCR was developed, DEN virus nucleic acid was identified in glial cells and 
macrophages in infected brain tissue (Lucia & Kangwanpong, 1994). The primers used 
in this case were described by Henchal et al. (1991).
LGT virus was used as a model to develop a system that would amplify cDNA from LGT 
and other viruses from the TBE serocomplex. A set of PCR primers was designed to be 
100% homologous to the published nucleotide sequence of LGT virus. These primers 
used in a PCR with random hexanucleotide primed cDNA. The authors suggest that these 
primers would also amplify cDNA from a number of related and highly virulent viruses 
including CEE, RSSE and POW viruses. Theoretical analysis shows that only viruses from 
the TBE serocomplex would be amplified in this system and thus this method could be 
used for the detection of these viruses (Campbell et al.. 1993).
The nucleotide sequence of the flavivirus genome contains regions conserved in either 
tick-borne or mosquito-borne viruses indicating a role of the encoded protein or viral 
genome in interaction with the arthropod vector. These sequences proved useful in design
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primers for use in RT/PCR to study the two groups of viruses. Pierre et al.. designed a 
primer from the 20 bases conserved in the 3’ end of the mosquito-borne flaviviruses, YF, 
DEN, JE and WN. The upstream primer was designed from the nucleotide sequence of 
the WMTTEDM motif conserved in the NS5 protein of all Flaviviruses (Pierre et al.. 1994). 
Other workers used the nucleotide sequence of NS3 genes from various mosquito-borne 
Flaviviruses to design a set of primers which amplified DEN-1,2,3 and 4, JE, KUN and YF 
viral cDNA. The cDNA was produced by RT primed by the downstream primer, random 
hexanucleotides or an oligo(dT) primer. JE and KUN viral RNA could not be reverse 
transcribed using the oligo(dT) primer suggesting they do not have polyadenylated 
stretches in their genomes (Chow et al.. 1993). Another group developed an RT/PCR to 
amplify a fragment of the envelope gene. Amplified products were obtained for DEN-2, 
WN, SLE and KUN virus RNAs however, some other mosquito-borne flaviviruses were not 
amplified. The authors suggest that the failure to amplify DEN viruses 1,3, JE and YF viral 
RNA is probably related to primer mis-match with the target particularly at the 3’ end (Puri 
et al.. 1994).
There are few regions of the genome conserved in all flaviviruses sequenced to date. 
Trent and Chang (1992) amplified a fragment of the NS5 gene from a range of flaviviruses 
including examples of mosquito-borne, tick-borne and non-arthropod transmitted . Apoi, 
a non-arthropod transmitted flavivirus did not produce cDNA by this amplification method.
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1.24 Project Aims
Recent advances in the molecular biology of flaviviruses have been due to the 
determination of nucleotide sequence data. However, many mechanisms of flavivirus life­
cycle, including protein function, are poorly elucidated. The NS5 and E gene products are 
essential for virus activity. The NS5 protein may be involved in virus replication, whereas 
the E protein has a role in virus fusion. Analysis of the nucleotide sequence of either of 
these genes could allow a logical method of virus classification.
The aims of this study were:
1. To produce flavivirus infected-cell RNA extracts which could be used as a 
template for amplification by RT/PCR.
2. Then compare the utility of pan-fiavivirus RT/PCR methods developed from NS5 
and E gene sequence.
Following the successful amplification of NS5 gene fragments this gene was investigated 
further.
3. Nucleotide sequence the NS5 gene pan-fiavivirus RT/PCR fragment from a tick- 
borne, mosquito-borne and non-arthropod-borne flavivirus (CEE, BAN and MOD 
viruses) to confirm the identity of the amplified product.
4. Amplify and nucleotide sequence RT/PCR fragments of the entire NS5 gene of 
BAN and MOD viruses.
5. Compare the encoded amino-acid sequences of BAN and MOD virus NS5 genes 
with those determined from other flaviviruses to identify regions important in protein 
function.
6. Analyse the NS5 gene nucleotide sequence including that determined for BAN, 
MOD and CEE viruses for suitability in phylogenetic studies which may be used for 
virus classification.
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2 MATERIALS AND METHODS
2.1 Materials
2.1.1 General Materials
Inorganic chemicals, solvents and agarose were obtained from Sigma Chemical Company 
(Poole, Dorset), BDH Ltd. (Poole, Dorset) or Boehringer Mannheim (Lewes, East Sussex) 
unless otherwise stated.
DNA modifying enzymes were mainly purchased from Boehringer Mannheim (Lewes, East 
Sussex).
Tryptone, yeast extract and "Bacto" agar were obtained from Difco Laboratories (West 
Molesey, Surrey). L-15 medium Leibovitz and Glasgow minimum essential medium was 
obtained from Sigma Chemical Company (Poole, Dorset).
2.1.2 Viruses
Virus strains used in this study were obtained from the NERC, Institute of Virology and 
Environmental Microbiology, Oxford, UK, Centre for Applied Microbiology Research 
(CAMR), Salisbury, UK or the University of Surrey, Guildford, UK. The viruses and types 
are listed in table 2.1.
2.1.3 Plasmids
Plasmid pUC18 Sma1 BAP was obtained from Pharmacia LKB Biotechnology Ltd. (Milton 
Keynes, Bucks). Plasmid pT7Blue(R) was purchased from AMS Biotechnology (Witney, 
Oxon).
2.1.4 Competent Cells
E.coli Sure™ Competent Cells were purchased from Stratagene Ltd. (Cambridge). E.coli 
NovaBlue competent cells were supplied by AMS Biotechnology (Witney, Oxon). The 
genotypes are listed in table 2 .2.
28
Chapter 2 Materials and Methods
Table 2.1 : Flaviviruses used in this study
Virus Strain Source
Turkish Tick-borne encephalitis not known CAMR
CEE Kumlinge A59 CAMR
Powassan L.B. CAMR
Rio Bravo 3360 IVEM
Japanese encephalitis Nakay IVEM
Murray valley encephalitis MVE/1/1951 IVEM
West Nile Sarawah SURREY
Kunjin 3282 IVEM
St. Louis Encephalitis TBH28 IVEM
n ii n H109 IVEM
ii ii ii MS1-7 IVEM
Meaban Brest/Ar/T707 IVEM
Israel Turkey menigoencephalitis TC 866 IVEM
Bagaza DAK/Ar/B209 IVEM
Banzi SAH 336 IVEM
Dengue-2 TC992 SURREY
Dengue-2 New Guinea, C SURREY
Modoc 3321 IVEM
Wesselsbron Van Tonder IVEM
Yellow fever P16065 SURREY
Yellow fever 17D 204 CAMR
Ileus B52456 IVEM
IVEM = Institute of Virology and Environmental Microbiology 
CAMR = Centre for Applied Microbiological Research 
SURREY = The University of Surrey.
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Table 2.2 : Genotype of E.coli Competent Cells
Cells Genotype Phenotype Comments
E.coli SURE e14(mcrA)A(mcrCB-hsdSMR-mrr)171, 
supE44,thi-1 ,gyrA96, endA1,relA1, lac, recB, 
recJ, sbcC, umuC:: Tn5(kanr), uvrC, [F , 
proAB, laclqZAM15, Tn10,(tet')]
Contain mutations in the pathways 
for secondary and tertiary 
structure formation, specifically 
cruciforms and Z-DNA.
E.coli NovaBlue endA1, hsdR17(rk-, mk+)supE44, thi-1, gryA96, 
re lA I, lac[F, proAB, laclqZAM15, 
TnlOftet^recAl
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2.2 General Methods
2.2.1 Phenol/Chloroform Extraction
Proteins were removed from RNA and dye terminator removed from sequencing reactions 
using phenol/chloroform extraction. Distilled phenol was saturated with TE (10mM Tris.CI, 
1mM EDTA, pH8.0). Chloroform was mixed with isoamyl alcohol in a ratio of 24:1. To j
! make phenol/chloroform equal volumes of each were mixed. Equal volumes of j
I
| phenol/chloroform and nucleic acid were vortexed briefly and centrifuged to separate the 
phases. The upper aqueous phase was retained as it contained the purified nucleic acid, j
2.2.2 Chloroform Extraction
Chloroform/isoamyl alcohol was used in a ratio of 24:1 to remove proteins from nucleic 
acids. The proteins are denatured by the chloroform. Isoamyl alcohol reduces foaming 
thus aiding separation of the phases. Equal volumes of chloroform/isoamyl alcohol and 
sample were vortexed briefly and then centrifuged to separate the phases. The upper 
aqueous phase contained the purified nucleic acid.
2.2.3 Preparation of solutions
All solutions were prepared using distilled or analar grade water (BDH). Where 
appropriate they were sterilised by autoclaving or filtration through a 0.22um filter.
2.2.4 Preparation of Culture Media
LB medium (L-broth or L-agar) was used for the growth of E.coli. One litre contained 10g 
tryptone, 5g yeast extract and 10g NaCI. L-agar also contained 15g "Bacto" agar which 
was added before autoclaving.
2.3 Viroloqical Methods
2.3.1 Propagation of virus
Cell line storage, preservation and resuscitation was performed by Mrs J. Drake (CBDE).
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Viruses were propagated by infection of either Vero cells or C636 cell monolayers at a 
multiplicity of infection of approx. 0.1 plaque forming units (pfu)/cell. Virus was allowed 
to absorb to the cell sheet for 30 mins at room temperature. Maintenance medium was 
then added and cultures were incubated at 37°C.
2.3.2 Extraction of vRNA
When an obvious cytopathic effect was seen, the cell monolayers were washed twice in 
cold phosphate buffered saline (0.1 M phosphate, 0.9% NaCI pH 7.2; PBS), resuspended 
in cold PBS and subjected to one further wash before resuspension in 900ul disruption 
buffer (0.15M NaCI, 0.1 M tris pH 7.5, 1.0M EDTA). Placental RNAse inhibitor (25U/ml, 
Sigma Chemical Company Ltd., UK) was added, and after swelling for 10 min at 37°C, the 
pellet was disrupted by the addition of NP40 to a final concentration of 1%, and vortexing. 
After removal of the nuclei by centrifugation, total RNA was extracted from the supernatant 
by the phenol/chloroform method, and precipitated with ethanol at -20°C. During the first 
phenol/chloroform extraction the samples were heated to 60°C for 15 min. Dr. R. 
Phillpotts propogated viruses and extracted RNA from infected cells to produce many of 
the RNA stocks.
2.4 Nucleic acid Methods
2.4.1 Design of Primers
Specific primers 18 to 32 nucleotides in length were designed by visual examination of 
available nucleotide sequence. Where possible primers were designed to have a G/C 
content of between 40% to 60%.
The details of the design of degenerate primers is discussed in the relevant chapters. In 
brief the first step was production of a computer generated alignment of available target 
nucleotide sequence followed by visual analysis. In complex cases analysis was 
performed by a software program written by Mr. K. Martin. This program examined each 
position in the alignment and assigned a score based on sequence homology, higher 
scores for high homology. Regions of 30 nucleotides with the highest scores were then 
visually examined for suitability for primer design. Later further selection criteria were 
included in the program such primers matching all the sequences at the 3’terminal
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nucleotide.
2.4.2 RT
Each viral RNA (vRNA) sample was mixed with 500ng of anti-sense primer and denatured 
by boiling for 5 min. Followed by cooling on wet ice for 5 min. The RT reactions were 
performed in 9/jI vols containing the vRNA/primer mix and 5mM Tris-HCI pH 8.3, 5mM 
KCI, 10mM MgCI2, 3mM dithiothreitol, 0.1% Nonidet P40, 0.7U//il RNAsin (Boehringer 
Mannheim UK), 1 mM each of the four deoxynucleotide triphosphates and 0.75U//il reverse 
transcriptase RAV2 (Amersham International, Buckinghamshire, England). The reactions 
were incubated at 42°C for 2 h or 56°C for 1 h (Lewis et al.. 1992).
2.4.3 PCR
Half the RT reaction mix was used as template in the subsequent PCR. 500/7g of each 
primer (sense and anti-sense) was added to the template. This mixture was boiled for 5 
min cooled on wet ice then heated to 94°C in a thermocycler (Perkin-Elmer Cetus) before 
the addition of 5/il x10 Taq buffer (Boehringer Mannheim, UK) and 0.6U Taq Polymerase 
(Boehringer Mannheim, UK). The final volume of the reaction mix was adjusted to 50 jul 
with HPLC pure H20 (Aldrich Chemicals Ltd).
The reaction mixes were incubated at 94°C for 4 min, 40°C for 2 min, 72°C for 3 min, 
followed by five cycles of 95°C for 1 min, 40°C for 2 min, 72°C for 3 min. Then thirty 
cycles of 95°C for 1 min, 45°C for 3 min, 72°C for 3 min preceded by a final cycle of 95°C 
for 1.5 min, 45°C for 2 min, 72°C for 10 min.
For some reactions the mixes were cycled at 94°C for 4 min, then twenty five cycles of 
94°C for 1 min, 65°C for 1 min, 72°C for 10 min and a final incubation of 72°C for 20 min 
(Lewis et al.. 1992).
2.4.4 Agarose Gel Electrophoresis
Electrophoresis was carried out in horizontal gel tanks (Bio-Rad) containing TAE (40mM 
Tris-acetate, 1mM EDTA) buffer and 0.5ug/ml ethidium bromide. Gels containing 1% to 
2% Agarose, were routinely used. The gels were also buffered with TAE and contained
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0.5ug/ml ethidium bromide. Nucleic acids were visualised after agarose gel 
electrophoresis and ethidium bromide staining by short wave UV illumination. They were 
photographed through a red filter with Polaroid 665 film (Sambrook et al.. 1989).
2.4.5 Purification of DNA from Agarose gels
j After agarose gel electrophoresis DNA bands were excised using a geneclean 
| kit (Biol01), (Strategene) according to the manufacturers instructions. Briefly 1.2ml ; 
of 6M Nal solution was added to each 0.4g of agarose excised from the gel. This was 
incubated at between 45°C and 55°C until the gel was dissolved. Following the addition 
of 5ul of glass milk (silica matrix in water) and brief vortexing the mix was incubated for 
a further 5 mins. The suspension was microfuged at 13,000 rpm for 1 min and the pellet 
washed twice with new wash buffer (50% ethanol, NaCI, Tris, EDTA solution). The nucleic 
acid was eluted in 10 to 50 ul water for use in subsequent reactions by incubation at 45°C 
to 55°C for 2 mins.
2.4.6 Blunt-Ending of PCR Fragments
Taq DNA polymerase adds a single non-template nucleotide (usually dA) to the 3’ end of 
PCR fragments thus the ends must be repaired if the fragment is to be cloned by blunt- 
end ligation. Klenow has 3’ to 5’ exonuclease activity and degrades from free 3’hydroxyl 
termini the exonuclease activity is blocked on double stranded DNA due to the 5’ to 3’ 
polymerase activity of the enzyme. Thus a blunt end is produced.
The cDNA produced by a single RT/PCR was incubated at room temperature for 45 mins 
in a final volume of 20ul containing 2mM dNTPs, 5 units klenow (Boehringer Mannhiem), 
50mM Tris-HCI pH 7.5, 10mM MgCI2, 0.1 mM DTT.
2.4.7 Kinasing 5’ Termini of PCR Fragments
Klenow treated PCR fragments lack phosphate residues at their 5’ termini. These 
phosphate residues are required for ligation of DNA fragments by T4 DNA ligase. T4 
polynucleotide kinase catalyses the addition of a phosphate residue to 5’OH termini of 
single or double stranded DNA or RNA from the y phosphate of ATP. This is known as 
the forward reaction. DNAs lacking 5’phosphate residues can therefore be prepared by
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T4 polynucleotide kinase.
The klenow treated cDNA was incubated for 70 mins at 37°C with 20 units of T4
|polynucleotide kinase, 3mM ATP, 7mM DTT, 50mM Tris-HCI (pH 7.6), 10mM MgCI2 in a 
jfinal volume of 50ul. The reaction was stopped by addition of EDTA to a final
I i
I concentration of 20mM. I
2.4.8 DNA Ligation
Two vectors were used for cloning of cDNA fragments.
2.4.8.1 Ligation into pUC18 Sma1 BAP
The first was pUC18 bought restricted with Sma1 and dephosphorylated with bacterial 
alkaline phosphatase (Boehringer Mannheim). Sma 1 produces a blunt ended restriction 
site ideal for ligation of other blunt ends. In order to prevent religation of the vector blunt- 
ends the restricted vector was dephosphorylated. Klenow, T4 polynucleotide kinase, 
treated cDNA from a single RT-PCR was incubated with 400ng pUC18 Sma1, BAP, 1 unit 
of T4 DNA ligase, 66mM Tris-HCI, 5mM MgCI, 1mM DTT, 1mM ATP pH 7.5. The 
incubation at 22°C was carried out overnight.
2.4.8.2 Ligation in pT7Blue-T-Vector
The second vector pT7Blue (Novagen) was prepared by the manufacturers by EcoRV 
digestion followed by the addition of a single 3’dT residue. This vector was supplied in 
a kit.
Purified cDNA from a single RT-PCR was incubated with 50ng pT7Blue-T-vector, 2 units 
T4 DNA ligase 5mM DTT, 0.5mM ATP, 20mM Tris-HCI pH7.6 and 5mM MgCI in a final 
volume of 10ul at 16°C overnight.
2.4.9 Transformation
Methods for transformation are mainly based on Mandel and Higa (Mandel & Higa, 1970). 
They showed bacteria treated with CaCI became "leaky" and could be transformed with
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a bacteriophage. Subsequently other workers developed methods for transformation of 
bacteria with plasmids (Cohen et al.. 1972). Further methods were developed by 
empirical methods, including treating bacteria with hexamminecobalt chloride (Hanahan, 
1983). In this study frozen compotent cells were purchased. These were E.coli Sure 
cells (Strategene) for transformation with pUC18 based recombinants and NovaBlue cells 
(Novagen) for transformation with pT7Blue-T-Vector recombinants.
The ligation mix was transformed into either E.coli Sure cells (Strategene) or NovaBlue 
cells according to the manufacturers instructions. E.coli Sure cells were thawed on ice 
and then aliquoted into appropriate quantities in polyproplene tubes, j3-mercaptoethanol 
was added to a final concentration of 25mM. The cells were incubated on ice for 10 mins. 
One tenth to one fifth of the ligation mix was then mixed gently with the cells and the 
incubation continued for a further 30 mins. This mix was subjected to heat shock at 42°C 
for 45 secs and then incubated on ice for 2 mins. 0.9 ml SOC medium was added and 
the culture incubated at 37°C for 1 hr with shaking at 225 -250 rpm. Finally the culture 
was plated onto L-agar containing 55ug/ml ampicillin, 76ug/ml isopropyl-/3-D- 
thiogalactopyranoside (IPTG) and 320mg/ml 5-Bromo-4-chloro-3-indolyl-j3-D- 
galactopyranoside (X-GAL). The method for transformation of NovaBlue cell was 
essentially the same except the /3-mercaptoethanol stage was omitted, the heat-shock 
incubation time was reduced to 40 secs and cells were grown in only 80ul SOC. After 
incubation of the plates for 18 hr at 37°C colonies containing recombinant plasmids were 
identified by PCR of the insert.
2.4.10 Plasmid Minipreps
Plasmid DNA was extracted from bacterial cells using a modification of the alkaline lysis 
method developed by Birboim and Doly (1979). Cells were pelleted from an 8ml 
overnight culture by centrifugation at 3000 rpm for 10 mins. Pelleted cells were 
resuspended in 200ul lysis solution (25mM Tris-HCI pH8.0, 10mM EDTA, 50mM glucose 
and 5mg/ml lysozyme). This solution was then incubated on ice for 15mins followed by 
addition of 200ul alkali/SDS solution (0.2M NaOH, 1% SDS) and gentle mixing. Finally 
300ul of high salt solution (2.5M Pottassium acetate, 2.5M sodium acetate) was added. 
After a further incubation on ice and vortexing the mix was microfuged at 13,000rpm for 
5 mins. The supernate was retained.
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A number of precipitation stages were then performed. Firstly with the addition of 500ul 
isoprpanol and incubation on ice for 15mins. Following microfugation at 13,000rpm for 
5 mins the pellet was resuspended in 200ul TE (10mM Tris.CI, 1mM EDTA) buffer. 100ul 
of 7.5M ammonium acetate was then added and the mix incubated on ice for 20mins. 
The precipitated proteins were pelleted in a microfuge and the supernate subjected to 
ethanol precipitation followed by two 70% ethanol washes. The final purified plasmid DNA 
was resuspended in 200ul of water.
2.5 Preparation of DNA templates for sequencing
2.5.1 Using Biotinvlated Primers
Single stranded DNA was produced using Dynabeads™ (Dynal A.S., Oslo, Norway) using 
a method described by the manufacturer. PCRs were carried out as previously described 
except that one of the primers was biotinylated at the 5’end during the oligonucleotide 
synthesis procedure. Dynabeads M-280 are uniform, magnetic, polystyrene beads with 
streptavidin covalently attached. Biotin and biotinylated molecules will bind to 
streptavidin. The dynabeads M-280 can be separated and concentrated using a Magnetic 
Particle Concentrator (MPC)
Once aliquoited into 20ul volumes the dynabeads were washed twice with x2 BW buffer 
(10mM Tris-HCI, 1 mM EDTA, 2M NaCI). The washed beads were incubated with the PCR 
at room temperature to allow binding of the biotinylated DNA molecules. This was 
followed by a further two washes in x1 BW buffer. The DNA/bead mix was finally 
resuspended in 100ul 0.15M NaOH, to separate the DNA duplex. The non-biotinylated 
DNA strand was then removed by two NaOH washes followed by a x1 BW buffer wash. 
Finally the biotinylated single stranded DNA was eluted in TE. Double stranded DNA was 
also purified using this method as it can be eluted after the initial washes in x1 BW buffer.
2.5.2 Microcon Purification
Microcon-100 concentrators are disposable ultra-filtration devices containing filters with 
a cut of 100,000 daltons or 125 base pairs (bp) of DNA. Dideoxy nucleotide 
triphosphates, primers and salts are filter through the membrane thus double stranded 
DNA from PCR can be purified.
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The microcon-100 device was placed in an eppendorff and washed with 500ul of water 
by centrifugation at 3000rpm in a microcentifuge. The wash solution was discarded. A 
sample containing DNA from a single PCR in a final volume of 500ul was pipetted in to 
the microcon-100 device and the centrifuged for 10 mins at 4000rpm. This was followed 
by a further wash step before the purified DNA sample was collected by inverting the 
microcon-100 device in a fresh eppendorff and centrifugation at lOOOrpm for 3mins.
2.5.3 Preparation of Plasmid Template
Plasmid DNA of sequencing quality was purified using a Qiagen kit according to the 
manufacturers instructions. The first steps are similar to the miniprep method described 
earlier. Harvested cells were resuspended in 50mM Tris/HCI, 10mM EDTA 100ug/ml 
RNase A and lysed by the addition of 100mM NaOH, 0.5% SDS. Cellular proteins, 
chromosomal DNA and the SDS were then precipitated by the addition of pottasium 
acetate to a final concentration of 1M. The crude plasmid extract was then further purified 
using a Qiagen column which contains an anion-exchange resin. The column containing 
resin was first washed with an equilibration buffer (750mM NaCI, 50mM MOPS, 15% 
ethanol, 0.15% Triton X-100). Next plasmid DNA bound to the resin as the sample flowed 
through the column. The resin was washed with 1 mM NaCI, 50mM Tris/HCI, 15% ethanol 
and then purified plasmid eluted in 1.25M NaCI, 50mM Tris/HCI, 15% ethanol. The eluted 
plasmid solution was then desalted by isopropanol precipitation at room temperature and 
washed with ice-cold 70% ethanol. Finally plasmid DNA was dried at room temperature 
and resuspended in water.
2.6 Nucleotide Sequencing Methods
2.6.1 Nucleotide Sequencing Reactions
Templates were nucleotide sequenced using fluorescence-based dideoxy nucleotides and 
cycle sequencing according to the manufacturers instructions using a taq dyedeoxy™ 
terminator cycle sequencing kit (Applied Biosystems) and a thermocycler (Perkin-Elmer 
Cetus), or a PRISM™ Ready Reaction DyeDeoxy™ Terminator Cycle Sequencing Kit and 
a CATALYST™ 800 Molecular Biology Work Station. In both systems the sequencing 
primer annealed to the single stranded template DNA at 50°C. The 3’ end of the primer 
was extended by addition of the appropriate dNTP using taq DNA polymerase. Thus
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copies of the template were obtained. The reaction mix also contained ddNTP’s when the 
appropriate ddNTP was incorporated it resulted in termination of the extending chain. 
This was carried out at 60°C. The two strands of template/terminated copy were then 
denatured at 96°C to allow further copies to be made. The DNA molecules were then 
separated by acrylamide gel electrophoresis according to length of the molecule. As 
each ddNTP was fluorescently labelled with different markers it was possible to read the 
sequence after electrophoresis through an acrylamide gel.
2.6.1.1 Taq Dyedeoxy™ Terminator Cycle Sequencing Kit
Reaction pre-mix was prepared containing 80ul 5X TACS buffer (400mM Tris-HCI, 10mM 
MgCI2, 100mM (NH4)2S04, pH 9.0), 4ul dNTP mix (750uM dITP, 150uM dATP, 150uM 
dTTP, 150uM dCTP), 4ul of each Dye Deoxy™ Terminator (A,T,C,G), 2ul AmpliTaq DNA 
polymerase (8 units/ul). Sequencing reactions contained 9.5ul of premix, 3.2pmol primer 
and 50 to 200ng of purified template. The final volume was 20ul. The reaction mixes 
were then subjected to twenty five thermocycles as follows, 96°C for 30 secs, 50°C for 15 
secs, 60°C for 4mins. The ramp rate for heating and cooling between temperatures was 
set at 1°C/sec. Dye terminators were removed by a phenol/chloroform reaction.
2.6.1.2 PRISM™ Ready Reaction DveDeoxv™ Terminator Cycle Sequencing Kit
These kits contain ready mixed pre-mix (1.58uM A-Dye Deoxy, 94.74uM T-Dye deoxy, 
0.42uM G-DyeDeoxy, 47.37uM C-DyeDeoxy, 78.95uM dITP, 15.79uM dATP, 15.79uM 
dCTP, 15.79uM dTTP,168.42mM Tris-HCI pH 9.0, 4.21mM (NH4)2S04, 42.10mM MgCI2, 
0.42 units/ul AmpliTaq DNA polymerase. 75ng to 120ng of primer was mixed with 500 
to 1000ng of template and made up to 16ul with 9% DMSO. The reaction mixes were 
then processed in a CATALYST™ 800 Molecular Biology Work Station. The work station 
contains a robotic arm that performs pipetting, two thermocyclers and two refrigerated 
storage areas. During the processing 9.5ul of premix is added to each sample and the 
samples are subjected to thermocycling as for 2.6.1.1.
2.6.2 Removal of Dye Terminators
Dye terminators were removed by two phenol/chloroform extractions. 10Oul of water was
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added to the sequencing reactions and the samples extracted twice with 
phenol/chloroform. The aqueous phase was then precipitated by the addition of 300ul 
of ice cold ethanol and 15ul 2M sodium acetate. Following 15 mins precipitation at -20°C 
the samples were centrifuged at 14,000rpm for 30mins. The ethanol was removed and 
the pellets dried at 80°C and stored at -20°C.
2.6.3 Electrophoresis
Electrophoresis and subsequent DNA analysis was performed using a 373A DNA 
Sequencing System (Applied Biosystems). This system consisted of an electrophoresis 
system containing a laser scanner linked to a Macintosh 2ci with software to collect raw 
data produced by scanning during sample electrophoresis, process and analyse the raw 
data and a program to manipulate DNA sequences.
Sequencing reaction pellets were denatured by addition of 4ul sample buffer (83.3% 
formamide, 8.3mM EDTA pH 8.0) and heating to 90°C for 2 mins. Reactions were then 
stored on ice before electrophoresis. Gel mix was prepared containing 6% acrylamide, 
8.3M Urea, 89mM Tris-borate, 89mM boric acid and 2mM EDTA. 300ul 10 ammonium 
persulphate and 33ul TEMED was mixed with 60ml of gel mix, it was poured between 
two horizontal clean glass plates separated by spacers. A well former was inserted at the 
top and the gel was allowed to polymerise for at least 2 hrs. The gel and plates were 
checked for imperfections by the laser reader. TBE buffer (89mM Tris-borate, 89mM boric 
acid 2mM EDTA) was placed in the upper and lower buffer chambers. The denatured 
samples were loaded into the wells. Samples were electrophoresed at 30watts (approx 
20mA, 1420V). Data collected from the gel were stored by the system according to the 
details entered into the sample sheet.
2.6.4 Data Analysis
Raw data produced required analysis mainly to correct for the different electrophoretic 
abilities of the fluorescent labels or occasionally to correct computer mis-interpretation of 
the data. The main mis-interpretations arose where the data collected were from the 
wrong lane or where the signal was weak. This could be readily corrected by re-tracking 
the lane and reanalysis of the newly tracked data.
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Re-analysis of the raw data could also be used to remove interfering signals and to 
specify the point where the nucleotide sequence began and ended. Removal of 
unwanted data or signal often improved the nucleotide sequence data signal.
2.7 Sequence Analysis
2.7.1 Nucleotide and Predicted Amino Acid Sequence Analysis
Sequence analysis was performed using either an Apple Macintosh (2ci, Quadra 950 or 
Power). Nucleotide sequences were connected using the multiple sequence editor 
software, SeqEd™ 675. All other analysis was performed using Lasergene Navigator 
software. This software contains the following applications. EditSeq for editing DNA or 
amino-acid sequences. MapDraw was used for restriction and translation analysis. 
Protean was used for detailed protein analysis and prediction of protein characteristics 
from primary sequence data. The methods used in this thesis were Gamier and Robson 
structural feature prediction (Gamier et al.. 1978), Kyteand Doolittle (1982) hydropathicity 
predictions and Emini surface probability predictions (Emini et al.. 1985). MegaAlign 
allows comparison of DNA or amino acid sequences, sequences in this project were 
aligned by the Clustal method (Higgins & Sharp, 1988). It also allows comparison of pairs 
of DNA or amino acid sequences based either on Wilbur and Lipman algorithm (Wilbur 
& Lipman, 1983) or a method combining Martinez (Martinez, 1983) and Needleman and 
Wunsch algorithms (Needleman &Wunch, 1970). Geneman is a sequence database tool. 
The databases used were GenBank, EMBL and NBRF-PIR.
2.7.2 Phylogenetic Analysis Using Parsimony (PAUP)
This analysis was carried out using an Apple Macintosh Power by the software program 
named PAUP. This software can be used at two levels either using the Macintosh interface 
with little user programming required or by inputting all data via user generated programs. 
In both cases the results obtained will be the same. The analysis in this study was carried 
out by "Bootstrap" analysis using 100 replicates and avheuristic algorithm. There are many 
parameters that can be altered, the following is a list of the parameters used in this study; 
minimal trees were kept, zero-length branches were collapsed, no topological constraints 
imposed, starting trees were established by simple, step-wise addition, the branch 
swapping algorithm was tree-bisection-reconnection (TBR). Rooting of trees was via an
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outgroup, the ingroup was monophyletic while the outgroup could be either paraphyletc 
or monophyletic to the ingroup.
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3 FLAVIVIRUS RT/PCR AND E GENE PRIMERS
3.1 Introduction
RT/PCR has assisted greatly in the study of Flavivirus genomes. The ability to readily 
study nucleotide and predicted amino acid sequence homology between related viruses 
has been important in determining the function of virus proteins, identifying virulence 
determinants and studying the classification of flaviviruses.
Nucleotide sequence derived from one virus has been used to design primers to amplify 
and nucleotide sequence regions of the genome of related viruses. This new nucleotide 
sequence data can then, in turn, be used to develop other primers. An example of this 
is the study of nucleotide sequence of the E and other structural proteins from viruses 
belonging to TBE serocomplex. The RNA encoding the E gene of Omsk haemorrhagic 
fever was amplified using primers homologous to previously determined sequence of 
regions of RSSE, LI, and CEE virus genomes (Gritsun et al.. 1993b).
The nucleotide sequence of the E gene of many flaviviruses has been determined. The 
gene is approximately 1500 nucleotides in length. Analysis of the predicted amino-acid 
sequences of the encoded protein shows a high degree of conservation of at least 41% 
between flaviviruses that have been sequenced (Heinz et al.. 1990). The most highly 
conserved region includes the sequence Gly-Leu-Phe-Gly which is the proposed to be 
involved with acid pH-induced virus fusion (Mandl et al.. 1989a). Other regions of the 
protein are conserved between groups of viruses probably due to a functional role for 
these regions of the protein.
The E protein is the major component of the surface of the virion and is also the major 
viral antigen. Flaviviruses are classified on the basis of serology (Calisher et al.. 1989). In 
1990 a phylogenetic comparison of the amino acid sequence of flavivirus E genes 
resulted in the viruses being grouped in a similar manner to classification based on 
serology (Heinz et al.. 1990). Also several groups of workers later confirmed the 
classification of flaviviruses not considered by Heinz et al.. within the TBE serocomplex 
by comparison of encoded amino acid sequence of the E gene (Whitby et al.. 1993b; 
Venugopal et al.. 1994a; Gao et al.. 1993b; Gao et al.. 1993a; Gritsun et al.. 1993b; 
Gritsun et al.. 1993a; Venugopal et al.. 1992; Shiu et al.. 1991). The most recent 
phylogenetic study included all the previously determined E gene nucleotide sequences
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plus TYU (Tyuleni) and SRE (Saumaras Reef) (Marin et al.. 1995). The phylogenetic study 
of the E gene sequence of these viruses was consistent with classification of the 
flaviviruses based on serology. Future classification of flaviviruses based on E gene 
sequence is likely to reflect the results of previous serological studies.
The aim of the research discussed in this chapter was to design pan-flavivirus RT/PCR 
primers from regions of the E gene encoding conserved amino acids. Initially these 
primers would be studied in a flavivirus PCR using cDNA clones as template. The next 
stage was to produce flavivirus RNA suitable for use as template in RT/PCR. Lastly the 
pan-flavivirus primers were to be used in RT/PCRs with the extracted flavivirus RNAs. This 
would allow further study of similarities between flavivirus E genes.
3.2 Phylogenetic analysis of the nucleotide sequence of flavivirus E genes
The E gene nucleotide sequences for each flavivirus reported to date were compared and 
analysed by PAUP software. A dendrogram of phylogenetic relationships was obtained 
(Figure 3.1).
3.3 Designing primers for RT/PCR
There are a number of criteria which should be applied in designing primers for use in 
RT/PCR but the greatest constraint will always be the availability of sequence data from 
which primers can be designed. Oligonucleotides designed for use as RT/PCR primers 
should be 18-30 nucleotides in length; shorter primers will tend to cross-react with non­
target sequences. In practice primers longer than 50 bases are difficult to synthesise.
The nucleotide sequence of RT/PCR primers will alter the way that the primer bonds with 
other nucleic acids. Firstly the G+C content will change the number of bonds between 
primer and target nucleotide. Ideally the C+G content should be between 40% to 60% so 
that if the primer temporarily anneals to non-target sequences this bonding is not strong. 
Secondly no primer should be able to form secondary structures within itself and also 
primers to be used together should not be able to readily anneal to each, thus stretches 
of complementary sequences should be avoided. Polynucleotide stretches are common 
in most nucleic acid molecules thus the occurrence polynucleotide lengths of more than 
four bases in primers should also be avoided as they make primers unpredictable.
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Figure 3.1 : Dendrogram of flavivirus E gene nucleotide sequence.
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The E gene nucleotide sequences were obtained from the EMBL database, from data
corresponding to the following accession numbers: DEN-1, D00501; DEN-2, M20558;
DEN-3, M25277; DEN-4, M14931, M17255; JE, U14163; MVE, X03467, M24220; KUN,
D00246; WN, M12294, M10103; SLE, M16614; YF, K02749; KFD, X74111; LI, M94957;
NEG, M94956; CEE, M27157, M21498; OHF, X66694,S54785; POW, L06436; RSSE
sequence is not in the database (Pletnev et al.,1990). Bootstrap percentage values are 
shown above the branches and branch lengths are shown below the branches.
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The above criteria are important in all techniques that require oligonucleotide primers. 
None the less, other considerations must be taken into account when designing 
degenerate primers. The most important is that the 3’ terminal end nucleotide should be 
complementary with the target sequence and there should be few degenerate positions 
at the 3’ end of the primer.
Degenerate primers can be designed in three ways; either by including a nucleotide 
analogue in the primer at degenerate positions such as inosine which bonds with all four 
nucleotides. Alternatively a mix of primers with different nucleotides at the degenerate 
positions could be designed. The first two approaches are most suitable where there are 
few degenerate bases. The third way is to design a single primer which will have mis­
matched bases in degenerate positions. The latter method is more suitable where the 
degeneracy is found through out the primer target sequence. The percentage identity of 
the primer with each target can be kept high by compromise in the nucleotide sequence 
of the primer at degenerate positions. Also using only a single primer will minimise the 
complexity of the method. Degenerate primers may be more successful if they are near 
to 30 bases in length as degeneracy in shorter primers will exert a greater effect in 
primer/target interactions.
3.4 Design of generic primers from the E gene
The general criteria discussed above were used to designing primers from the E genes. 
Potential generic primers were designed from flavivirus nucleotide sequences of E genes 
available in the Genebank/EMBL databases (DEN 1, 2 and 3, JE, SLE, MVE, KUN, WN, 
YF and CEE virus Neudoerfl; Table 3.1).
The reported nucleotide sequences were aligned using Clustal software and generic 
primers designed using software as described in chapter 2. For some primers a base was 
then added or removed from the designed primer so that the 3’ nucleotide was 
conserved if possible when compared with all flavivirus E gene nucleotide sequences 
reported at that time.
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Table 3.1 : Nucleotide sequences used in the design of generic primers from the E gene.
Virus (strain) EMBL accession 
no.
References
DEN-1 (CV1636/77) D00501 (Chu et al.. 1989)
DEN-1 (AHF82-80) D00502 (Chu et al.. 1989)
DEN-1 (924-1) D00504 (Chu et al.. 1989)
DEN-2 (various) M24444 to M24451 (Blok et al.. 19891
DEN-2 (S1 vaccine) M19197 (Hahn et al., 1988)
DEN-2 (Jamaica) M 15075 (Deubel et al., 1986)
DEN-3 (H87) M25277 (Osatomi & Sumiyoshi, 1990)
JE (JaOArS982) M 18370 (Sumioshi et al., 1987)
JE (Nakaya) M 16574 (Mcada et al., 1987)
KUN (MRM61C) D00246 (Coia et al.. 1988)
SLE (MSI.7) M16614 (Mandl et al., 1988; Mandl et al.. 1989b)
MVE (MVE/1/1951) X03467, M24220 (Dalgarno et al.. 1986)
WN (Nigera) M 12294, M 10103 (Wengler et al., 1985; Castle et al.. 1986; Castle et al., 
1985)
YF (17D) X03700, K02749 (Rice et al.. 1985)
CEE (Neudoerfl) M27157, M21498 (Trent et al.. 1987)
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3.4.1 Design of primer E1
Primer E1 was designed from the region of the E gene (nucleotides 1271-1304 of the YF 
genome) which encodes the conserved amino acid sequence GWGN(G/H)CGLFGK 
(Mandl et al.. 1989a) (figure 3.2). This region is proposed to be involved in flavivirus fusion 
activity (Mandl et_al., 1989a).
3.4.2 Design of primers E4. E3 and E2
«
Primers E4, E3 and E2 were designed from a region of the E gene corresponding to 
nucleotides 2217 to 2249 of the YF virus genome. Each primer was 30 bases in length 
and overlapped each other by 29 bases (Figure 3.3). The region encoded by these 
nucleotides is part of a larger conserved region of unknown function identified in fifteen 
flavivirus E genes (Mandl et al.. 1989a).
3.4.3 Primer Pairs
Three sets of primer pairs were selected (E1/E2, E1/E3, E1/E4). The expected product 
sizes from amplification of YF virus RNA with these primers were 976bp, 975bp and 974bp 
respectively (figure 3.4).
3.4.4 Specific primers
Four primers, AJ7, CAG, YF7 and YF100, specific for YF viral RNA amplification were a 
gift from Dr. A.D.T. Barrett ( Department of Pathology and Center for Tropical Diseases, 
University of Texas Medical Branch, Galveston, Texas). Primers CAG was designed from 
the M gene sequence. Primers YF7 and AJ7 were designed from the E gene nucleotide 
sequence and primer YF 100 was designed from the NS1 gene sequence. These primers 
formed two primer sets CAG/YF7 which when used in an RT/PCR produced a predicted 
product of 687bp and AJ7/YF100 which produced a predicted product of 1331 bp with YF 
virus infected-cell RNA extracts (Figure 3.4).
3.5 RNA Extraction
Total RNA was extracted from a range of flaviviruses propagated in tissue culture. The 
extracted RNA was analysed by electrophoresis through a 1% agarose gel (figure 3.5).
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Chapter 3 Flavivirus E Gene RT/PCR
Figure 3.5 : Analysis of RNA extractions by electrophoresis through a 1% agarose gel 
(virus strains are described in chapter 2 )
A 1 2 3 4 5 6 7
A : RNA extracts of flavivirus infected-cells and non-infected cells as indicated
Lane 
A2: MOD 
A3: KUN 
A4: SLE 
A5: RB 
A6: WSL 
A7: CEE
Lane 1: DNA molecular weight markers (DRIgest Ill.Pharmacia)
52 continued overleaf
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Figure 3.5 (continued) : Analysis of RNA extractions by electrophoresis through a 1% 
agarose gel (virus strains are described in chapter 2 )
B 1 2 3 4 5 6 7
B : RNA extracts of flavivirus infected-cells and non-infected cells as indicated
Lane 
B2: BAN 
B3: JE 
B4: ILH 
B5: YF
B6: Vero cells 
B7: CEE
Lane 1: DNA molecular weight markers (DRIgest III,Pharmacia)
53 continued overleaf
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Figure 3.5 (continued) : Analysis of RNA extractions by electrophoresis through a 1% 
agarose gel (virus strains are described in chapter 2 )
C 1 2 3 4 5 6 7 8
C : RNA extracts of flavivirus infected-cells and non-infected cells as indicated 
Lane
C2: C636 cells 
C3: Vero cells 
C4: DEN-2 
C5: Vero cells 
C6: Vero cells 
C7: POW 
C8: TTE
Lane 1: DNA molecular weight markers (DRIgest III,Pharmacia)
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The main component of the RNA extraction was ribosomal RNA (rRNA), the viral RNA was 
a minor component of the extract. However, provided the rRNA was not degraded it was 
assumed the viral RNA would also be un-degraded.
3.6 PCR of cDNA clones
Plasmids containing cloned cDNA enpoding the E gene of CEE virus Kumlinge and YF 
virus were gifts from Dr. A.D.T. Barrett and Dr. E.A. Gould respectively. Plasmid DNA was 
prepared and the authenticity of the extracted plasmid confirmed by restriction digests.
The plasmid DNA was used as template in a PCR with primers E1 and E2 or E1 and E3 
or E1 and E4. Primer set E1/E2 produced a single DNA fragment of the predicted size 
from both templates (figure 3.6). Primer set E1/E3 also produced a product containing a ; 
single DNA fragment of the predicted size from both templates. Primer set E1/E4 | 
produced amplified product containing multiple DNA fragments from plasmid containing 
the CEE virus E gene. j
3.7 Preliminary RT/PCR
YF extracted RNA was used as the template in a RT/PCR with primers AJ7 and YF7, also 
primers YF100 and GAG. The products were electrophoresed through a 1.5% agarose gel 
(figure 3.7). In either case a single DNA fragment of the predicted size was observed, 
control lanes showed no DNA fragments.
3.8 Pan-flavivirus RT/PCR and E gene primers
RNA extracted from cells infected with a variety of flaviviruses were then subjected to 
RT/PCR with primer set E1/E2. Only RNA extractions from JE and TTE virus infected cells 
yeilded cDNA products when tested. Small quantities of a single product of the predicted 
size was obtained from the JE virus extracted RNA amplification (estimated 10-15ng total). 
Four products (approx. 220 bp, 290 bp, 500 bp, 1000 bp) were obtained from the TTE 
extracted RNA amplification of which a DNA fragment of the predicted size (approx.
10OObp) was a minor component.
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Figure 3.6 : PCR products of plasmids containing E gene cDNA
Flavivirus E Gene RT/PCR
B 1 2 3
A and B: PCR products amplified by primers E1 and E2 from plasmids containing cDNA 
of flavivirus E genes as indicated.
Lane
A2: YF 976bp B2: KUM 976bp
A3: control - B3: control
Lane 1 : DNA molecular weight markers (DRIgest III, Pharmacia)
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Figure 3.7 : Products of RT/PCR amplified from YF RNA.
Flavivirus E Gene RT/PCR
B 1 2 3
A and B: RT/PCR products of YF infected-cell RNA extracts amplified by the following 
primers
Lane A2: YF100 and AJ7 1331 bp 
A3: -ve control
B2:YF7 and CAG 687bp 
B3: -ve control
Lane 1:DNA molecular weight markers (DRIgest III, Pharmacia)
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Single stranded cDNA obtained by RT of YF RNA primed by YF100 was used as a 
template for PCR with primers E1 and E2. An amplified product of 1287bp was obtained 
(figure 3.8) which corresponded to the predicted size of the YF100/E1 product. No 
product of 978bp was observed, this is the expected size of the E1/E2 product.
3.9 Discussion
Subsequent to the design of primers reported in this chapter many additional nucleotide 
sequences have been published for the E gene of different flaviviruses. Data have now 
been reported for viruses from the TBE serocomplex POW, LGT, LI, NEG, KFD, RSSE, 
OHF and Meaban viruses. The nucleotide sequence of DEN-4 E gene has also been 
determined. Marin et al.. (1995) included the E gene nucleotide of TYU and SRE in 
phylogenetic studies of the nucleotide sequence of flavivirus E genes. Marin et al.. 
aligned nucleotide sequence based on an amino-acid alignment, the phylogentic study 
presented in section 3.2 used a similar method of alignment. Nucleotide sequence data 
aligned on the basis of the encoded amino acid homology will reflect both convergent 
and divergent evolution, thus a more accurate analysis is likely to be obtained. Both the 
studies of Marin et al and the phylogenetic analysis presented in section 3.2 show that 
phylogenetic analysis of the E gene nucleotide sequences of each flavivirus reported to 
date reveals a pattern of relatedness similar to that obtained by serology. The only 
difference between the dendrogram presented in this chapter and that presented by Marin 
et al.. is that in the Marin et al.. study DEN-4 is paraphyletic with respect to the other 
viruses of the DEN serocomplex and in the dendrogram presented here DEN-2 and DEN- 
4 are monophyletic sisters to DEN-1 and DEN-3. This is due to interpretation of the data 
by the respective software programs. However, both studies separate the flaviviruses into 
groups similar to the groups defined by the serocomplexes. The nucleotide sequences 
reported to date represent viruses from only four of the flavivirus serocomplexes and also 
YF virus, as further E gene nucleotide sequences are determined classification on the 
basis of this sequence can be compared to the serological classification (table 1.1).
An RT/PCR method for flavivirus extracted RNA was successfully tested using primers 
(CAG/YF7 and AJ7/YF100) known to be able to amplify a fragment of the YF virus 
genome. This was an important step in proving that both the RT/PCR method and RNA
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Figure 3.8 : Amplification of YF infected-cell RNA extract
Flavivirus E Gene RT/PCR
RT/PCR products amplified from YF infected-cell RNA extracts by primers as indicated. 
Lane
1: DNA molecular weight markers (DRIgest III,Pharmacia)
2: -ve control 
3: -ve control
4: RT primer - YF100, PCR primers - AJ7 and YF100 1335bp
5: " " " , PCR primers - E1 and E2/YF100 1287bp
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extraction method could be used reliably to generate products of the expected size.
Primers E1/E2 and primers E1/E3 amplified single products of the expected size in PCR 
of cDNA containg the E gene from YF and CEE viruses. Analysis of the homology of 
these primers with their target nucleotide sequences (figure 3.2 and 3.3) shows that these 
primers are at least 73% homologous with the YF virus and CEE virus nucleotide 
sequence and in all cases the 3’ nucleotide is conserved.
Primers E1/E4 produced multiple products from a plasmid containing the CEE virus E 
gene suggesting that one of the primers was annealing to non-target sequence. Primer 
E4 is unlikely to anneal to the correct target sequence of CEE virus because it shows four 
bases mis-matched at the 3’ end.
Amplified products were obtained from only JE and TTE infected- cell extracted flavivirus 
RNA subjected to RT/PCR with primers E1/E2. Neither YF or CEE infected-cell RNA 
extracts were amplified, suggesting that primer E2 poorly primes RT or that either primer 
E1 or E2 preferentially anneal to non-target sequences. Further experimentation confirmed 
this. When single stranded cDNA produced from priming of YF extracted RNA with primer 
YF100 was subjected to PCR with primers E1/E2 a product of 1287bp was obtained which 
corresponds to that expected from amplification with primers YF100/E1 no smaller 
product from primers E2/E1 was observed. Thus it would seem that primer E2 inefficiently 
anneals to the target sequence in the YF virus infected-cell RNA extract.
RT/PCR products were successfully amplified from YF cell-infected RNA extracts with YF 
specific primers. The primers designed in this chapter amplified YF and CEE cDNA and 
also reverse transcribed and amplified JE and TTE infected-cell RNA extracts. However, 
the primers described here proved to be of limited use. Analysis of the more recent 
nucleotide sequence data available for flavivirus E genes may aid future work in this area. 
The major problem in designing further pan-flavivirus primers from E gene nucleotide 
sequence is the lack of nucleotide sequence conserved in all flaviviruses. The NS5 gene 
is the most highly conserved flavivirus gene. This gene proved useful for further analysis 
of the relationships between flavivirus, and is discussed in subsequent chapters.
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4.1 Introduction
The NS5 gene sequence has been reported for a number of flaviviruses (Tables 4.1,
4.2 and 4.3). This gene varies in length in different flaviviruses, for which the NS5 gene 
sequence has been reported, from 2691 to 2715 nucleotides. The protein encoded by the 
NS5 gene is highly conserved at the amino acid level with homology of greater than 55% 
amongst the flaviviruses sequenced to date. The greatest divergence in amino acid 
sequence occurs between mosquito-borne viruses and tick-borne viruses. For example, 
tick-borne CEE virus and the mosquito-borne DEN-4 virus are 55.3% homologous 
whereas the mosquito-borne viruses KUN and WN show homology of 94.9% (Tanaka et 
a|., 1991). The tick-borne virus LGT has homology of 94% with both RSSE and CEE 
viruses.
Certain regions of the NS5 protein show a higher degree of homology between 
flaviviruses than others probably because of the functional activities of these regions. A 
putative function of some of these conserved sequences has been suggested (Koonin, 
1991; Koonin, 1993).
The conservation of amino acid sequence is reflected in the nucleotide sequence. The 
identity between flavivirus NS5 gene sequences is greater than 55% for nucleotide 
sequences reported to date. Figures for identity at the nucleotide level tend to be slightly 
lower than for amino acid homology due to the degeneracy in the coding sequence.
Regions of high identity between virus nucleotide sequences are essential for designing 
good genus-wide RT/PCR primers. The NS5 gene therefore appeared to be suitable for 
development a pan-flavivirus RT/PCR system.
Two groups of workers have designed pan-flavivirus RT/PCR primers from the NS5 gene 
(Figure 4.1). Trent and Chang (1992) identified two regions of the NS5 gene which were 
highly conserved in all flaviviruses for which nucleotide sequence data have been 
reported. These regions began at nucleotides 9166 and 9977 in the DEN-2 genome. This 
group showed amplification of an NS5 gene fragment from a wide range of
6 1
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Table 4.1: Flavivirus NS5 gene sequences contained by EMBL database used in the 
design of NS5 gene primers.
Virus (strain) EMBL accession no. References
DEN-2 (S I) M19197 (Hahn et al., 1988)
DEN-2 (New Guinea-C) M29095, M 19727 (Irie et al., 1989)
DEN-2 (16681-PDK53) M 84728, M 85258 (Blok et al.. 1992)
DEN-2 (16681) M84727, M 85259 (Blok et al.. 1992)
DEN-4 M 14931, M 17255 (Mackow et al., 1987)
JE (SA-14-14-2) M55506 (Nitayaphan et al.. 1990)
KUN (MRM61C) D00246 (Coia et al., 1988)
WN (Nigera) M 12294, M 10103 (Castle et al.. 1986)
YF (17D) X03700, K02749 (Rice et al.. 1985)
CEE (Neudoerfl) M27157, M21498, M33668 (Mandl et al., 1989b)
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Table 4.2 : Flavivirus NS5 gene sequences contained by EMBL database unavailable for 
primer design.
Virus (Strain) EMBL accession no Reference
DEN-1 (Singapore S275/90) M87512 (Fu et al.. 1992)
DEN-2 (16681) M 84727, M 85259 (Blok et al.. 1992)
DEN-3 (H87) M93130 (Osatomi & Sumiyoshi, 1990)
JE (SA14) U14163 unpublished
JE (JaOArS982) M 18370 (Sumioshi et al.. 1987)
JE (SA-14-14-2) D90195 unpublished
JE (SA14) D90194 unpublished
YF virus (17D-204) X15062 (Dupuy et al.. 1989)
LGT (TP21) S35365, M 86650 (lacono Connors & 
Schmaljohn, 1992)
POW  (LB) L06436 (Mandl et al., 1993)
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Table 4.3 : Flavivirus NS5 gene sequences not contained by EMBL database
Virus (Strain) Reference
MVE (Lee et al.. 1990)
YF (Asibi) (Hahn et al.. 1987)
RSSE TBE (Sofjin) (Pletnev et al., 1990)
RSSE TBE (205 (Safronov P.F. et al.. 1991)
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Chapter 4 NS5 Gene Pan-flavivirus RT/PCR
flaviviruses, they also developed a number of virus specific primers from the reported NS5 
gene sequences.
More recently Pierre et al. (1994) designed primers from the NS5 gene and the 3’ NC 
region which could amplify a cDNA fragment from a range of mosquito-borne flaviviruses. 
They designed the sense primer which was degenerate at the third base position of each 
codon. The only exception to this was the final 3’ nucleotide which was conserved in all 
flaviviruses. There are 20 bases conserved in the 3’ NC region of the mosquito-borne 
flaviviruses, YF, DEN, JE and WN. These bases are found as an identical repeat 
approximately 70 nucleotides apart in viruses of the DEN and JE serocomplexes and as 
a single copy only in YF virus. The anti-sense primer was designed from this conserved 
sequence. In the RT/PCR DEN-1, 2, 3, 4, Zika, YF, WN and JE viral RNAs were amplified. 
The nucleotide sequences of the amplified products were determined, including Zika virus 
which had not previously been sequenced. The relationship revealed by comparison of 
the nucleotide sequence of the RT/PCR fragments was similar to the relationship shown 
by serology. The cloned RT/PCR products were used in nucleic acid hybridisation with 
RT/PCR products from infected mosquitoes to verify the type of flavivirus infection (Pierre 
et al.. 1994). The anti-sense primer designed by Trent and Chang (1992) and the sense 
primer designed by Pierre et al. (1994) were both from the nucleotide sequence of the 
WMTTEDM motif conserved in the NS5 protein of all flaviviruses.
The aim of this section of the project was to analyse the NS5 nucleotide sequences of 
flaviviruses reported to date and to design pairs of primers which had the potential to 
amplify a range of flaviviruses. And subsequently test the designed primers in an RT/PCR 
with the a range flavivirus extracted RNAs (chapter 3) and compare these with the primers 
designed by Trent and Chang (1992). Thus similarity in nucleotide sequence of the NS5 
gene of flaviviruses in this study would be investigated.
4.2 Design of Generic Primers from NS5
The general criteria discussed in chapter 3 were used when designing primers from the 
NS5 genes. Potential generic primers were designed from flavivirus nucleotide sequences 
of NS5 genes available in the Genebank database at the time. These sequences were 
DEN-2 and 4, JE, KUN, WN, YF virus and CEE viruses (Table 4.1).
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The reported nucleotide sequences, at the time of design, were aligned using Clustal 
software and generic primers designed using software as described in chapter 2 (Figure 
4.1). For some nucleotide positions of the primer the consensus nucleotide was not 
chosen, to ensure that the overall identity of the oligonucleotide with all NS5 sequences 
was maximised. It was essential that the 3’ terminal nucleotide of the primers was 
complementary with as many sequences as possible in the alignment. Visual analysis of 
the designed primers and the nucleotide alignment revealed that this was not always the 
case. Therefore, in some primers a base was added or removed from the designed 
primer so that the 3’ nucleotide was conserved when compared with the flavivirus NS5 
nucleotide sequences reported at that time. Primers were screened for homology with 
nucleotide sequences in the Genebank data base.
4.2.1 Design of Primer FG1
Primer FG1 was 28 nucleotides in length and was designed from a region corresponding 
to nucleotides 8270 to 8297 of the YF virus genome (Rice etaj., 1985) (Figure 4.2). The 
3’ terminal nucleotide of this primer is conserved in all flavivirus nucleotide sequences 
reported to date. FG1 shows overall maximum homology of 93% with DEN-2 virus 
nucleotide sequences and minimum homology with JE virus nucleotide sequences of 
75%. This nucleotide sequence encodes the amino acids SRNSTHEMY in YF virus. The 
residues SRNS (T/N) HEMY are conserved, in this region in all flavivirus NS5 amino acid 
sequences reported to date.
4.2.2 Design of primers FG3 and FG4
The two primers FG3 and FG4 are 29 nucleotides in length and an exact reverse 
complement of each other (Figure 4.3). FG4 is the sense primer, FG3 is an anti-sense 
primer. They correspond to nucleotides 9048 to 9078 on the YF virus genome. The 
nucleotide sequence of both primers show a conserved 3’ terminal nucleotide and a high 
percentage homology of at least 86% when compared with all flavivirus nucleotide 
sequences reported. The amino acids encoded by this region are conserved in all 
flavivirus sequences reported to date (SRAIW(Y/F)MWLG). The reported genome 
nucleotide sequence of flaviviruses in this study were analysed for non-target sequences 
complementary to the six 3’ terminal nucleotides of FG3 (Table 4.4).
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Table 4.4 : Occurrence of non-target sequences in flavivirus vRNA complementary to the 
six 3’ terminal nucleotides of the primer.
vRNA Non-target sequences in 
genomic RNA from which 
FG3 could be extended
Non-target sequences in 
genome RNA from which 
FG2 could be extended
CEE(Neudoerfl) 3 2
POW 1 2
KUN 5 2
YF (17D) 3 0
JE (SA-14-14-2) 7 1
DEN-2 (New Guinea-C) 8 1
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4.2.3 Design of primers FG2 and FG5
These primers correspond to the region from nucleotide positions 9228-9258 on the YF 
virus genome (Figure 4.4). FG2 is 31 nucleotides in length and is an anti-sense primer. 
The primer FG5 has the same nucleotide sequence as primer CFDDJ9166 designed by 
Trent and Chang (1992). The nucleotide sequence of primer FG2 is a minimum of 80% 
homologous and shows a conserved 3’ terminal nucleotide with all flavivirus nucleotide 
sequences reported. Primer FG5 is 21 nucleotides long, it shows a minimum homology 
with LGT virus nucleotide sequence. The reported genome nucleotide sequence of 
flaviviruses in this study were analysed for non-target sequences complementary to the 
six 3’ terminal nucleotides of FG2 (Table 4.4). Primer FG2 may anneal at and prime 
extension from these non-target sequences. FG5 shows a 3’ terminal nucleotide mis­
match with four flaviviruses [DEN-2 (16681-PDK53), DEN-2 (16681), DEN-1 and RSSE 
(Sofjin)] nucleotide sequences determined to date. The encoded amino acids 
YADDTAGWDT are conserved the all NS5 proteins of flavivirus reported to date. This 
encoded amino acid sequence was identified as motif A in RNA-dependent polymerases 
by Pouch et al. (1989) and motif IV of RNA-dependent RNA polymerases by Koonin et 
al. (1991).
4.2.4 Design of FG6 and FG7
The primers FG6 and FG7 were derived from a region corresponding to nucleotides 
10061 to 10076 in the YF virus genome (Figure 4.5). This region has been used by two 
other groups of workers to design pan-flavivirus primers and is discussed in the 
introduction to this chapter. FG6 and FG7 are both anti-sense primers and overlap each 
other by sixteen nucleotides. Primer FG7 is 30 nucleotides in length and was designed 
as previously described. Primer FG6 is only 21 nucleotides in length and was has the 
same sequence as the anti-sense primer designed by Trent and Chang (1992). Both 
primers show good homology at their 3’ terminal end including the 3’ terminal nucleotide 
with nucleotide sequences reported to date. Primers FG6 and FG7 show a minimum of 
85% homology and 73% homology respectively with all flavivirus nucleotide sequences. 
The amino acids WMTTEDML (T/A/S/K/Q/E/A/D/R)VWN are encoded by this region of the 
nucleotide sequence. Only one of the amino-acids is not conserved, this appears to be 
highly variable.
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Chapter 4 NS5 Gene Pan-flavivirus RT/PCR
4.2.5 RT/PCR Primers Sets
The six primers designed as described above were paired for use as RT/PCR primers 
(Figure 4.1). Four sets of primers were identified (Table 4.5).
4.3 Testing Primers Against Test Panel
The four primer sets (A, B, C and D) (Table 4.5) were used in RT/PCRs with extracted 
RNA from thirteen flaviviruses and two control RNA extracts from monkey kidney Vero and 
mosquito C6/36 cells (Table 4.6). The amplified products were electrophoresed through 
1.5% agarose gels and the size of the DNA fragments in the product were estimated by 
comparison with molecular weight markers. Where a product of the predicted size was 
amplified the reaction was deemed successful. The results of the RT/PCR are shown in 
Table 4.6.
Primer set A produced amplified products with only one significant band of approximately 
1kb from 12 of the 13 flavivirus RNAs (Figure 4.6). The only viral RNA not amplified by 
primer set A was extracted from SLE virus infected cells. No amplified products were 
detected for either control (Table 4.6). Primer set B produced amplified products as a 
single band of the expected size for 5 of 13 flavivirus RNA templates, products were 
obtained from CEE, POW, TTE, KUN and YF viruses. The control templates produced no 
bands but amplified mosquito C6/36 cell extracted RNA appeared as a smear. Amplified 
products of the expected size for 6 flavivirus RNA templates, POW, TTE, JE, KUN, DEN-2 
and YF viruses were produced by primer set C. However, two other amplified DNA 
fragments of less than 600 bp were also observed for Vero cell RNA extract RT/PCR 
products appeared as a smear, though no DNA fragments were amplified using either 
control template. Primer set D produced amplified product of the expected size from 6 of 
the 13 flavivirus template RNAs namely POW, TTE, JE, BAN, DEN-2, and YF (Table 4.6). 
However one or two other amplified products smaller than 600bp were also observed for 
these six RNAs. Amplification of both control extracts produced no single DNA fragments 
but the product appeared as a smear. Each primer set amplified products from POW, TTE 
and YF virus infected-cell RNA extracts. The amplified POW virus cDNA produced from 
each primer set are shown in figure 4.7.
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Table 4.5 : Pan-flavivirus primer sets identified for use in RT/PCR.
Set Anti-sense primer  ^
(nucleotide position )
Sense primer 
(nucleotide position )
Predicted product 
size (bases )
A FG2 (9228-9258) FG1 (8270-8297) 988
B FG3 (9048-9078) FG1 (8270-8297) 808
C FG7 (10061-10090) FG4 (9048-9078) 1042
D FG5 (9236-9256) FG6 (10056-10076) 840
*
- Predicted from YF virus nucleotide sequence
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Chapter 4
Figure 4.6 : RT/PCR amplified products with primer set A.
NS5 Gene Pan-flavivirus RT/PCR
A cDNA products amplified by primer set A from flavivirus RNA as indicated and 
electrophoresed through a 1.5% agarose gel.
Lane A2: KUN 
A3: MOD 
A4: KUM 
A5: POW 
A6: TTE 
A7: YF
Lanes 1 and 8: DNA molecular weight markers (DRIgest III, Pharmacia)
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Figure 4.6 (continued) : RT/PCR amplified products with primer set A.
B: cDNA products amplified by primer set A from flavivirus RNA as indicated and 
electrophoresed through a 1.5% agarose gel.
Lane B2: JE 
B3: RB 
B4: BAN 
B5: ILH 
B6: WSL 
B7: DEN-2
Lanes 1 and 8: DNA molecular weight markers (DRIgest III, Pharmacia)
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Figure 4.7 : RTPCR of POW virus infected-cell RNA extracts amplified with primer sets A, 
B, C and D.
Flavivirus cDNA products amplified by primer sets as indicated and electrophoresis 
through a 1.5% agarose gel.
Lane A2 : Set A 988bp
A3 : Set B 808bp
B1 : Set D 840bp
B2 : Set C 1042bp
Lanes A1 : DNA molecular weight markers (DRIgest III, Pharmacia)
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Primer set A was investigated further and used in RT/PCR with 7 additional flavivirus 
infected cell RNAs (Table 4.7). None of the primer pairs produced amplified product from 
the SLE virus infected cell RNA. Extracts of three newly acquired strains of SLE were 
prepared and subjected to RT/PCR with primer set A. Hepatitis C RNA purified from 
infected liver tissue , RNA extracted from non-infected liver tissue and nucleic acids 
preparations from Bacillus cereus and Escherichia coli also were included in this RT/PCR. 
The hepatitis C infected and non-infected liver tissue RNA extracts were a gift from Dr. 
E. Fagan (Royal Free Hospital School of Medicine, London). B.cereus and E.coli nucleic 
acid extracts were provided by Dr D. Leslie (CBDE). All flavivirus infected-cell RNA extracts 
produced DNA fragments of the expected size. No DNA fragments were produced from 
the bacterial templates or from either non-infected or hepatitis C infected liver extracts. All 
the liver extracts produced products which appeared as smears. This is typical of 
RT/PCRs performed on liver tissues (Personal communication Dr.E.Fagan, Royal Free 
Hospital School of Medicine, London)
4.4 Confirmation of the gene fragment by nucleotide sequencing
The DNA fragment produced in the RT/PCR with primer set A (FG1 and FG2) and viral 
RNA template extracted from CEE virus strain Kumlinge was characterised further. The 
nucleotide sequence of 100 bases at the 5’ and 3’ terminal ends of the product were 
determined. The nucleotide sequence obtained was compared with the previously 
reported nucleotide sequence of the CEE virus Neudoerfl (Mandl et al.. 1989b) (Figure 
4.8). The comparison showed that the 5’ end of the Kumlinge product had 96% 
homology with nucleotides 8328-8427 of the Neudoerfl genome and the 3’ terminal end 
of the Kumlinge product showed 100% homology with the Neudoerfl genome nucleotides 
9155-9244.
4.5 Discussion
Since the primers described in this study were designed the nucleotide sequence of a 
number of flavivirus NS5 genes has been determined. They are DEN-1 and 3, MVE, SLE, 
LGT and POW, MVE and two RSSE TBE viruses (Tables 4.2 and 4.3) and also the 
proposed flavivirus CFA. In these more recently determined nucleotide sequences the 
predicted target binding sites are homologous to the primers designed in this chapter.
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Table 4.7 : Results of RT/PCR with primer set A of virus infected cell RNA extracts
SEROCOMPLEX TEMPLATE (vRNA) S E T A  (FG2.FG1)
JE MVE (MVE/1/1951) YES
WN YES
SLE (TBH28) YES
SLE (H109) YES
SLE (MS1-7) YES
TYULENIY MEA (Brest/Ar/T707) YES
NTAYA IT (TC 866) YES
BAG (DAK/Ar/B209) YES
UNASSIGNED YF virus (P16065) YES
HCV NO (SMEAR)
Template (Nucleic acid extract)
B.cereus NO
E.coli NO
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The four primer sets described above have been used in an RT/PCR with thirteen flavivirus 
infected cell RNA extracts. Primer set A proved to be the most versatile. At least one virus 
infected cell RNA extract from each flavivirus serocomplex and a number of unassigned 
virus infected cell RNA extracts were amplified using primer set A, including viruses for 
which nucleotide sequence has not been reported. The partial nucleotide sequence of 
one of the amplified RT/PCR products was determined to confirm the authenticity of the 
product. Primer set A did not amplify a product from hepatitis C virus extracted RNA.
Initial experiments showed primer set A was able to amplify all but the SLE virus infected 
cell RNA extract from the initial 13 viruses examined. None of the primer sets were able 
to amplify cDNA from this SLE virus extract. Other workers in the laboratory were unable 
to identify the virus by traditional antibody techniques and new stocks of three strains of 
SLE virus were obtained. Subsequent experiments showed that SLE virus-infected cell 
RNAs from the new virus stocks produced an amplified product of the expected size in 
an RT/PCR with primer set A. Thus it was concluded that the original SLE virus infected 
cell RNA extract contained no SLE virus RNA.
In order to extend the virus-infected cell RNA extracts tested in RT/PCRs with primer set 
A a number of other flavivirus RNAs were extracted. All of these produced a single cDNA 
fragment of the expected size. The nucleotide sequences to which primer set A annealed 
are therefore conserved in all the flaviviruses examined in this study and are potentially 
conserved in all flavivirus NS5 genes.
Hepatitis C viruses and Pestiviruses are two separate genera in the Flaviviridae family 
and may be the closest relatives of the flavivirus genus. Comparison of the nucleotide 
sequences of primers FG1 and FG2 with the nucleotide sequence of Hepatitis C viruses 
and the pestivirus revealed some sequence homology less than 67% with either primer. 
These potential primer annealing sites were not suitable for producing RT/PCR products 
because of their positions on the genome. Primer set A amplified no visible cDNA 
fragments in an RT/PCR with highly purified hepatitis C RNA. Similarly, no visible DNA 
fragment product was amplified in the other less related control extracts. RT/PCR products 
of the extracted flavivirus RNA produced only a single band. The nucleotide sequence of 
CFA was also examined for homology with primers FG1 and FG2. The analysis indicated 
that these primers may amplify a product from CFA but due to lack of availability of viral 
RNA this was not attempted. Thus it would seem that in these experiments primer set A
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is pan-flavivirus and genus specific.
The nucleotide sequence determined from the cloned RT/PCR product of CEE virus 
Kumlinge confirmed that the expected NS5 gene fragment was amplified from this virus. 
The alignment of the 3’ and 5’ 100 nucleotides of the cloned RT/PCR product with the 
genome sequence of Neudoerfl was as expected for this RT/PCR product. Previous 
workers have shown that the E gene nucleotide sequence of the CEE viruses Kumlinge 
and Neudoerfl are 98% homologous (Whitby et al.. 1993a). The 200 bases of CEE virus 
Kumlinge NS5 gene determined in this study also show the homology between the 
viruses to be 98%. Thus, it is concluded that the DNA products generated were CEE virus 
in origin.
Primer set B amplified the least number of flavivirus infected cell RNA extracts. Set B 
used primer FG1 from set A and a new primer FG3 which showed high homology with 
all the target nucleotide sequence determined to date. Also the predicted RT/PCR product 
from set B is smaller that the predicted product with set A and should therefore be more 
readily amplified.
Little is known about the secondary structure of the flavivirus genomic RNA. The 5’ and 
3’ NC regions have been studied and it is likely that the remainder of genome will form 
secondary structures particularly in its interaction with capsid protein (Chambers et al.. 
1990a). To overcome secondary structure many workers have introduced an initial 
denaturation stage to aid RT/PCR of flavivirus RNAs. Primer FG3 may be unable to anneal 
to its target sequence due to secondary structure. Primer FG2 anneals to a region 
downstream of the FG3 binding site which suggests that the FG3 binding region can be 
reverse transcribed.
Another possibility is that primer FG3 anneals preferentially to contaminating nucleic acid 
molecules in the virus-infected cell RNA extracts for example ribosomal RNA or DNA from 
the tissue culture cells. There is some evidence to support this suggestion as the control 
nucleic acid extract from C6/36 cells produced a smear in RT/PCR with primer set B.
The nucleotides at the 3’ terminal end of RT and PCR primers are thought to be most 
important for binding and subsequent extention. In 12kb of random nucleotide sequence 
a particular six nucleotides will probably occur three times. The occurrence of non-target
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nucleotide sequence in the entire flavivirus genome complementary to the six 3’ terminal 
bases for primers FG2 and FG3 was noted (Table 4.4). There are few non-target 
sequences in the flavivirus RNA genome available for primer FG2. In the flavivirus 
extracted RNAs which were amplified by primer set B there are also few non-target 
sequences available for primer FG3. In contrast many non-target sequences are available 
for primer FG3 in the DEN-2 and JE virus genome, these virus-infected cell RNA extracts 
were not amplified by primers FG1/FG3.
Primer set C (primers FG4 and FG7) amplified products of the expected size from six of 
the thirteen virus-infected cell RNA extracts but a number of additional fragments were 
generated. The smaller unpredicted DNA fragments noted may be due to cross-reaction 
of the primers with non-target sequences. Primer FG4 is the reverse complement of FG3 
and may reflect some of the problems of FG3 but primer set C was able to amplify virus 
infected-cell RNA extracts from JE and DEN-2 viruses which were not amplified by set B. 
The results obtained using primer set C are difficult to compare with those obtained from 
set B and the problems encountered using primer set C are probably multi-factorial.
Primer set D produced an amplified product of the expected size from only six of the 
thirteen extracted flavivirus RNAs, other amplified DNA fragments were also noted with this 
primer set. Both FG5 and FG6 primers are shorter than other primers in this study, which 
may explain why they are less specific. Also, primer FG5 shows some mis-matches at the 
3’ terminal nucleotide with four flavivirus NS5 sequences. This set of primers were 
theoretically the least likely to be useful as pan-flavivirus primers but were included 
because the original author reported that a RT/PCR assay using these primers 
successfully amplified a wide range of flavivirus RNAs (Trent & Chang, 1992). The results 
presented here agree with the author’s results in that the virus RNAs which were amplified 
here were also amplified in the original study. The viral RNAs which could not be amplified 
by primer set D in this study were not reported in the original study (Trent & Chang, 
1992).
The amplified cDNA produced by RT/PCR can be nucleotide sequenced and thus the 
amino-acid sequence can be predicted. The determination of the nucleotide sequence of 
the NS5 gene of flaviviruses has lead to two potential enzymatic functions of the encoded 
protein being identified and has corroborated experimental evidence of the role of NS5 
protein in virus replication (Koonin, 1993; Koonin, 1991; Poch et al.. 1989) . Nucleotide
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sequencing of the amplified fragments produced by the research described in this chapter 
will expand the nucleotide sequence database for flaviviruses not previously investigated.
The nucleotide sequence from NS5 genes would also be useful in the classification and 
study of the evolution of all flaviviruses but particularly unassigned and emerging viruses.
Flavivirus RT/PCR and in particular a pan-flavivirus system could be used in detection and 
diagnosis of flavivirus infections. If required, this initial rapid diagnostic procedure could 
be followed by more specific diagnosis possibly based on the nucleotide sequence of the 
RT/PCR product. Rarer flavivirus infections for which diagnosis is still non-routine could 
be detected by this type of system.
In conclusion, the four sets of RT/PCR primers designed were used to amplify a range of 
flavivirus RNAs. Primer set A proved to be pan-flavivirus reactive for all flaviviruses in this 
study, including viruses for which no nucleotide sequence information has been reported. 
An RT/PCR system including primer set A will aid in the determination of nucleotide 
sequence from any of these viruses. This is investigated further in chapter 5.
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5 ANALYSIS OF THE NUCLEOTIDE SEQUENCE OF THE PAN-FLAVIVIRUS RT/PCR
FRAGMENT FROM BAN VIRUS. MOD VIRUS AND CEE VIRUS KUMLINGE
5.1 Introduction
The RNA-dependent-RNA-polymerase is essential for replication of the genome of 
flaviviruses. Several groups of workers have analysed the encoded amino-acid sequence 
of the RNA-dependent-RNA-polymerasesfrom positive-sense single-stranded RNA viruses 
and revealed motifs of homology (Poch, 1989; Koonin, 1991; Koonin, 1993). Some 
homologous motifs are also found in RNA-dependent-RNA-polymerases of negative-sense 
or double-stranded RNA viruses, in reverse trancriptases and in DNA-dependent-DNA- 
polymerases. The conserved motifs in RNA polymerases correspond to three functions 
attributed to these enzymes: RNA polymerase functions such as polymerization or 
nucleoside triphosphate binding activities; RNA helicase activities and methyl-transferase 
activity (Ishihama & Barbier, 1994).
Two putative enzymatic activities for the flavivirus NS5 protein have been identified, 
namely RNA dependent-RNA polymerase activity and methyl-transferase activity. The 
amino acid sequences possibly associated with these activities have been identified 
(Koonin, 1993; Koonin, 1991). The experimental evidence for the RNA polymerase activity 
was discussed in chapter 1.
The similarity of RNA polymerase from positive-sense RNA viruses suggest that they could 
be compared for phylogenetic studies of the relationships between and within these virus 
groups. This analysis could proveto be useful in classification of these viruses. The recent 
phylogenetic analysis of the E gene and the NS5 gene nucleotide sequence, determined 
to date, reveals that comparison of either gene sequence produces a logical classification 
of the flaviviruses (Marin et al.. 1995) when compared to that obtained from serological 
data (Calisher et al.. 1989).
The aim of the work described in this chapter was to nucleotide sequence the NS5 gene 
fragment produced by the pan-flavivirus RT/PCR from MOD, BAN viruses and CEE virus 
Kumlinge. The nucleotide and encoded amino-acid sequences were then compared with 
the homologous sequences from other flaviviruses, to study protein function and to allow 
phylogenetic study of these and other flaviviruses nucleotide sequenced to date.
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5.2 Amplification, cloning and sequencing of the viral RNA
A fragment of approximately 990 nucleotides of the NS5 from BAN virus, MOD virus and 
CEE virus Kumlinge was reverse transcribed and amplified from RNA extracts using primer 
set A as described in chapter 4. The products were separated by agarose gel 
electrophoresis and the purified products were cloned into a plasmid vector. At least two 
purified recombinant plasmids were sequenced for each viral RNA and where necessary 
microcon purified RT/PCR product was sequenced directly. Sequencing was initiated 
either from the M13 universal primer or -40 primer and further sequencing primers were 
designed. The sequencing primers and strategy used for each amplified cDNA are 
shown in Figures 5.1, 5.2 and 5.3 also Tables 5.1, 5.2 and 5.3.
The nucleotide sequence determined for BAN virus was 930 bases in length (Figure 5.1) 
whereas the fragment amplified from MOD virus (Figure 5.2) and CEE virus Kumlinge 
(Figure 5.3) infected cell RNA extract were both 927 bases in length. The G/C content of 
the fragments was 51%, 45% and 53% respectively. However, the purine content of the 
fragments was 58%, 61% and 60%. Comparison of the nucleotide sequence of these 
fragments with reported NS5 sequences confirmed the identity of these three cDNA 
fragments.
5.3 Comparison of nucleotide sequence & predicted amino-acid sequence
The nucleotide sequences of the NS5 gene fragments obtained from BAN virus, MOD 
virus and CEE virus Kumlinge are shown in Figures 5.1, 5.2 and 5.3. Comparison of the 
nucleotide sequence of the NS5 gene fragment from CEE Kumlinge with the homologous 
sequence from CEE Neudoerfl, revealed an identity of 97.6%. The deduced amino acid 
sequences from the NS5 gene fragments were compared and aligned with the deduced 
amino-acid sequences reported for the homologous region in NS5 gene from other 
flaviviruses (Figure 5.4).
The nucleotide sequence of the RT/PCR fragment encodes NS5 protein motifs I, II, III and 
the beginning of motif IV previously identified by Koonin (1991). These motifs are partially 
conserved in all flavivirus sequences reported and also in the NS5 encoded protein of the 
putative flavivirus, CFA (Cammisa-Parks et al.. 1992).
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Table 5.1 : Sequencing primers for RT/PCR fragment of BAN virus.
Primer Nucleotide sequence
BANF3 5’TCGGTTGCCAGTGAAGCGGGTCCTTTGGAC 3’
BANF4 5’TCCTACGTGGCCAAGCAGAGCGG 3’
BANF2 5’CTGACCCCACATTCTGGAGCCTAGTT 3’
BANF7 5’ CAGGGCAATCTGGTACATGTGG 3’
BANR3 5’ATGGTCTTCATTGAGGAATCCCAGTGCCTC 3’
BANR4 5’CAGTTAGAATTCCTCCCAGTGC 3’
d  A K i n n 5’TTCTGTATGGATGATCAG 3’
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Table 5.2 : Sequencing primers for RT/PCR fragment of MOD virus.
PRIMER NUCLEOTIDE SEQUENCE
MNS5F5 5TTCTAATCACCCTTATCGCACGTGGAACTA 3’
MNS5F7 5’GGCAATGTCAATGACAGACACCACAGA 3’
MNS5F10 5’GGGAAATGTGAGATGTGTGTG 3’
MBR 5’CCGAGCCACATGTACCAGAT 3’
MNS5R3 5’GTCAACTGCCTCCACAGCTGAGCTCCACC 3’
MNS5R2 5TGCTGAAGCTCTTTGTTCCCA 3’
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Table 5.3 : Sequencing primers for RT/PCR fragment of CEE virus Kumlinge.
PRIMER NUCLEOTIDE SEQUENCE
KNS5F1 5’TACAAGAGAGGATCAGAGCG 3’
KNS5F9 5’AGGCACAAGAGCCTCAGCCCGGTAC 3’
KNS5F2 5’ATGCGCGCACTGCGTGTAC 3’
KNS5R5 CGAACTCCAGAAAGCGACTCC 3’
KNS5R2 5’CCAGTTTCTTCTCTCTCTTG 3’
KNS5R9 5’ACCACATCTTCCCGTGCGTTCC 3’
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Figure 5.4 : Alignment of the encoded amino-acid sequence of the RT/PCR fragment of 
the NS5 gene.
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The encoded amino acid sequence of DEN1 virus is shown. Positions where the amino- 
acid is identical to of that found in the DEN1 sequence are indicated by a dot (.) and 
amino-acids shown in the alignment indicate differences at that position when compared 
with DEN1 virus.
NPYKTWAYHGSYEVKPSGSASSMVNGWKLLTKPWDAIPMVTQIAMTDTTPFGQQRVFKEKVDTRTPKAKRGTAQIMEVT
.R 
.R..T. 
.R. .T. 
•R. .T. 
•R..T. 
.R..T. 
.R..N. 
.R..N.
.R. .T, 
.R..H 
.R..H 
.R..H. 
.R..Q, 
.R..Q, 
.R..Q, 
.R..Q, 
.R..Q, 
.R..N. 
..SFK.
...T.QT. 
...T.QT. 
..T.QT. 
..T.QT. 
..T.QT.
, .G....R. 
.. .R. 
..FR. 
..FR. 
. ..R.
.....AT....
....PPST..P.
.....AT....
......AT....
 AT....
 AT....
 ....AT....
 .....T....
......T....
...W..
...W..
...W..
, . . w . .
, . . w . .
...M.....
. ..M.....
. ..M....
. ..M.....
. ..M....
.L.. 
• L., 
.L.. 
.L.. 
.L.. 
.L..
 MS.
...E.MS.
 MS.
 MS.
 MS.
...R..S. 
...R..S.
  TL.,
•C...VT.T....A...,
•C...VT.T A--
....VA.Q..T.A..1, 
W.T.RTA.T...A.LI, 
W...RTA.T...A.LI. 
HAA-TACANRVGGALI, 
W...RTPAT...A.LI, 
W...KTAAT..SA.LL. 
....R.RDV.TRA.A., 
F..FVTDDVKVGGQA..
...R..S. 
..1.1..Y 
..1.1..Y 
...SG 
...SW 
...SW 
...SW 
. . . S W  
. . .S W  
. . .S W  
RKIMW
...W..
,. .V__
 AN
 AN
 AN,
 AN,
 AN,
...T.TN,
.MGT.TN,
 TG,
...R.EE, 
, ..R.EE, 
...R.EE, 
, .N.RED, 
, .N.RED, 
..N.RED. 
.N.RED, 
.N.RED. 
, .GKMEK. 
•ETLTS.
. ..M... 
, ..L.V. 
,.TM... 
•TM... 
.TM... 
•TM... 
.TM... 
.TM... 
.TM... 
.TM... 
.RM... 
.RM... 
.NM... 
VRM... 
VRM... 
VRM... 
.RM...
•AIH
VRM.....A
LAMS....A
VGFS...VSTYS
......... QEP.E..KKL.KI.
......... QEP.E..KKL.KI.
......... QEP.E..KKL.KI.
......... QEP.E..KKL.KI.
......... QEP.E..KKL.KI.
......... .RPMP..RKV..1.
   QP.P..RMV.TT.
....... KA.EPPA.AKEVLNE.
....... KA.EPPA.AKEVLNE.
 ...... KA.EPPA.AKEVLNE.
  KA.EPPA.AKEVLNE.
....... KA.EPPA.AKEVLNE.
....... KA.EPPE.VKYVLNE.
....... KA.EPPE.VKYVLNE.
...... .KA.EPPQ.VKTV.DE.
....... .AKDPPA..RK..K.V
........ AKDPPA..RK..K.V
........ A.EPPQ..RE..K.V
... .D....KAQEPQP..RV..RAV 
... .D....KAQEPQP..RV..RAV
    KAQEPQP. .KV. .RAV
....... KAQEPQP..RV..RAV
....D....KAQEPQP..KI..RAV
....... KA.EPNIQVKKV.RKV
K.LR VI. PBPQHIRRVNRTI
95 continued overleaf
Chapter 5 Nucleotide Sequence Analysis of RT/PCR Fragments from BAN, MOD and CEE
Figure 5.4 : Alignment of the encoded amino-acid sequence of the RT/PCR fragment of 
the NS5 gene, (continued)
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The encoded amino acid sequence of DEN1 virus is shown. Positions where the amino- 
acids are identical to of that found in the DEN1 sequence are indicated by a dot (.) and 
amino-acids shown in the alignment indicate differences at that position when compared 
with DEN1 virus. The RNA-dependent RNA polymerase motifs I, II and III identified by 
Koonin (1991) are marked POL I, POL II and POL III respectively.
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Motif I is from amino-acid 239 to 250 in Figure 5.4. Variable amino acids have been 
identified at positions 246 and 247. The encoded BAN virus NS5 protein sequences 
shows a Pro at position 246; this amino-acid is also found at this position in the NS5 
protein of JE, and CFA viruses, other flaviviruses contain a Leu at this position. At position 
247 BAN virus NS5 protein has a Ser as does CFA and YF virus, all other flaviviruses 
contain Gly. Motif I in the NS5 protein of MOD virus also contains a Pro residue at 
position 246. All the viruses of the TBE serocomplex for which the NS5 gene sequence 
has been reported encode the same conserved motif I.
Motif II is from amino acids 251 to 280. The BAN virus NS5 predicted amino-acid 
sequence contains a Arg residue at position 251, other mosquito-borne flaviviruses NS5
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CFA has a Glu. A change from Arg to Lys is a functionally conserved substitution. Motif 
II encoded by MOD virus NS5 is most similar to that found in tick-borne viruses but there 
are a few exceptions. There is a non-conservative substitution of an Ala residue for a Thr 
residue, CFA is the only other flavivirus which also contains this substitution. At position 
272 most flaviviruses contain an Ala residue, MOD virus has a Ser residue. MOD virus 
also has a different residue at position 273, all other flaviviruses and CFA contain an Leu 
at this position but MOD virus contains a Phe residue.
Motif III shows greater variability than motifs I and II. In the BAN virus NS5 protein this 
motif is most similar to that in other mosquito-borne flaviviruses. Motif III of MOD virus 
shows similarity with the flavivirus sequences in the alignment except in position 295 
where the MOD virus NS5 protein contains a Pro. All the mosquito-borne viruses and CFA 
contain a Gly at this position, whereas the tick-borne viruses contain a Ser. The CEE virus 
Kumlinge motif III shows similarity to that found in other tick-borne flaviviruses.
The alignment of the amino-acid sequences has also revealed a further conserved motif 
not previously reported in the flavivirus NS5 protein this motif is from 124 to 144. This 
motif of unknown function is discussed in detail in chapter 6.
In many other positions the differences between the NS5 proteins are functionally 
conservative substitutions. An example of this is seen in position 1 of the alignment where 
the amino-acid is either a Trp, Tyr or Phe residue, these residues are all aromatic amino 
acids. The functional groups of amino-acids and full names are shown in appendix A.
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The amino acid alignment also shows several positions where the amino-acid sequence 
is conserved or functionally conserved only between groups of related viruses. An 
example of this is found at position 233 where all the mosquito-borne viruses contain an 
amino acid with an aliphatic hydroxyl side chain (Thr or a Ser) and all the tick-borne 
viruses contain a basic His residue. At this position MOD and CFA both contain a Met 
residue.
At several positions MOD and CFA viruses differ from all the other flaviviruses. For 
example, at residue 257 where these two viruses share a Thr residue and all the other 
viruses contain a Ala residue. In other positions CFA and MOD vary from the other 
flaviviruses but do not contain the same amino-acid. For example, position 106 where 
MOD contains the basic residue His, OFA contains a Pro and all the other flaviviruses 
contain the aliphatic residue Gly.
Some patterns in the gaps in the alignment also seem to be reflected in part by the 
relatedness of groups of flaviviruses. Position 29, 30 and 31 in the alignment show that 
viruses from the DEN serocomplex and YF virus contain a single amino acid deletion 
when compared with the other mosquito-borne flaviviruses from the JE serocomplex. 
Flaviviruses from the TBE serocomplex have a two amino acid deletion which is shared 
by MOD and CFA viruses. Also MOD and CFA contain an extra Lys residue at position 
169 which is not found in the other flaviviruses.
The percentage homology between the flaviviruses for the encoded amino-acid sequence 
from this region was calculated (Table 5.4). The amino acid alignment obtained was then 
used as a basis for phylogenetic analysis of the nucleotide sequence and a dendrogram 
produced using PAUP software (Figure 5.5).
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Chapter 5 Nucleotide Sequence Analysis of RT/PCR Fragments from BAN, MOD and CEE
Figure 5.5 : Dendrogram of phylogenetic relatedness of flaviviruses based on the 
nucleotide sequence of the NS5 pan-flavivirus RT/PCR fragment.
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5.4 Discussion
Enzymes with polymerase activity can incorporate any deoxynucleotide triphosphate 
(dNTP) into an extending DNA molecule but there are in built controls to prevent mis- 
incorporation of bases. The first is the ability of the polymerase to discriminate between 
dNTPs so that the correct nucleotide is chosen. The second control is the ability of the 
polymerase to continue extending the molecule from a mis-incorporated base and the last 
is the 3’ to 5’ exonuclease activity of some polymerases so that mis-incorporated bases 
can be removed. Reverse transcriptases and Tag DNA polymerase do not have the latter 
activity and are therefore dependent on the first two mechanisms to limit mis- 
incorporation. It is probable that some of the molecules in products of RT/PCR using 
reverse transcriptase and Tag DNA polymerase will contain mutations. The exact number 
of these mutations depends on many factors including the nucleotide sequence of the 
template molecule and the reaction conditions. However, the RT/PCR methods used in 
this study have been optimised to reduce the error rate. Thus, the concentration of each 
dNTP was the same, the overall dNTP concentrations were as recommended for each 
enzyme and the number of cycles in the PCR were minimised. At least two clones of each 
RT/PCR product were nucleotide sequenced to ensure that the sequence obtained was 
equivalent to the original sequence of the viral RNA. The RT/PCR fragment nucleotide 
sequenced from the CEE virus Kumlinge was 97.6% identical to the homologous region 
from the CEE virus Neudoerfl. This corresponds to the similarity between the two viruses 
found by previous workers who showed the E gene sequences from these viruses are 
98% homologous (Whitby et al.. 1993a). However, in a virus stock there will be variants 
in the population so the nucleotide sequence presented will represent the average 
nucleotide sequence of the stock viruses.
The nucleotide sequences and predicted amino acid sequences obtained from the 
RT/PCR fragments of BAN virus, MOD virus and CEE virus Kumlinge were compared with 
the sequence of the equivalent fragment from flavivirus NS5 genes reported to date. RNA 
polymerase motifs I, II and III were encoded by the fragment (Koonin, 1991). The amino- 
acid sequence of motifs I, II and III of the NS5 protein of BAN virus shared many 
similarities with the sequence of these motifs in other mosquito-borne flaviviruses. These 
three motifs in the MOD NS5 protein had several unique substitutions or substitutions that 
were also shared with the NS5 protein of CFA. The CEE virus Kumlinge showed most 
sequence homology with other tick-borne flaviviruses.
101
Chapter 5 Nucleotide Sequence Analysis of RT/PCR Fragments from BAN, MOD and CEE
The amino-acid sequence differences found for these motifs in flaviviruses were mainly 
conservative substitutions. However, some of the non-conservative substitutions could 
reflect virus adaptation to its life-cycle, in particular to the transmission vector in which the 
virus replicates. These motifs are also found partially conserved in many RNA 
polymerases and could have the same role in all RNA polymerases, this role has not 
yet been elucidated. Motif III may have a structural rather than a functional role as the 
precise sequence is more variable than in motifs I and II and there are many functionally 
and structural conserved substitutions (Appendix A).
The amino-acid sequences aligned show a high degree of functional homology. Positions 
or regions where there are major differences between individual flaviviruses amino-acid 
seauence or b°f'A/een th e  s®™ ip n rp s  rvf n rn n n s  n f v ir iis p s  m a u  rp n re s p n t p fu n n tio n a l^ ^    C3' I     ■ 1— J ‘ ’ ■ ■ - —  ----'  
difference. It is probable that some of the functionally non-conservative substitutions are 
due to virus/vector/host associations. Also MOD and CFA viruses may show variation in 
amino-acid sequence because of their adaptation in life-cycle. However, no motifs have 
been identified which are unique to an individual flavivirus suggesting that the part of the 
protein encoded by the NS5 gene fragment has a similar role in all flaviviruses.
The encoded amino-acid sequence of the BAN virus fragment shows highest similarity 
(70%) with the equivalent sequence of YF. The BAN virus sequence is between 56% to 
61 % homologous with all the other flavivirus sequences. The MOD virus amino-acid 
sequence analysed here was 48% to 56% homologous to other flavivirus sequences. The 
CEE virus Kumlinge predicted amino-acid sequence was most homologous to other 
viruses of the TBE serocomplex and, as expected, was 98% homologous with the CEE 
virus Neudoerfl. Also the nucleotide sequence of the CEE virus Kumlinge was 97.6% 
similar to the homologous region of the CEE virus Neudoerfl. Thus it was concluded that 
the expected fragment of the CEE virus Kumlinge had been amplified by the RT/PCR and 
the result gives confidence to other sequence data generated in this thesis.
The amino-acid alignments were then used as a basis to compare the nucleotide 
sequences of all flavivirus NS5 genes reported to date including the three sequences 
obtained in this section of the thesis. Thus the nucleotide sequence alignment would 
reflect the comparison of amino-acids which may have functional importance. A 
dendrogram was produced from a phylogenetic analysis.
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Flavivirus phyiogeny based on the nucleotide sequence of the pan-flavivirus NS5 RT/PCR 
fragment is consistent with previous serological and ecological analysis of the 
relationships between flaviviruses (Calisheretal., 1989). Other workers have demonstrated 
mosquito-borne and tick-borne viruses are separated into two distinct serological groups. 
The analysis of nucleotide sequence data presented here indicates for the first time that, 
MOD virus forms a third group not previously seen. This group could represent non­
arthropod-borne flaviviruses.
The mosquito-borne flaviviruses form four groupings, three of these groups correspond 
to the DEN serocomplex, the JE serocomplex and YF viruses. The cluster representing 
viruses of the DEN serocomplex is exactly the same as that predicted by Marin et al. 
f1995\ on the basis nf F none nuolenfirle semienro Based on the NS5 aene fraoment\  ----/ - .......-   ~ ■ — c; ~ ~    ••--------------------------------1 fcl lw 1 52 " vtyM,w,u
nucleotide sequence JE viruses are paraphyletic with other viruses of the JE serocomplex. 
However, on the basis of E gene sequence JE and MVE viruses are monophyletic sisters 
of WN and KUN viruses. This difference could be due to the inclusion of SLE virus 
sequence in the E gene study. In the NS5 sequence study SLE virus could not be 
included as no nucleotide sequence has been reported for this gene. The fourth group 
contains only BAN virus and may be representative of all viruses from the Uganda S 
serocomplex. The encoded amino-acid sequences of the RT/PCR fragment from BAN and 
YF is high at 70% but the two viruses form two distinct groups.
The tick-borne flaviviruses form essentially one group of viruses from the TBE 
serocomplex, this group is then subdivided to distinguish between different viruses of the 
serocomplex. The CEE virus Kumlinge clusters with the other CEE virus Neudoerfl.
Several groups of workers have suggested that all RNA viruses could be classified on the 
basis of comparison of the nucleotide sequence of their polymerases. The classification 
of flaviviruses on the basis of the phylogenetic analysis presented here is in accordance 
with the classification of flaviviruses as defined by cross-neutralisation and complement 
fixation tests (Calisher et al.. 1989). However seventeen flaviviruses have not been 
assigned to serocomplexes, an improved taxonomic system on the basis of the nucleotide 
sequence may in the future allow all the flaviviruses to be classified.
The study reported by Marin etal. (1995) and the phylogenetic analysis performed in this 
study showed classification of flaviviruses on the basis of NS5 or E gene nucleotide
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sequences produced similar results. The E protein interacts directly with the host cell and 
is thought to be responsible for virus/vector specificity. It is therefore likely that strong 
evolutionary pressure is being exerted by the vector and host environment on the E gene. 
The NS5 protein is less adapted to the particular vector/host organism, as demonstrated 
by KUN virus RNA which could act as a substrate for DEN-2 virus polymerase in-vitro and 
vice versa (Bartholomeusz & Wright, 1993). Therefore, the evolutionary pressures on the 
NS5 gene may be weaker and base changes will reflect relationships between the viruses. 
Although flavivirus classification on the basis of E or NS5 gene sequence will be similar 
for many flaviviruses there may be viruses, in particular with those with unusual 
transmission vectors, for which classification based on NS5 sequence will be preferable.
Other workers have used CFA virus as the out-group in phylogenetic studies of flaviviruses 
separating tick-borne and mosquito-borne viruses. However, the amino-acid sequence 
alignment here demonstrated similarities between the MOD virus and CFA virus predicted 
NS5 amino-acid sequences. Therefore a polymerase gene from an unrelated organism 
(B.subtillus RNA polymerase sigma factor) was used as the out-group. The phylogenetic 
study presented here and that presented by Marin et al. suggests that CFA virus is related 
to the flaviviruses and may be a member of the genus flavivirus or a separate genus within 
the family Flaviviridae.
Current diagnosis of flavivirus infections are based on the medical history of the illness 
and the individual followed by serological testing. Specific diagnosis can occur only when 
virus is isolated in fatal cases or from the blood of the individual. Specific diagnosis will 
also rely on immunological techniques such as neutralisation tests. Due to cross-reactivity 
of flavivirus antibodies correct diagnosis can be difficult and unusual cases are not 
identified or routinely investigated. Simultaneous epidemics may be identified as one.
The pan-flavivirus RT/PCR developed in this thesis may be useful as a diagnostic tool for 
flavivirus infection. Further analysis of the RT/PCR product would be required for specific 
identification, this would be based on the nucleotide sequence of the produced DNA 
fragment. The nucleotide sequences for this region of the NS5 gene are unique for each 
flavivirus allowing identification of each flavivirus present during an epidemic, diagnosis 
of rare flavivirus infections and geographical studies on the spread of an epidemic.
The pan-flavivirus RT/PCR would also be useful for surveillance studies of flaviviruses in
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the arthropod vector. Routine surveillance of the mosquito and tick population aids in 
policy decisions such as when and where to spray to control the potential outbreaks of 
disease and identification of people at risk from flavivirus infections for which vaccines are 
available. This method could also be used to detect spread of flaviviruses to new areas.
A generic flavivirus RT/PCR method would be useful in basic research of flaviviruses, firstly 
to identify new viruses as flaviviruses and, secondly, as a tool for further investigation of 
the whole NS5 gene and ultimately the whole viral genome.
In the next two chapters the work presented shows how this pan-flavivirus RT/PCR tool 
was used to determine the nucleotide sequence of the entire NS5 gene and flanking 
regions of BAN virus, Also to resolve the nucleotide sequence of most of the MOD virus 
NS5 gene and the 3’ NC region.
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SEQUENCE OF THE NS5 GENE AND FLANKING REGIONS OF BAN VIRUS
6.1 Introduction
The flavivirus serocomplexes JE, DEN, Ntaya and Uganda S all contain mosquito-borne 
flaviviruses and many of the unassigned flaviviruses are also mosquito-borne. However, 
only mosquito-borne viruses highly pathogenic to man, such as YF virus and viruses from 
the JE and DEN serocomplexes, have been extensively studied.
Many of the less well-characterised flaviviruses do cause disease, though this may be 
infrequently. These diseases ranging from fatal encephalitis caused by Rocio infection to 
mild febrile illness caused by BAN virus infection. Human infection with Bussuquara, Ileus, 
Sepik, Spondweni, Usutu, Wesselsbron or Zika viruses also cause disease with mild 
symptoms. In regions of the world where these viruses are endemic mild illnesses are not 
routinely reported or investigated provided the patients make a rapid recovery. Therefore 
the incidence of infection with these mosquito-borne flaviviruses may be higher than 
expected from recorded data, particularly in remote areas.
Man is not the natural host for flaviviruses, the mosquito-borne flaviviruses mainly infect 
other non-human primates, bats, rodents, marsupials and birds. Some of the mosquito- 
borne flaviviruses not found to be highly pathogenic for man cause disease in domestic 
or livestock animals. Wesselsbron is of veterinary health importance because it causes 
abortion in sheep and Israel turkey meningoencephalitis is found in diseased turkeys.
The comparison of nucleotide and deduced amino-acid sequences have lead to advances 
in the understanding of the molecular biology of flaviviruses pathogenic for man. The 
nucleotide sequence previously determined for mosquito-borne flaviviruses is generally 
from viruses highly pathogenic to man. The only exception to this is the KUN virus 
genome. A study of a wider range of mosquito-borne flaviviruses would expand the 
understanding of all flavivirus infections and could indicate sequences associated with 
pathogenicity. Also analysis of nucleotide sequence may, in the future provide a reliable 
method for the classification of flaviviruses.
The NS5 gene is approximately 25% of the flavivirus genome and may play an essential 
role in virus replication. Study of this gene also allows phylogenetic analysis of flaviviruses
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as demonstrated in chapter 5.
The genes upstream of the NS5 gene are NS4A and NS4B. The function of the two small 
proteins encoded by these genes has not been determined but they have been 
implicated in the viral replication complex (Chambers et al.. 1990a). These proteins are 
the least conserved of all the flavivirus proteins.
A length of nucleotides termed the 3’ NG region is found down stream of the NS5 gene. 
The nucleotide sequence of the 3’ NC regions reported from mosquito-borne flaviviruses 
all contain two short regions (less than 30 nucleotides) called CS1 and CS2. Also other 
conserved and repeated features have been observed for individual mosquito-borne 
flaviviruses. DEN-2 and DEN-4 contain a repeat of CS2, viruses of the JE serocomplex 
also contain a repeat of CS2 and also two copies of a sequence 25 nucleotides in length. 
YF virus has a set of three closely spaced repeats and only one copy each of CS1 and 
CS2. The 3’ NC region may have a role in virus replication allowing circularisation of the 
RNA molecule. The nucleotide sequences reported for the 3’ NG regions of all flaviviruses 
have the potential to form similar stable secondary structures which may also have a 
functional role in replication of the genome.
The aim of this section of the project was to nucleotide sequence the NS5 gene from BAN 
virus which belongs to the Uganda S serocomplex. Then compare the BAN NS5 gene 
with all other flavivirus NS5 genes sequenced to date and in particular other NS5 genes 
from mosquito-borne flaviviruses. The strategy employed also allowed the determination 
of nucleotide sequence of part of the NS4B gene and 3’ NC region which is also analysed 
in this chapter.
6.2 Strategy to obtain RT/PCR fragments containing BAN NS5 gene.
Three overlapping RT/PCR fragments were produced containing the entire NS5 gene 
(Figure 6.1). The first fragment was produced from primer set A as described in chapter 
4 and the nucleotide sequence of this fragment was determined (chapter 5).
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Chapter 6 Analysis of Banzi virus NS5 gene sequence
6.2.1 Design of primers for amplification of the 5’ fragment
A fragment containing the 5’ end of the gene was amplified from BAN virus infected cell 
RNA extracts by RT/PCR using an anti-sense primer (BANR2) designed from the 
previously determined sequence (Table 6.1) and a consensus sense primer (NS41) 
designed from alignment of mosquito-borne flavivirus NS4A/B nucleotide sequence 
(Figure 6.2). Primer NS41 contained two inosine molecules (I), this molecule is a purine 
base which occasionally occurs in cellular tRNA and is capable of forming bonds with 
all four bases (A, T, C and G). Also NS41 is a mixed primer containing primers with a T 
or a C at position 20.
\J.C-.C- u c o i m i » u i  ^ / i i i i i c i o  i u i  q i i i p i i i l u a t i u i i  u i  m e  u  i i a y i n i e i i i
The 3’ end of the gene was obtained by amplification of the extracted RNA with an anti­
sense primer (END1) designed from conserved sequences found in the 3’ NC region of 
mosquito-borne flaviviruses sequenced to date (Figure 6.3) and a sense primer (BANF2) 
designed from the previously determined nucleotide sequence of the central NS5 gene 
fragment (Figure 6.1).
6.3 Cloning and nucleotide seguencing of the BAN virus NS5 gene
The RT/PCR products were electrophoresed through a 1% agarose gel (Figure 6.4) and 
the purified DNA fragments were then cloned. Duplicate recombinant plasmids were then 
nucleotide sequenced. Sequencing was initiated using the M13 -40 and universal primer, 
the subsequent sequencing primers in Table 6.2.
The nucleotide sequence and deduced amino-acid sequence of the BAN virus NS5 gene 
are shown in Figure 6.5. The gene is 2715 nucleotides in length and the predicted protein 
contains 906 amino acids, with a molecular weight of 103kd. The RNA base composition 
of the gene is 28.25% A, 28.58% G, 21.14% U and 22.03% C. This bias affects codon 
usage (Figure 6.6) The nucleotide sequence of the target annealing sites of primers FG1, 
FG2, FG3, FG4, FG5, FG6 and EMF1 was examined and compared with the primer 
nucleotide sequence (Figure 6.7).
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Table 6.1 : Nucleotide sequence of BAN virus specific primers.
Primer Orientation Nucleotide Sequence
BANR2 anti-sense 5’TTCTGTATGGATGATCAG 3’
BANF2 sense 5’CTGACCCCAGATTCTGGAGCCTAGTT 3’
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Figure 6.4 : RT/PCR of the 5’ and 3 ’ terminal fragments of the BAN NS5 gene.
1 2 3
1774
1232
Amplification of BAN virus infected cell RNA extracts with primers as indicated.
Lane 1 
2 
3
Primers END1 and BANF2 1774bp
Primers END1 and BANF8 1505bp
Primers BANR2 and NS41 1232bp
1 1 3
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Table 6.2 : Sequencing primers used to determine the nucleotide sequence of the BAN 
virus NS5 gene.
Primer Nucleotide Sequence
BANF11 5TGCTGGGGTGATGAGAGGGAACC 3’
BANF13 5TGGCTACCTAAGGCCTACCGG 3’
BANF16 5’TGACATAGGAGAGTCCAGTT
BANR8 5’CATTCTGAAGTGCTGTTCAC 3’
BANR10 5’CTGGTGATGTCACTCTTATCC 3’
BANR13 5’TTCTCCATAGGTGAGGGCACTGC 3’
BANF7 5’CAGGGCAATCTGGTACATGTGG 3’
BANF8 5’ATGTCGCAGAAGAGGTAGCCC 3’
BANF9 5’ATGGCCCAGGAGGGAAG 3’
BANF10 5’GCAATGTCAAAGACCCGTAAAG 3’
BANF12 5’GTTCGGCTGTCCCGATTGATTG 3’
BANF14 5’GGAGAATGGATGTCATCAGATGAC 3’
BANF15 5TCCATCATGACCTCTGTGCACAG 3’
BANR5 5’TGCTTGCAAGGTCCGGTCCTTGCC 3’
BANR7 5’CCTGTGCACAGAGGTCATGATGG 3’
BANR9 5’CTGATGACATCCATTCTCCTG 3’
BANR6 5’CATTCTGAAATGTCTTTACGGG 3’
BANR12 5’ACATCGTTGCGGGTGATCACGT 3’
BANR3 5’ATGGTCTTCATTGAGGAATCCCAGTGCCTC 3’
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Figure 6.5 : Nucleotide and deduced amino-acid sequence of the BAN NS5 gene. The 
methyl-transferase motifs 1 and 2 are marked (MT 1, MT 2), also RNA polymerase motifs 
(POL) I to VIII.
GGTGGAAGCAGTGCCCTCACCTATGGAGAAGTTTGGAAAAGACAGTTGAACCTCCTCGGCAAGCAGGAATTCATGAATTACAAGGTCAGTGACATCCTGGAGGTTGACCS n o
g g s s a l t y g e v v k r q l n l l g k o e f m n y k v s d i l e v o r
TAGCCATGCTAGAGAGGTGCTAAACTCAGGGAATGATGCCGTAGGCGTTGCCGTGTCTAGGGGATCATCCAAGTTGAACTGGCTGATCGAGCGTGGCTACCTAAGGCCT* 2 2 0  
S H A R E  V L N S G  N D A V G V A V S R G  S S K L N V L  I  E R G . Y L R P
1---------------------------- — M T 1 -------------------   1
CCGGAAGAGTGGTGGATCTCGGCTGCGGATGGGGAGGATGGAGTTACACATGTGCCGCCGAGAGACAGGTCACCAGTGTGAAAGCATACACATTGGGCAAGGAGGGCCAC 3 3 0  
T G R V V D L G C G  V G G V S Y T C A A E R  O V . T S  V K A Y T L G K E G H
GAGAAGCCTCGCTTGATTCAGAGCTTGGGTTGGAACATCATCAAGTTTAAGGATAAGAGTGACATCACCAGAATGACTCCTCATGCCAGTGACACCCTTCTATGTGACAT A W  
E 1C P R L  I O S L G V N  I I  K F  K D K S D 1 T R M T P H  A . S  D T L L C , 0  I
AGGAGAGTCCAGTTCAAATCCAGAGGTTGAAAAAGAAAGGACCCTTCGAGTCATTGAGGCAGTGGAAAAGTGGATGTCTCCAACCACTGTGTCATTTTGCTTCAAGGTGC 5 5 0  
G E S S S N  P E V  E K  E R T L R V  I E A V E K V M S P T T V S F  C F  K V
t g g c t c c a t a c a a g c c c g a c g t c a t c g a g g c g c t g g a g a g g t t c c a a c t t a a g c a c g g a g g a g g g a t t a t a c g a a a c c c c t a c t c c a g a a a c t c a a c c c a t g a g a t g t a t  6 6 0
L A P Y K P D V  1 E A L E R F  O L  K H G G G  I  I  R N P Y  S R N S T H E  M Y
TACGTCTCTGGAGTGAGAAACAATATCCTGCACATGGTGAACAGCACTTCAAGAATGTTGATGAGGAGAATGTCTCGTCCATCTGGAAGATCAACTGTGGTCCCTGACTT 7 7 0  
Y V S G V R N N  1 L  H M V N S T S R M L M R R M S  R P S G R S T V V P 0 L
GATTTACCCCACCGGAACCCGGTCGGTTGCCAGTGAAGCGGGTCCTTTGGACCTGGAAAAGGTTAAGGCTAGAATCAACAGGCTGAAAGAAGAGCAGGAAAGTACTTGGT 8 8 0  
1 Y P T G T R S V A S E A  G P L D L E K V K A R I N  R L K E E  0 E S T V
TCGTTGACTCTGATCATCCATACAGAACATGGCATTATCATGGATCCTACGTGGCCAAGCAGAGCGGTACGGCAGCTTCAATGATCAATGGGGTTGTCAAACTGCTGTCT 9 9 0  
F V D S D H P Y R T V H Y H G S Y V A K  Q S G T A A S M I N G  V V K L  L S
GGCCCCTGGGACAGAATAGAAGAAGTCACCAACATGGCAATGACTGACACCACACCTTTCGGCCAGCAGAGGGTATTCAAAGAAAAAGTTGACACCAGAGCTCCTGAGCC 1 1 0 0  
G P V D R  I  E E V T N M A H T D T T P F G O O R V F K E K V D T R A P E P
ACCCCAGGGAACTAGAGAAATCATGAAAGTGGTCAACCAGTGGCTTTTTGATTACTTGGGGCGCACAAAGCAACCCCGCATCTGCACCAAGGAAGAATTCATCAACAAGG 1 2 1 0  
P O G T R E  I H K V V N O V L F  D Y L G R T K Q P R  I C T K E E F  I N K
TCAGGTCGCATGCCGCACTGGGAGGAATTCTAACTGAGCAGGAAGGTTGGAGCTCGGCAGCAGAAGCTGTAGCTGACCCCAGATTCTGGAGCCTAGTTGACAAGGAGCGT 1 3 2 0  
V R S H A A L G G I  L T E Q E G V S  S A A E A V A  D P R F V S L V O K E R
CAGGCCCATTTAGAAGGAAGGTGTGAAACATGCATCTACAACATGATGGGGAAGAGAGAAAAGAAACCATCTGAATTCGGGAGAGCCAAAGGAAGCAGGGCAATCTGGTA 1H 3 0
Q A H L E G R C E T C I Y N  H M G K R E K K P S E F  G . R  A K G S R A I V Y
I RNA POL MOTIF I ------------------------- 1-------------------- RNA POL MOTIF U-------------------
CATGTGGCTTGGGGCTCGCTTTCTGGAGTTTGAGGCACTGGGATTCCTCAATGAAGACCATTGGCTCGGCAGAGAGAATTCCAAGGCGGGAGTTGAGGGGATCGGGCTCC 1 5 4 0  
M V L G A R F L E F E A L G F L N E D H . V L G R E N S K A G V E G I G L  
  -----------------------------------------------RNA POL MOTIF I I ------------------------------  1---------------------------------------- RNA POL MOTIF III-----------------------------------------
AGTATCTTGGCTATGTCGTAGAAGAGGTAGCCCGGAAAGGTAATGGACTTGTTTATGCAGATGATACAGCAGGCTGGGACACTAGGATCACTGAAGCTGATTTGGAGGAT 1 6 5 0  
O Y L G Y V V E E V A  R K . G N G L  V Y A D D T A G V O T R  I  T . E A O L E  D 
------------------RNA POL MOTIF III---------------------------------------- >----------------------------------------- -R N A  POL MOTIF IV ----------------------------------------------■
GAACAATACATCATGAAGAGAATGAGCGCTGAGCACCGACAACTGGCATGGGCCGTGATGGAGTTGACCTACAGAAACAAGGTCGTCAAGGTTCCTCGTCCTGGACCAGG 1 7 6 0  
E Q  Y I M K R H S A E H R O L A V A V H E L T Y R N K V V K V  P R P G P G
AGGGAAGATTCTCATGGATGTCATCAGCCGCAGGGATCAACGGGGTTCGGGCCAGGTGGTCACCTATCCACTGAACACAGCAACCAACATGAAAGTGCAGCTCATCAGGA 1 8 7 0  
G K  I L M O V  I  S R . R D Q R G S G Q V  V T Y P L N T A T N M K V Q L  I  R
-  RNA POL MOTIF V -
TGGCCGAAGCCGAGAACGTGATCACCCGCAACGATGTTGAGAAGGTTTCATTGATCACACTGAAGGAGTTGCAACTATGGCTTGAAGTGAATGGGGTCAACAGGCTTGAG 1 9 8 0  
H A E A E N . V  I  T R N D V E K V S L  I T L K E L Q L V L E V N . G V N R L E  
 RNA POL MOTIF V  1 1—  RNA POL MOTIF V I--------
AGGATGGCCGTCAGTGGTGATGATTGCATTGTGGCCCCTGTGGATGAGTCATTTGCTGGAGCTCTCCATCACCTGAATGCAATGTCAAAGACCCGTAAAGACATTTCAGA 2 0 9 0
R M A V S G O D C  I  V . A P V D E S F  A G A L H H L N A M S K T R K O  I  S E  
--RNA POL MOTIF V I-------------------------------------------- ‘
ATGGGAAAACAGCAGAGGTTGGACCGACTGGGAGTCGGTTCCCTTCTGCTCACATCACTTCCACACCCTCTATCTAAAAGATGGTCGTACCATCATTGCCCCATGCAGAT 2 2 0 0
V E N S R G V T O V  E S V P F C S H H F  H T L Y L K D G  R T  1 1 A P C R
I— -------------- RNA POL MOTIF V II 1 I------------RNA POL MOTIF V III--------------
GTCAGGATGAGCTGATAGGGAGAGCCCGCATTTCACCAGGGAATGGCTGGATGATCAAGGAAACAGCTGGGCTCAGCAAAGCTTATGCCCAAATGTGGACACTGATGTAT 2 3 1 0
C O D E L  I G R A R  I  S P G N G V M  I  K E  T A G L  S K  A Y A 0  M V  T L  H Y 
•RNA POL MOTIF VIIIJ
TTCCACAGAAGAGATCTCAGACTCATGGCAAACGCGATCTGTTCGGCTGTCCCGATTGATTGGGTCCCCACAGGAAGAACAACATGGTCAATCCATGCCACAGGAGAATG 2 4 2 0  
F H R R D  L R L H A N A  I C S A V P  I D V V P T G R T T  V S  I  H A T G E V
GATGTCATCAGATGACATGCTTGAGGTGTGGAACAAGGTGTGGATTCAGGACAATCCGCATGTGAAAGACAAAACGCCAATCTTTGCCTGGCGGGATGTTCCCTACATTC 2 5 3 0  
M S S D D M L  E V V N K  V V . I O O N P H V K D K T P  I F A V R D V P  Y I
AAAAAGGGCAAGACAGGGCTTGTGGATCACTCGTGGGCACATCCCTGAGAGCGTCCTGGGCTGAATCCATCATGACCTCTGTGCACAGGGTGAGGATGCTCATTGGAAAT 2 6 4 0  
O K G Q O R  A C G S L V G T S L R A S V  A E S I M  T S V H R V R M L I  G N
GAAAGATATGTGAACTACATGGAATCTATGGACAGGTATGCCACACAGAGGTGTAGTGCATACGGAGAGTTGCTGTAA 2 7 1 8  
E R Y V N Y M E S H D R Y A T O R C S A Y G E L L  .
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Chapter 6 Analysis of Banzi virus NS5 gene sequence
Amino-acid motifs previously identified as being conserved in all flavivirus NS5 proteins 
were also conserved in the BAN virus NS5 deduced amino-acid sequence (Figure 6.5).
The encoded NS5 gene amino-acid sequences of other flaviviruses which have been 
reported to date were compared and the percent homology between each sequence 
determined (Table 6.3). An alignment of these amino-acid sequences was also 
constructed (Figure 6.8).
6.4 Conserved Motifs
In the BAN virus encoded NS5 protein the putative methyl transferase domain is partially
hnm nlnnnni? tn  thiQ rln m ain  in n th o r fla \/i\/iri iqdc /F in u ro  R Tho rln m n in  n n n tain c tw n  ■-------a  —   -----------  ■ — ... .— “ v ■a--*-'
conserved motifs separated by seventeen amino-acids. However, the BAN virus encoded 
motif 1 shows a functionally non-conservative substitution; an aliphatic amino-acid (Arg) 
present in all other flaviviruses and CFA has been replaced with an aromatic amino-acid 
Trp (position 84). An Arg residue is found in this position in the homolog of the putative 
methyl-transferase motif 1 in other organisms such as yeast and bacteria but has not 
previously been reported in a flavivirus NS5 protein. Thus, it is probable that the 
substitution maintains the universal functional role of motif 1.
The BAN virus NS5 predicted amino acid sequence also contains the eight previously 
identified regions of sequence conservation within the encoded amino-acids of the 
flavivirus NS5 gene and other RNA polymerases (Figure 6.8 (Koonin, 1991)). The encoded 
RNA polymerase motifs I, II and III of BAN virus NS5 protein are similar to these motifs in 
other flavivirus NS5 proteins and were discussed in detail in chapter 5. The second amino- 
acid of motif IV in the BAN virus NS5 protein is an Asn, whereas all other flaviviruses 
sequenced to date and CFA contain a Gly at this position. In motif V BAN virus contains 
a Pro residue whereas the other flaviviruses contain an aliphatic amino-acid, either Ala or 
Gly. The BAN virus encoded motif VI shows greatest homology with other mosquito-borne 
flaviviruses. The motif contains the sequence GDD which is preceded by a serine residue 
and followed by cystine residue, both these residues are conserved in all of the predicted 
amino acid sequences of flavivirus NS5 proteins reported to date. Motifs VII and VIII of 
the encoded BAN virus NS5 protein are similar to all other flaviviruses sequenced to date.
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Chapter 6 Analysis of Banzi virus NS5 gene sequence
Figure 6.8 : Alignment of deduced amino-acid sequence of flavivirus NS5 proteins.
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The encoded amino acid sequence of DEN1 virus is shown. Positions where the amino- 
acids are identical to of that found in the DEN1 sequence are indicated by a dot (.) and 
amino-acids shown in the alignment indicate differences at that position when compared 
with DEN1 virus. The methyl-transferase motifs identified by Koonin (1993) are marked 
MT 1 and MT 2 respectively.
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Figure 6.8 (continued) 
proteins.
Alignment of deduced amino-acid sequence of flavivirus NS5
CLLTKPWDAIPMVTQIAHTDTTPFQQQKVFKEKVDTRTPKAKRGTAQ IHEVTA-RNLWGFLSRNKKPRICTREEFTRKVRS NAAIGAVFVDENQNNSAKEAVEDZRFNDL
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The encoded amino acid sequence of DEN1 virus is shown. Positions where the amino- 
acids are identical to of that found in the DEN1 sequence are indicated by a dot (.) and 
amino-acids shown in the alignment indicate differences at that position when compared 
with DEN1 virus. The RNA-dependent RNA polymerase motifs I, II, III, IV and V identified 
by Koonin (1991) are marked POL I, POL II, POL III, POL IV and POL V respectively.
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Figure 6.8 (continued) 
proteins.
Alignment of deduced amino-acid sequence of flavivirus NS5
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.P IFA .R . . . 
.R .D E .R .T . 
ER.KE.R. . . 
EKIAE.R .. .  
Q T.C E .R .I. 
E S IE . .D .I .
. . . . L  
. . . . I  
. . . . I  
. . . . I  
. . . . I
. . . . I  
. . . . I  
. . . . I  
.T ..Q .X L . 
.T ..Q .K L . 
IQ.GQ.RA.
• P .S Q .IL .S  
.P.AQ.HL.S  
.P.SH.KL.S  
.P.TQ .LV.S  
.H .K Q .IT ..
 S .......... K . . . T . .
 S.......... K . . . T . .
 S .......... X . . . A . .
 S .......... X . . . A . .
 S.......... K . . . T . .
  S .......... Q . .L T ..
 S S . . . .
, . . . T R S . . . .  
, . . . T R S . . . .  
, . . .TR S .. . .  
, . . . T R S . . . .  
. . . . T R S . . . .  
, . . .T R .  . . . .  
. . . .TR T .. . .  
, • • .TR T .• • •  
. . . . M . N . . . .  
. . . H . N . . . .  
..V .T S L ..S . 
..V .R G E ..E . 
..V .R R E ..E . 
..V .R X E ..E . 
..V .R K E ..E . 
. . . . V X E . . . .
.X . .H T .. 
. E . . I A . . 
■E ..T A .. 
. E . . I A . .  
.E . . I A . . 
.E ..X A ..  
. E . . . . . .
. E . . I A . .
. B . .H . . .
.SH.HLV.
.SH.HLV.
•ES.HTSV
.K..WG.V
.K..WG.V
.X ..V G .V
.K..WGSV
.RE.BNSV
D S fl(S ingaporeS 275 /90 ) 
DEN2(Jam acica/N ,1409) 
ISN2(Hew G uinea-C) 
DEN2(16681-POK53) 
DSN2(16681)
EEN2(S1)
DSN3(H87)
EEN4
JS( JaQArS982)
JE(SA-14)
JE (SA 14-14-2)
JB(SA(V))
JS(SA14)
K1M(K!«61C)
NVE(NVE/1 /1 9 51 ) 
N NF(N igera)
IF (1 7 D -2 0 4 )
IF (1 7 D )
BAN(SAH336)
LGT(TP21)
CEE(Neudoerf1 ) 
RSSS(Sofin)
POH(LB)
CFA
890 900 910 920
NQVRRLIGNEN ILDIMTSMXRFXNESDPKGHSGESTHL
. . . . S ...........E------- . T . . . P ............ RR.EE-----EA.VLH.
. . .  . S . . . .  .E-------- . T . . .P ............ RK.EE-----EA.VLH
. . . . S ...........E------- . T . . . P ............ RR.EE-----EA.VLH
. . . . S ........... E------- . T . . . P ............RR.EE-----EA.VLH
. . . . S ........... E------- . T . . . P ............ RR.EE-----EA.VLH
Q .. .S  E F . .  . .P  RX.EESE. A IH .
T . . .N . . .K .E  - . V . . .PV . . .ISAP.ESE. ^VL.
. . .  .AV. .X . . -------- .V  LR.T------ E.VLIQEDRVI.
. . . . X V . . K . . -------- .V  LR.T------ E.VLIQEDRVI.
. . .  .AV. .X . . -------- .V  LR.T------ E.VLIQEDRVI.
. . .  .AV.  ______ .V  LR.T------E.VLIQEDRVI.
. . . . A V . . K . . ---------. V . . . . . L R . I  E.VLIQEDRVI.
. . .  .S I .  .D .X -—— . V . . .S .L . .T  E.TTLVEDTV-L
. . .  .SV. .K .K-------- . V . . .Q .LR .T------ EETHVSEDRVL.
. . .  .SV. .E .K -------- . V . . .S .L R .T ------ E .T IW EDTVL.
H R I.T . . .Q .X------- .T .  .L .V .D .IS V D A .— LQL. . L I .
H R I.T .. .Q .X------- .T .  .L .V .D .IS V D A .— LQL. . L I .
HR. .H  R------- .VN. .E . .D.IATQRC— SAX. .LL .
E K ...M ..P .H  .R ..LS ..D .H D LH K E L.LE .S -IF .
EX. .KM. .P .X ------- FX. .LSC.D.HDLHHELRLE.S-I-I
EX. .KM. .Q .X------- FK. .LSC.D.KDLHHES.LE.S-I-I
EX. . X . . .P .D ------- .R . .LS . .D .HDLH HEL.LE .S -II.
IS ...I.D A .TG VLNT.X .ELSV.S.IRRG N.-------------V I .
D SNl(S in9aporeS275/90) 
DEN2(Jam acica/N ,1409) 
DEN2(Nev G uinea-C) 
DEN2(16681-PDK53) 
DEN2(16681)
EEN2(S1)
IEN3(H87)
EEN4
JE(JaQArS982)
JE(SA-14)
JE ( SA14—1 4-2  )
JB(SA(V))
JE(SA14)
XDN(MRM61C)
KVB(KVE/1 /1 9 5 1 )  
HNF(N igera)
IF (1 7 D -2 0 4 )
IF (1 7D )
BAN(SAH336)
LGT(TP21)
CEE(Neudoerf1 ) 
RSSB(Sofin)
POH(LB)
CFA
The encoded amino acid sequence of DEN1 virus is shown. Positions where the amino- 
acids are identical to of that found in the DEN1 sequence are indicated by a dot (.) and 
amino-acids shown in the alignment indicate differences at that position when compared 
with DEN1 virus. The RNA-dependent RNA polymerase motifs VI, VII and VIII identified by 
Koonin (1991) are marked POL VI, POL VII and POL VIII respectively.
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A conserved motif not previously reported in RNA polymerases was also identified during 
the study. The PIR and SWISS databases were screened for amino-acid sequences 40% 
homologous to the sequence MAMTDTTPFGQQRVFKEKVDT. A number of genes encode 
this amino-acid sequence including genes involved in replication functions (Table 6.4).
Amino-acids conserved in all mosquito-borne viruses studied to date were identified at 
positions V-36, F-180, E-198, K-395, A-587, N-508, G-517, S-605, A-672, L-787 and G-861. 
At these positions a different amino-acid is conserved in all tick-borne viruses.
A structural prediction of the BAN virus NS5 encoded protein was obtained and the 
position of the conserved motifs identified in the proposed structural features (Figure 6.9). 
The m e th v l- t ra n s fe ra s e  d n m a in s  a re  n re d in te r l to  h e  re n in n s  of 6-sheet not on the Drotein--------  * * ------- J - ------------------------------ --------------------- -- —  — | -   ---- --------------------------------. w i i w w *  I i w *  w  . . *.. . w  | ^ i  w  fcw.i  •
surface. The conserved motif of unknown function identified by this study has no strong 
structural features. The RNA polymerase motifs I and II are likely to be exposed on the 
surface of the protein. The motifs III and IV also have no predicted strong structural 
features. Motif V appears to be partially contained within an exposed turn. Motifs VI, VII 
and VIII are probably internal in the protein, motif VI contains a /3-hairpin region.
The nucleotide sequence of flavivirus NS5 genes reported were aligned with respect to 
the amino-acid sequence alignment. The aligned nucleotide sequences were analysed by 
PAUP software to generate a dendrogram of phylogenetic relatedness (Figure 6.10).
6.5 Analysis of the nucleotide sequence of BAN NS4B gene and 3’ NC region
The upstream RT/PCR fragment amplified also contained part of the NS4B gene, the 3’ 
terminal 298 bases of nucleotide sequence and encoded amino-acid sequence of this 
part of the NS4B gene is shown in Figure 6.11 . The G/C content of this sequence was 
found to be 53% and the purine content was 56%. The encoded NS4B amino-acid 
sequence was aligned with the homologous sequence from other flaviviruses (Figure 
6.12). The percentage similarities between the flaviviruses in this encoded sequence were 
obtained (Table 6.5). The BAN virus encoded amino-acid sequence was 60% homologous 
to the YF virus encoded protein, homology with all the other flaviviruses was low (21.2% 
to 30.3%). Only six amino-acids from ninety-nine are conserved between all the 
flaviviruses. The YF and BAN virus NS4B fragments were most similar both with respect 
to amino-acid identity and conservative substitutions. The homology between the NS4B
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Table 6.4 : Proteins containing the partially conserved sequence. Percent homology with 
the sequence of the flavivirus conserved region is shown in brackets.
Description Nucleotide sequence
Flavivirus conserved region* MAMTDTTPFGQQRVFKEKVDT
DEN-2, DEN-3, JE, KUN, MVE, WN, YF 
and BAN virus’ NS5 protein
MAMTDTTPFGQQRVFKEKVDT (100%)
RSSE and POW virus’ NS5 proteins MAMTDTTAFGQQRVFKEKVDT (95.5%)
DEN-1 virus NS5 proteins IAMTDTTPFGQQRVFKEKVDT (95.5%)
LGT and CEE virus’ NS5 proteins MAMTDTTAFGQQRVFKDKVDT (90.9%)
DEN-4 virus NS5 proteins LAVTDAIHFGQQRVFKEKVDT (81.9%)
CFA virus NS5 protein FSMTDVSTYSQQKVLREKVDT (52.4%)
Squirrel monkey retrovirus, pol MDVTHFTPFGKQRFVHVTVDT (52.4%)
D.melanogaster lodestar, glutamate 
receptor
SAFTSTNKEGVARVRKEKGGY (42.9%)
A.tumefaciens RNA polymerase sigma- 
A factor
LACTGTLSSGQERRYKELKDQ (42.9%)
R.blastica ATP synthase IGAENITPQGFQIVFKTWGDT (42.9%)
B.thuringiensis crystal toxin RGSTDITIQGGDDVFKENYVT (42.9%)
E.coli, isocitrate dehydrogenase 
kinase/phosphate
MVMLVFTLPGFDRVFKVIKDR (42.9%)
Chicken, proteoglycan LNMTFSTPEGEQRKATEKSPA (42.9%)
D. melanogaster lodestar, Helicase LAITDTSTDGQQSVANAGDDG (42.9%)
* Consensus sequence
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Chapter 6 Analysis of Banzi virus NS5 gene sequence
Figure 6.10 : Dendrogram of phylogenetic relatedness of flavivirus NS5 genes.
DEN1 (SingaporeS275/90) 
DEN3(H87)
DEN2(Jamacia/N,1409)
DEN2(NewGuinea-C)
DEN2(16681-PDK53)
DEN2(16681)
DEN2(S1)
DEN4
JE(JaOArS982)
JE(SA-14)
JE(SA(A))
JE(SA(V))
JE(SA14)
KUN(MRM61C)
WN (Nigera)
MVE(MVE/1/1951)
YF(17D-204)
YF(17D)
BANZI
LGT(TP21)
CEE(Neudoerfl)
RSSE(Sofjin)
POW(LB)
CFA
Bootstrap percentage values are shown above the branches and branch lengths are 
shown below the branches.
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Chapter 6 Analysis of Banzi virus NS5 gene sequence
Figure 6.11 : Nucleotide and encoded amino- acid sequence of the 3’ terminal portion of 
BAN virus NS4B gene determined in this study.
AAACCCCACTGTTGATCTTGAAAAAGAGAATGATATGCCGGACTTGTATGAGAAGAAACT 6 0  
N R T  V D L E K E N D M P D L Y E K K L
AGCTCTGGTGGCACTGGGAATGGCTGCAGTCCTGAACGCTGCAATGGTCAGAACTGCGCT 1 2 0  
A L V ' A L G  M A A V L N A A M V R T A L
CACAACAGCTGAGATGGTGGTCCTGGGCTCAGCAGCCGTAGGGCCGTTGCTTGAGGGCAA 1 8 0  
T T A E M V V L G S A A V  G P L L E G N
CACCAGCGCCTTCTGGAATGGACCACTGGCTGTGGCAGTTGCTGGGGTGATGAGAGGGAA 2 4 0  
T S A F W N G P L A V  A V  A G V M R G N
CCACTACGCCCTGATCGGGATTGTTTACAACCTGTGGTTGCTGAAAACAGCTAGAAGA 2 9 8  
H Y A L I G I  V Y N L V L L K T A R R
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Figure 6.12 : Alignment of flavivirus NS4B gene encoded amino-acid sequences 
homologous to the BAN virus NS4B sequence determined in this study.
10 20 30 40 50 60
 _____________I_____________ I_____________ I_____________ I_____________ I_____________ L
IVAIDLDPV-VYDAKFEKQLGQIMLLILCTSQILLMRTTWALCESITLATGPL— TTLWE DENI (SingaporeS275/90)
TV--- .I-P..P..... . .V. .... VT.V.M. ....... AL. .... I— S. ... DEN2(Jamacica/N,1409)
TV.... .I-P..P..... . .V. ..V..VT.V.M. ....... AL. .... I— S. ... DEN2(New Guinea-C
TV.... .I-P. .P. ...'.. . .V. ..V..VT.V.M. ....... AL. .....I— S. .S. DEN2(16681-PDK53)
TV--- .I-P..P..... . .V. ..V..VT.V.M. ....... VL. .... I— S. .. DEN2(16681)
TV___ .I-P..P..... . .V. ..V..VT.V.M. ....... AL. .... V— S . ... DEN2(S1)
MT.... .-I..S...... . .V. ..V..AV.L... ..S.....VL. ..... I— .. .. DEN3(H87)
TV...E .I-S..P..... . . DEN4
M. . T . VPELERTTPLMQ . KV . . VL . IGVSVAAF . VNPNVTTVR. AGV. V . AAT--L. .. D JE( JaOArS982) 
M..T.VPELERTTPLMQ.KV..VL.IGVSVAAF.VNPNVTTVR.AGV.V.AAT— L...D JE(SA-14)
M. .T.VPELERTTPLMQ.KV. .VL. I GVSVAAF. VNPNVTTVR. AGV. V.AAT— L.. .D JE(SAl4-14-2) 
M..T.VPELERTTPLMQ.KV..VL.IGVSVAAF.VNPNVTTVR.AGV.V.AAT— L...D JE(SA(V))
M. .T.VPELERTTPLMQ.KV. .VL. IGVSVAAF. VNPNVTTVR. AGV. V.AAT— L.. .D JE(SA14)
. . .T .VPELERTTPIMQ.KV. .V. .ILVSLAALWNPSVKTVR.AGI.I.AAA--V KUN(MRM61C)
.. .T.VPELERTTPVMQ.KV. . .I.ILVSMAAVWNPSVRTVR.AGI.T• AAA— V. . . . WN(Nigera)
NPTV.IEEAPEMP.LY. .K.ALYL. .A.SLASVAMC. .PFS.A.G.V. .SAA.GPLI YF(17D)
NPTV.ZEEAPEMP.LY. .K.ALYL. .A.SLASVAMC. .PFS.A.G.V. .SAA.GPLI YF(17D-204)
NPTV. .EKENDMPDLY. .K .ALVA.GMAAVLNAAMV. .ALTTA.M W .GSAAVGPLL BAN(SAH336)
D.INPFGDGEAKP.LY.RK.SL.LA.V. .LASWMN. .FV.VT.AGAVGVAAAMQLL LGT(TP21)
D.INPFGEGEAKP.LY.RKMSLVLATV. .LMSWMN. .VASIT.ASAVGLAAAGQLL CEE(Neudoerf 1)
D.INPFGEGEAKP.LY.RKMSLVLAIV. .LMSWMN..-----•----- VPSTPRLL. .D RSSE(Sofin)
EIINPIPDGDPKP.LY.RKMSLFLAIG..IAAVA.N. .AA.MT.AGAV.VAA.GQLL POW(LB)
i i : i I
70 80 90 100 110
i i i_______________j_____________  »
 GSPGKFWNTTI AVSMANIFRGSYLAGAGLAFSLMKSLGGG— RR
 .N. ,R..... ......................L. .1. .NTTNT— . .
 .N. .R..... — .. ..................L. .1. .NTTNT -
 ,N. .R..... ..... . .  ..............L. .1. .NTTNT— . .
 .N. .R..... ........ .............L. .1. .NTTNA— ..
 N. .R..... -.. .............. . . . .L. .1. .NTTST— ..
 .......... ........ ..............L.I...V.T.--K.
 N . .R..... .... .. .T.................. I.NAQTP— . .
 -NGASAV. .S.T— ;— .TGLCHVM.......GSI.WT.I.NADKPSLK.
 NGASAV ..S.T— — . TGLCHVM...... GS I.WT.I. NADKPSLK.
 NGASAV . . S . T---- . TGLCHVM...... GSI.WT . I. NADKPSLK .
 NGASAV. .S.T-TGLCHVM.  GSI.WT.I.NADKPSLK.
 NGASAV.. S . T-. TGLCHVM ....... GSI. WT. I .NADKPSLK .
 NGASSV. .A.T-----IGLCH.M. .GW.SCLSITWT.V.NMEKPGLK.
 NGASSV. .A.T---- .IGLCH.M. .GW.SCLSIMWT.I.NMEKPGLK.
 E.NTSLL. .GPM   .TGVM. .NHY.FV.VMYN WKMKTG 
 E . NTSLL. . GPM-------- TGVM . . NHY. FV .VMYN. — WKMKTG-..
 E.NTSA.. .GPL----. .AV.GVM. .NHY.LI.IVYN.— W.LKTA-. .
 RPEMDVL.TMPV---- .CG.SGW. . .LWGLLP.GHR.— W.RTTGT. .
 RPEADTL.TMPV---- .CG.SGW. . .LWGFLP.GHR.— W.RASGG. .
WRQRDNCSNQRR.PFGRCQ.CGLSGW. . .LWGFCP.GHR.— W.RASGS. .
 RPEEESW.TMPM---- .CG..GLV. . .LWGLLPVLHRI— W.RTQGA. .
The encoded amino acid sequence of DEN1 virus is shown. Positions where the amino- 
acids are identical to of that found in the DEN1 sequence are indicated by a dot (.) and 
amino-acids shown in the alignment indicate differences at that position when compared 
with DEN1 virus.
DENI(SingaporeS275/90) 
DEN2(Jamacica/N, 1409) 
DEN2(New Guinea-C 
DEN2(16681-PDK53)
DEN2(16681)
DEN2(S1)
DEN3(H87)
DEN 4
JE(JaOArS982)
JE(SA-14)
JE(SA14-14-2)
JE(SA(V))
JE(SA14)
KUN(MRM61C)
WN(Nigera)
YF(17D)
YF(17D-204)
BAN(SAH336)
LGT(TP21)
CEE(Neudoerf1) 
RSSE(Sofin)
POW(LB)
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Chapter 6 Analysis of Banzi virus NS5 gene sequence
encoded amino-acid sequence of this region of flaviviruses virus is high between viruses 
of the same serocomplex (more than 74.5% between viruses of the DEN serocomplex, 
greater than 72.3% between viruses of the JE serocomplex and more than 68% between 
TBE viruses). However homology between viruses of different serocomplexes is low (less 
than 40%).
The downstream fragment contained 315 nucleotides of the 3’ NC region (Figure 6.13). 
The BAN virus nucleotide sequence of this region is most similar to that of YF virus with 
both viruses containingasequence (5’AACCGGGATA[C/T]AAAC[C/T][A/T][C/T]GG) which 
is repeated three times. The BAN virus repeated sequence is 72% to 77% homologous 
to the YF virus sequence. However, in BAN virus the repeats are more widely spaced than 
in YF virus. Like YF virus, BAN virus must also contain a sequence homologous to CS2 
because the anti-sense primer used to amplify this fragment was complementary to the 
sequence of CS2.
6.6 Discussion
BAN virus is a mosquito-borne flaviviruses which is serologically related to Uganda S. 
virus (Smithburn etal.. 1959) and YF virus (Casals, 1957). The nucleotide sequence of the 
pan-flavivirus RT/PCR fragment of the NS5 gene derived in this study confirms this 
relationship . The consensus primers (Table 6.2 and 6.3) used to generate the 5’ and 3’ 
terminal fragments of the NS5 gene were designed from previously determined 
nucleotide sequence of other mosquito-borne flaviviruses. The BAN virus specific primer 
BANR2 was used to prime the reverse transcription of the 3’ fragment, thus the effects 
of the degeneracy in primer NS41 during the PCR, with primers BANR2/NS4,1 would be 
minimised. The nucleotide sequence of primer END1 is between 81% to 100% 
homologous with mosquito-borne flaviviruses nucleotide sequenced to date and therefore 
could be expected to prime reverse transcription from BAN virus cell infected RNA 
extracts.
The start of the NS5 gene was identified by examining the deduced amino acid sequence 
(Figure 6.5) and identification of a putative dibasic cleavage site conserved amongst all 
flaviviruses. Cleavage at this site would form the N-terminus of the NS5 protein. In BAN 
virus the two basic amino acids were both Arg (Figure 6.12). A TAA stop codon in the 
gene was identified 2716 nucleotides downstream of the NS5 gene start codon.
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Figure 6.13 : Nucleotide sequence of the BAN virus 3’ NC region determined in this study, 
repeat sequences are underlined.
GCGACCGCAAAAGAAACCGGGATACAAACCTTCGTGCAGGTCCGGACCTCGCACACAGTA 6 0
REPEAT
AATTGGAAGGATTAACCGGGATACAAACTATGGCTTAGAACCGGACTAAGCACCTGAAAT 120
REPEAT
GGCAAAATAAATTATTTTGCCATTTTGAAGTCAGGCCACAAAGTGCCAGGGGTAAGCTGT 1 8 0  
AAGCCCCTGCTGTCTGTATCAGCTGTAAAACCGGGATATAAACCACGGCAAGGACCGGAC 2 4 0
H " — REPEAT
CTTGCAAGCAGGAAGAACGCATCCGACCTGCAAATGGAGCCTGGAACCAATACAGATCAC 3 0 0  
■ ■ r e p e a t H I
TGGTCTTGGTGTTAA 3 1 6
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The BAN virus NS5 gene was found to be 2715 nucleotides in length. The NS5 genes of
YF, JE, WN and MVE viruses are also 2715 nucleotides in length whereas the NS5 genes
of DEN-1 is 2712 nucleotides, the NS5 gene of DEN-2, 3 and 4 viruses are 2700
nucleotides and the NS5 genes of the viruses LGT, POW and CEE-TBE are 2709
nucleotides in length. The G+C content of the gene is 50.61%, and the purine (A+G)
content is 56.83. These values are typical for flavivirus genes, the high purine content,
may reflect an adaption due to the virus life-cycle. The CG doublet frequency is 2.7% and
is comparable with the CG doublet frequency of the YF genomic nucleotide sequence
(Rice et al.. 1985). Rice etal. (1985) suggest that this low CG doublet frequency may be
due to the adaptation of the flaviviruses to their arthropod and vertebrate hosts. This bias
also affects the codon usage, codons containing CG and also UA are infrequently used.
For example the codon for Ala is GCN (N= A,C,G or T ), there are sixty-one Ala residues
in the deduced amino-acid sequence but in only 5 cases is the final nucleotide of the 
codon a G residue (Figure 6.6). Other examples can be seen in the codon usage for lie,
Leu, Pro, Thr and Val (Figure 6.6).
In chapter 4 a number of primers were designed and BAN virus infected cell RNA extracts 
were subjected to RT/PCR with these primers. The nucleotide sequence of the target 
annealing site of these primers are partially conserved and have been identified in the 
BAN NS5 gene sequence. The target nucleotide sequences for primers FG1 and FG2 are 
highly homologous with the primer (82% and 84%). Target homology with FG5 and FG6 
is also high (90% and 76%). Both these primer sets amplified products from the BAN virus 
cell-infected RNA extracts. Primer FG3 is also highly homologous to the BAN virus target 
sequence (86%) but primers FG1 and FG3 were unable to amplify product from the BAN 
virus-infected cell RNA extracts, this may be due to virus secondary structure or primer 
FG3 annealing to non-target sequence and is discussed in detail in chapter 4. Primer FG4 
is 86% homologous with the BAN virus target sequence but primer FG7 is less 
homologous (70%) and contains a mis-match base at the 3’ terminal end when compared 
with the BAN target sequence. This mis-match may explain why no product was amplified 
from the BAN virus infected-cell RNA extract by primer FG4 and FG7.
Koonin et al. suggested that the NS5 protein contained two domains each having an 
enzymatic activity; a methyl transferase activity domain situated in the N-terminal portion 
of the protein (Koonin, 1993) and a domain for RNA polymerase activity in the C-terminal 
portion (Koonin, 1991). Poch etal. had also identified RNA polymerase conserved motifs
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in the C-terminal portion of the NS5 protein (Poch et al., 1989). The function of each of 
these motifs has not been identified. A homolog of motif VI in HIV-1 contains the 
sequence (Y)MDD, which exists on the /3-hairpin in the enzyme active site and has been 
implicated in metal ion binding (Ishihama & Barbier, 1994). The homologs of motif VI in 
Q p replicase and poliovirus RNA polymerase have been shown to be essential for enzymic 
activity (Ishihama & Barbier, 1994). Koonin et al. speculated on functions for the other 
RNA polymerase motifs including, RNA-binding function for motifs I and VII, also substrate 
binding function for motifs V and VI (Koonin, 1991).
The BAN virus NS5 protein contains motifs homologous to these previously identified 
methyl transferase and RNA polymerase domains. The limited differences in the encoded 
amino-acid sequence of the BAN virus protein may be due to an adaptation of the virus 
to its particular life-cycle.
The predicted secondary structural features of the BAN virus NS5 encoded protein 
suggests that the methyl-transferase motifs are contained in/3-sheet. The RNA-polymerase 
motifs I and part of II are predicted to be found on the external surface of the protein 
which would be expected of motifs involved in initial stages of RNA binding. No function 
has been proposed for motifs III and IV and are predicted to contain no strong structural 
features. Motif V was predicted to be contained within an exposed turn which is consistent 
with the proposed substrate-binding function. Motif VI is not predicted to be on the 
surface of the protein but as in HIV-1 is predicted to be on a /3-sheet hairpin (Kohlstaedt 
et al.. 1992). Motifs VII and VIII are predicted to be internal in the protein structure but 
separated by a turn, motif VIII may also contain a turn.
The alignment of flavivirus deduced NS5 amino-acid sequences identified a motif partially 
conserved in all flaviviruses which has not previously been reported. Several other 
proteins include this partially conserved motif including a retrovirus pol gene which 
encodes reverse transcriptase, a bacteria RNA polymerase sigma factor, and a fruit fly 
helicase (Table 6.4). It is therefore possible that the partially conserved motif has a role 
in the protein interaction with nucleic acids . However, no distinct secondary structure 
features are predicted for this motif and several other genes not related to interactions 
with nucleic acids also encode this motif with a similar level of homology, including a 
bacterial insect toxin and metabolic enzyme, also a chicken proteoglycan.
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Fora number of positions in the NS5 protein alignment an amino-acid is conserved in all 
mosquito-borne flaviviruses, a different amino-acid is conserved for tick-borne viruses. The 
Ser-605 and Ala-672 are functionally conservative substitutions in tick-borne and 
mosquito-borne flaviviruses. However in the other positions the substitutions are non­
conservative and may reflect functional differences in the proteins between mosquito- 
borne and tick-borne viruses.
Flaviviruses have been classified on the basis of their antigenic relationships as 
determined by cross-neutralisation with polyclonal antisera (Calisher et al.. 1989). 
Comparison of the predicted amino acid sequence of the E protein of flaviviruses results 
in a similar pattern of classification (Heinz et al.. 1990). Pierre et al. (1994) compared the 
nucleotide sequence of an RT/PCR product spanning 300 bases at the 3’ end of the NS5 
gene and a portion of the 3’ NC region of selected mosquito-borne flaviviruses. They also 
were able to show a relationship between mosquito-borne flaviviruses similar to that 
obtained by serology. Recently Marin et al. (1995) compared the results of phylogenetic 
study of the entire nucleotide sequences reported for the flavivirus E and NS5 genes. 
They deduced analysis of either gene showed the same relationships between the viruses 
and would produce a valid classification system.
The predicted amino-acid sequences of the NS5 gene from viruses in the same 
serocomplex are 73.0% to 99.6% for the DEN serocomplex, 80.9% to 99.7% for viruses 
in the JE serocomplex and 83.2% to 99.9% for viruses in the TBE serocomplex. Initial 
comparison of the encoded amino-acid sequence of the NS5 genes reveals distinct 
relationships between groups of viruses. In particular the deduced amino-acid sequence 
of the BAN NS5 protein is 66.7% homologous with the NS5 protein of YF virus, 57.2% to 
60.5% homologous with other mosquito-borne flavivirus NS5 amino-acid sequences and 
between 56.4to 57.9% homologous with the deduced amino-acid sequences of tick-borne 
flavivirus NS5 proteins.
A dendrogram indicating the phylogenetic relationship of all flavivirus NS5 genes reported, 
including BAN virus NS5 gene, was prepared. Serological analysis and comparison of 
NS5 gene nucleotide sequence show a similar pattern of relationship between flaviviruses. 
Mosquito-borne and tick-borne viruses are separated into two groups. Within the 
mosquito-borne virus group all four DEN viruses are grouped together and the JE, KUN 
and WN viruses form another distinct group. The tick-borne viruses LGT, CEE (Neudoerfl),
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RSSE (Sofjin), and POW form a third separate group. YF virus and BAN viruses have a 
common ancestor with all mosquito-borne flaviviruses but appear to be members of two 
separate groups.
The 1.2 kb fragment generated containing the 5’ end of the BAN virus NS5 gene also 
contained the 3’ end of the NS4B gene. The 3’ fragment contained the 3’ of the NS5 gene 
and part of the 3’ NC region.
The BAN virus 3’ NC region contains a similar set of repeated sequences to the YF virus 
3’ NC region. Like YF virus, BAN virus is also likely to contain a sequences homologous 
to CS2. If these sequences are involved in virus replication YF and BAN viruses may have 
similar mechanisms of replication. The spacing between the repeated and mosquito-borne 
virus conserved sequences in BAN virus are different from those in YF virus suggesting 
a structural role of theses sequences in virus replication.
The NS4B gene encoded amino-acid sequence was most similar to the YF virus encoded 
sequence, while the homology with all other flaviviruses that have been sequenced was 
low. Analysis of the YF and BAN virus sequences reveals only 18 positions where the 
amino-acid is not conserved or functionally homologous. This suggests that the NS4B 
protein of YF and BAN viruses may share similar mechanisms.
The NS4B protein has been implicated in viral replication complexes (Chambers et al, 
1990a). Analysis of reported nucleotide and amino-acid sequence has revealed that of the 
viruses with similar 3’ NC region features have similar NS4B nucleotide sequences. 
Further nucleotide sequence for the other flaviviruses is required before conclusions can 
be drawn from this observation, however it is possible NS4B and the 3’ NC region are 
closely associated in virus replication.
The BAN virus NS5 gene is the first nucleotide sequence determined for a virus of the 
Uganda S serocomplex. BAN virus is the most divergent mosquito-borne flavivirus for 
which nucleotide sequence has been reported to date. The results presented here 
corroborate previous work on regions of the NS5 protein which are predicted to have 
functional importance and a identify a further conserved motif. The analysis of the NS5 
protein and comparison with other flavivirus NS5 protein indicates that a phylogenetic 
comparison of flaviviruses based on NS5 proteins reflects the previously suggested
135
Chapter 6 Analysis of Banzi virus NS5 gene sequence
serological relationships. In addition BAN NS5 amino acid sequence displays features 
characteristic of mosquito-borne flaviviruses.
7 ANALYSIS OF THE NUCLEOTIDE SEQUENCE OF THE MOD VIRUS NS5 GENE
AND 3’ NC REGION
7.1 Introduction
The flaviviruses from the Rio Bravo and MOD serocomplexes, with no known arthropod 
vector, have not been well characterised. This may be because they usually infect bats 
and rodents and are not thought to be of public health importance nor to infect animals 
of economic importance. However, the study of these viruses will aid in the complete 
understanding of flavivirus infections and may provide an insight in to the mechanisms of 
virus pathogenicity. Such studies are facilitated since the safety requirements for working 
with these viruses tend to be less restrictive than those for highly pathogenic viruses.
MOD virus is the type virus for the serocomplex and has been isolated from rodents in 
four American states (California, Colorado, Oregon and Montana). The research carried 
out on this virus showed that it causes paralysis and death in laboratory mice and 
viraemia in hamsters and chicks. It would not replicate in either ticks or mosquitoes (The 
subcommittee on information exchange of the Americian committee on arthropod-borne 
viruses, 1985).
Comparison of the MOD virus NS5 gene sequence with that of other flaviviruses may 
identify motifs common to all flaviviruses which could reflect protein function in all 
flaviviruses, also regions of the protein important for virus/vector interactions and 
pathogenesis. The aim of the research reported in this chapter was to nucleotide 
sequence the MOD virus NS5 gene using cDNA fragments which overlap with the NS5 
gene fragment described and sequenced in chapters 4 and 5.
7.2 RT/PCR of the NS5 gene and flanking regions of MOD virus
Two RT/PCR fragments were generated from MOD virus infected-cell RNA (Figure 7.1). 
These fragments overlapped with the central fragment of the MOD virus NS5 gene 
(chapter 5).
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Chapter 7 Analysis of Modoc Virus Nucleotide Sequence
7.2.1 Amplification of the overlapping fragments
Initially two sense primers were designed (FGNS41 and FG NS42) from the aligned NS4A 
and NS4B sequences from a range of flaviviruses (Figure 7.2). These primers were used 
in separate RT/PCRs with the anti-sense primer MNS5R2 (Chapter 5). However no cDNA 
fragments were amplified from MOD virus infected cell RNA extracts. RT/PCR using the 
sense primers NS41 (chapter 6) and MNS5R2 also produced no amplified fragments.
To resolve this problem a sense primer (YFNS52) was then designed from the aligned 
nucleotide sequence of the NS5 gene of YF and other mosquito-borne flaviviruses (Figure 
7.3) and used in RT/PCR with the anti-sense primer MNS5R2 (chapter 5). A 730 base 
pair upstream fragment was produced by RT/PCR (Figure 7.4).
The overlapping down-stream fragment (Figure 7.1) was amplified using the anti-sense 
primer END1 (chapter 6) and the sense primer FG5 ( chapter 4). This fragment was 1300 
bp in length (Figure 7.4).
The two cDNA fragments were cloned in a plasmid vector and nucleotide sequenced, 
primers used to obtain the sequence of the upstream and downstream fragments are 
shown in Table 7.1.
A fourth fragment (Figure 7.1) 700 bp in length was also produced and nucleotide 
sequenced directly (Figure 7.4). This fragment was generated by RT/PCR of MOD virus- 
infected cell extracted RNA with the anti-sense primer MNS5R6 designed as a sequencing 
primer from the down-stream fragment and sense primer MNS5F7 designed as a 
sequencing primer from the central fragment of the NS5 gene produced by the pan- 
flavivirus RT/PCR fragment, described in chapter 5.
The nucleotide sequence of the MOD virus genome obtained from these RTPCR 
fragments contained 2432 nucleotides of the NS5 gene and 188 nucleotides of 
sequence from the 3’ NC region. No cDNA fragment containing the 5’ terminal end of 
the NS5 gene was obtained, future strategies to obtain the nucleotide sequence of this 
portion of the NS5 gene are outlined in the discussion of this chapter.
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Chapter 7 Analysis of Modoc Virus Nucleotide Sequence
Figure 7.4 : RT/PCR fragments generated from MOD virus infected-cell extracted RNA and 
separated by agarose gel electrophoresis
A 1 2 3 4 5
1 3 5 3
1078.
872
603
*III!
A and B: Electrophoresis of RT/PCR products of MOD virus infected-cell RNA extracts with 
primers as indicated through a 1% agarose gel.
Lane
A2
A3
A4
A5
MNS5R2 and YFNS5 731 bp
li ii II n
3END1 and FG5 1260bp
li ii ii ii
B2
B3
B4
B5
B6 MNS5R6 and MNS5F7 693bp 
Lanes A1 and B1 : DNA molecular weight markers (DRIgest III, Pharmacia)
1 4 2
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Table 7.1 : Sequencing primers of the MOD amplified cDNA
Primer Sequence Fragment
MNS5F13 5’ TTGATTACGTGTAAGTCCA 3’ Up-stream
MNS5F15 5’ AGCAATCCAACAGCAGCTGTTG 3’ li
MNS5R13 5’ CCCTCCCTGCTCCTCCATTC 3’ ii
MNS5R14 5’ CCAGCCATGTTGAAATCACG 3’ ti
MNS5F8 5’ CATGGATGTCATATCCAGGACCG 3’ Down-stream
MNS5F9 5’ GTGAGGAAAGACATTGACCTATGG 3’ ii
MNS5F11 5’ ACCACTTGGTCCCTCATGG 3’ n
MNS5F14 5’ AGGAGCCGGCGAGAAGGTGAGGAAC 3’ u
MNS5R12 5’ ATGGAGCTTCTTCTTGTGACTCATA 3’ ii
MNS5R15 5’ GGACCAAGTGGTGCGTCC 3’ it
MNS5R9 5’ TGT G ACT CATACCTACCCAT GTTCC 3’ li
MNS5R7 5’ CAGTCATCACCACTGACCAGCATTC 3’ n
MNS5R6 5’ CTGAATAGTGTCGAAGCCAGATTC 3’ ii
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7.3 Analysis of MOD virus NS5 gene nucleotide sequence
The nucleotide sequence and deduced amino-acid sequence obtained from the MOD 
NS5 gene are shown in Figure 7.5. The G/C content of this sequence was found to 
be 46%, while the purine content was 59%. The high purine content affects the codon 
usage (Figure 7.6) and in particular the occurrence of CG and UA doublets.
The nucleotide sequence encodes 810 amino acids towards the C terminus of the 
protein. The deduced amino acid sequence was compared with homologous 
sequence reported for other flaviviruses and a comparative alignment produced 
(Figure 7.7). The previously identified methyltransferase domain 2 and the eight RNA 
polymerase motifs were identified. The methyl-transferase motif 2 in MOD virus is most 
similar to the homologous motif from POW virus. The sequence of the RNA 
polymerase motifs I, II and III were discussed in chapter 4. Motif IV from MOD virus 
contains an amino-acid deletion found only in CFA, but the remainder of this motif is 
most homologous to POW virus. The motif V of MOD virus NS5 protein sequence 
is similar to this motif in all other flaviviruses with least homology (71%) with viruses 
of the DEN serocomplex. The first six amino-acids of motif VI are variable between 
all flaviviruses, the remainder of this motif from MOD virus is identical to this motif from 
all other tick-borne flaviviruses. The MOD virus motif VII contains two amino-acids 
unique to MOD and CFA only, the first is a basic amino acid at position 630 and the 
second a Glu at position 632. All other flaviviruses contain a Pro at this position. Motif 
VIII of MOD virus contains a Thr at position 657 whereas the other flaviviruses contain 
a Glu and CFA an Asn.
Previously (chapter 6.4) positions were identified where an amino-acid was conserved 
in all mosquito-borne flaviviruses and a different amino-acid was conserved for tick- 
borne viruses. At position 92, 517 and 773 the MOD NS5 protein contained the same 
amino-acid as mosquito-borne viruses, at positions 400, 584 and 699 the protein 
contained the same amino-acid as tick-borne viruses. At positions 307 and 420 the 
MOD NS5 protein has an amino-acid from with the same functional group as POW 
virus. The MOD protein contains unique amino-acids at positions 110 and 429 not 
found in either tick or mosquito- borne flaviviruses.
From the amino-acid alignment the percentage homology of this region between
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flaviviruses was noted. MOD virus shows similar homology with all the other 
flaviviruses (49.6% to 56.1%) (Table 7.2)
The amino-acid alignment was then used as a basis for a nucleotide sequence 
alignment. Phylogenic analysis of the nucleotide sequences then produced a 
dendrogram of evolutionary relationships (Figure 7.8).
7.4 Analysis of the nucleotide sequence of 3’ NC region of MOD virus
The nucleotide sequence of 163 bases of the 3’ NC regions determined for MOD 
virus is shown in Figure 7.5. This region has no significant homology with the 3’ NC 
region nucleotide sequence reported from any other flavivirus.
7.5 Discussion
The NS5 gene from MOD virus had a G/C content (46%), and a high purine content 
(59%), both of which are typical of the flavivirus genome. This nucleotide distribution 
affects codon usage and codons containing CG or UA are infrequently used (Figure 
7.6). As previously discussed in chapter 6 this could be a reflection of the 
evolutionary origins of flaviviruses and an ancient adaptation to the virus host 
environment. Comparison of the sequence obtained with the NS5 gene sequence of 
other flaviviruses reveals that the sequence obtained does not include the 
approximately 300 bases at the 5’ terminal end of the MOD NS5 gene. However, 
analysis of the sequence obtained will allow comparison of the encoded amino-acid 
sequences with that of other flaviviruses and may provide further insight into the 
relationships between the arthropod and non-arthropod transmitted flaviviruses. Also, 
the results of this analysis may allow development of new strategies for obtaining the 
sequence of the remainder of the gene.
The over all homology of the MOD NS5 gene encoded sequence with that of viruses 
of the TBE serocomplex (54.1 %-56.1 %) is not significantly higher than with that of 
mosquito-borne flaviviruses (49.6%-54.4%). The encoded amino-acid sequence 
contains the motifs though to be important for methyl-transferase and RNA polymerase 
activity. Several of these motifs appear to be similar to those in POW and other TBE
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Figure 7.5 : Nucleotide and predicted amino-acid sequence of the majority of the NS5 
gene and 3’ NC region of MOD virus determined in this study.
GTTACTATGCGGCTTCGCAACCAAATGTGAGAGAAGTGAAGGCCTACACGCTAGGAACTTCAGGTCATGAGAAGCCAAGACTTGTGGAAACTTTTGGATGGAACTTGATTACGTTTAAGT 1 2 0  
Y Y A A S Q P N V R - E V K A Y T L G T S G H E K P R L V E T F . G V N L  I T F K
CCAAAGTCGATGTCACAAAGATGGAACCCTTTCAAGCTGATACAGTGCTATGTGACATAGGTGAAAGCAATCCAACAGCAGCTGTTGAAGCCAGCAGAACCTTAACTGTGTTAAACGTGA 2 4 0
S K V D V T K M E P - F Q  A D T V L C D . I G E S N P T A A V E A S R T L T V L N V
■------------------ MT 2 ---------------------1
TTTCAAGATGGCTGGAATACAATCAAGGCTGTGGGTTTTGCGTCAAAGTCTTAAATCCATATAGCTGTGATGTTCTTGAGGCACTAATGAAAATGCAAGCAAGATTTGGAGGGGGTCTCA 3 6 0  
I S ' R W L E Y N Q G C G F C V K V L N P Y S C D V L E A L H K H O A R F G G G L
TTAGAGTCCCTCTATCAAGAAATTCAACACATGAGATGTACTTTGTCTCAGGCATAAAGAACAATATTATGGGTAATGTAACCGCTGTATCCAGGCAACTCCTGAAAAGAATGGAGGAGC <180 
I R V P L S R N S T H  E M  Y F V S G I K N N I M G N V T A V S R Q L L  K R M E E
AGGGAGGGGAAAGAGTGGTTCCAGACTATAAATTCTCTACAGGAACAAGATCCAATCTTACCCAAAAGATTGAGGTGCCAGAAGAAGAAGTCCAGATGAGAGTAGACAAAATCAAGGCTG 6 0 0  
Q G G E  R V V P O Y K F  S T G  T R S N L T Q K  I E V P E E E V Q  M R V D K  I  K A
AGAAATCAGGCACCTGGTGTTTTGATTCTAATCACCCTTATCGCACGTGGAACTATCATGGATCATACCGTGTGAGGGATGTGGGAACAAGAGCTTCAGCAGTCAATCATGTTGTGAAGT 7 2 0  
E K S G T V C F D S N H P Y R T V N Y H G S Y R V R D V G T R A S A V N H V V K
TACTTAGTTGGCCTTGGGGTAAGATGGAGAAAGTACTGGCAATGTCAATGACAGACACCACAGCGTTTGGACAGCAAAGGGTGTTTAAAGAAAAAGTGGACACCAAGGCCCCAGAACCAA 8 4 0
l l s v p v g k m e ' k v l a m s h t d t t a f g q o r v f k e k v o t k a p e p
ATATCCAGGTGAAAAAAGTGATGAGGAAAGTATTTAAATGGTTGATCGAAAGAATTAAAACCAAAGGTGGGAAAGTGAGAACATGCACAAAAGAAGAGTTCATCCAAAAAGTAAGATCTC 9 6 0  
N ' I Q V K K V M R K V F K V L  I E R  1 K T  K G G K V R T C T K E E F  I Q K V R S
ATGCTGCTATCGGGGCCTGGTCGTCAGATATGGAAGGGTGGAGCTCAGCTGTGGAGGCAGTTGACGATCCTAGGTTCTGGAACATGGTGCAGAAAGAAAGAGATTTACACCTACAAGGGA 1 0 8 0  
H A A I G A t f S S D M E G V S S A V E A V O D P R F V N H V Q K E R D L H L  Q G
AATGTGAGATGTGTGTGTACAACCTCATGGGAAAAAGAGAAAAGAAACCTGGGGATTTTGGAGTTGCCAAGGGGAGCCGTACCATCTGGTACATGTGGCTCGGCAGTAGATTCCTGGAAT 1 2 0 0  
K C E M C V Y N L . H G K R E K K P G D F G V A K . G S R T I V Y H V . - L G S R F L E
I-----------------------------------RNA POL MOTIF I ------------------------------------ >---------------------------------------- RNA POL MOTIF I I-----------------------------------------
TTGAAAGTTTTGGATTTCTGAATGAAGAACATTGGGCTTCACGGGAGTTGAGTGGGGGAGGAGTCGAAGGGATTCCCCTAAATTATTTAGGATACCATCTCAGAGAAATGGCCCAAAAAC 1 3 2 0  
F E S F G F L N E E H . V A S R E L S G G G V E G I P L N Y L G Y H L R E M A Q K ,  
--------------------- RNA POL MOTIF I I ----------------------1--------------------------------------------------------------------------------RNA POL MOTIF-III--------------------------------------------------------------------------------- >-
CAGGAGTGCTATATGCTGATGACACAGCTGGATGGGACACCCGCATTACCATGCCAGATCTGGAGGATGAAGGCATGCTGCTTGACATGATGAGCGGAGAACACAAGAAACTGGCTTCGG 1 4 4 0
J1
CACTATTCAGTAAAGCTTACAAAGTGAAAGTGGCCTTGTGCCCCAGACCTGGACCCAAAGGAGGAACTCTCATGGATGTCATATCCAGGACCGACCAAAGAGGGTCTGGCCAAGTAGTGA 1 5 6 0  
A L F S K A Y K V K V A L C P R P G P . K G G T L H O V I S R . T D O R G S G O V V
I------------------- RNA POL MOTIF V ----------------------
CTTATGCACTCAACACCCTGACCAACATAAAAGTGCAGCTTATCAGAATGGCAGAAGCCGAAGGAGTTCTTGGAGCAACTTTTGAGGACTTCGGGATTGACAGATGGTTGCAGGAACATG 1 6 8 0  
T Y A L N T  L T N  I K V Q L  I R M A E A E G  V L G A T F E D F G ]  D R V L Q E H .  
----------------------- :--------------------------------- RNA POL MOTIF-V ---------------------------------------------------------1 L
GTGAAGACCGAGTTGAAAGAATGCTGGTCAGTGGTGATGACTGTGTAGTCAATGCTATAGATGAAAGGTTTGGGTCAAGTCTGAATTGGTTGAATGCCATGGAAAAAGTGAGGAAAGACA 1 8 0 0
J 1
TTGACCTATGGAAACCATCACCCTCATTTAGAAACTGGGAACGGGTTGAATTCTGCTCTAATCACTTCCATGAGATGACAATGAAAGACGGGAGAGTCATTGTGGCGCCCTGTCGTGGCC 1 9 2 0  
I D L V K P S P S F R N V . E R V E ' F C S N H F . H E H T H K O G . R V I V A P C R G
I------------------ RNA POL MOTIF VII------------------1 I------------ — RNA POL MOTIF V l» ---------------
AAACTGAATTGATAGCAAGAGGGACASTCAACCAGGGGGGATGTGTTGGAGTGGAATCAACAGGCTGTCTAGCCAAGGCGTATGCGCAAATGTGGCTTTTGCTTTATTTCCACAGAAGAG 2 0 4 0  
O T E L  I A R G T V N Q G G C V G V E S T G C L A K A . Y A Q M V L L L Y F H R R  
• RNA POL MOT1 J
ACCTCAGAACGCTGGCTCTAGCTGTTATGTCAGCTGTGCCAAGCAATTGGATTCCAACAGGACGCACCACTTGGTCCCTCATGGTGAAAGGAGAATGGATGACTGATGAAGACATGTTGG 2 1 6 0  
D L  R T L A L A V  H S A V P S N V I P  T G R T T V S L H V K G E V M T O E O M L
CTGTGTGGAATAGGGTTTGGATTGAAGACAACCCTTTCATGGAAGACAAGAGAGAGGTGGAAAGGTGGAGTGAAGTCCCTTACCTTCCAAGAAACCAGGACAAGTCATGTGGTAGCCTAA 2 2 8 0  
A V V N R V V 1 E D N P F M E D K R E V E R V S E V P Y L P R N Q D K S C G S L
TTGGGACTACTGCTAGGGCAGAATGGGCCAAGTTGCTTCCAGGAGCCCGTGAGAAGGTGAGGAACATCTTTGGGAAGCAAAGATTCAGAAACTACCTTAGGAACATGGGTAGGTATGAGT 2 4 0 0  
1 G T T A R A E  V A K L L P G A R E K V R N I F G K 0 R F R N Y L R  N H G R Y E
CACAAGAAGAAGCTCCATTTTCAATGTATTAAACAATGAAATAATTAAATGAAAGAGTGTTGAGGGCAACCAGTGGGCTAGCCACATGGGTATGACGCACCCACCCTCTGCATTCTTGTA 2 5 2 0
S Q E E A P F  S M Y
AATACTTTGGCCAGTCATTGTAAATAGGTTAGGGAGCCGGGCCCAACCCAGCTAGGGATAGCCTTTCTGGGGTAAGGACTAGAGGTTAGAGGAGACCCAA 2 6 2 0
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Figure 7.7 : Alignment of the deduced amino-acid sequences of flavivirus NS5 proteins 
homologous to the MOD virus NS5 encoded sequence determined in this study. The 
methyl-transferase motif 2 identified by Koonin (1993) is marked MT 2.
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The encoded amino acid sequence of DEN1 virus is shown. Positions where the amino-acid is identical to of 
that found in the DEN1 sequence are indicated by a dot (.), amino-acids shown in the alignment indicate 
differences at that position when compared with DEN1 virus.
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Figure 7.7 (continued): Alignment of the deduced amino-acid sequences of flavivirus NS5 
proteins homologous to the MOD virus NS5 encoded sequence determined in this study. 
The RNA polymerase motifs I, II, III, IV, V, VII identified by Koonin (1991) are marked 
POI I, POL II, POL III, POL IV, POL V, and POL VII respectively
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The encoded amino acid sequence of DEN1 virus is shown.Positions where the amino-acid is identical to DEN1 
sequence are indicated by a dot, amino-acids shown in the alignment indicate differences at that position.
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Figure 7.7 (continued): Alignment of the deduced amino-acid sequences of flavivirus NS5 
proteins homologous to the MOD virus NS5 encoded sequence determined in this study. 
The RNA polymerase motif VII and VIII identified by Koonin (1991) are marked POL VII 
and POL VIII respectively
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i ------- 1-------------------- 1-----------
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• E----------. T . . .P ............RR.EE------ EA.VLW. DEN2( J a m a c ic a /N ,1 40 9 )
.E ----------.T .  . . P ............RK .EE------ EA.VLW DEN2( New G u in e a -C )
•E------- - . T .  . . P ........... RR .EE------ EA.VLW DEN2(1 6 6 8 1 —PDK53)
.E --------- . T . . .P ............RR .EE------ EA.VLW D E N 2 (1 66 8 1)
-E ----------.T .  . . P ............RR .EE------ EA.VLW DEN2( S I )
D E N 3(B 87)
.E ----------. V . . . PV. . .Y S A P .E S E .— — V L . DEN 4
. . ----------. V ............LR . Y-------E . V L IQ E D R V I. JE (Ja O A rS 9 8 2)
. . ----- — . V ...........LR. Y------ E . V L IQ E D R V I. JE(SA—1 4 )
. . ----------. v ............LR. Y-------E .V L IQ E D R V I. J E (S A 1 4 -1 4 -2 )
. . ----------. V ............LR . Y------ E . V L IQ E D R V I. J E (S A (V ) )
J E (S A 14 )
KUN(MRM61C)
.X ----------.V .  . .Q .L R .Y -— EETHVSEDRVL. K V E (M V E /1 /1 9 5 1 )
.X -------— . V . . .S .L R .Y ------E .T IW E D T V L . WN
.X ----------. T . . L .V .D .Y S V D A .L Q L — . . L I . Y F (1 7D )
.X ----------.T .  .L .V .D .Y S V D A .L Q L — . . L I . Y F (1 7 D -2 0 4 )
.R ----------,VN . .E ..D .Y A T Q R C S A Y -- ..L L . BAN(SAH336)
.H ----------. R . . L S . . D .B D L H W E L .L E .S -IF . LG T(TP 21)
.X --------- FK. .L S C .D .B D L B W E L R L E .S -I-I C E E (N e u d o e rf1 )
.X --------- FK. . LSC. D.BDLHWES.LE. S - I - I R S S E (S o fin )
,D--------- . R .  .L S . .D.BDLHW EL.LE. S - I I . PCW(LB)
jr --------- FRN.LRN.G.YESQEEAPFS--------MYL MOD(3 3 2 1 )
.TGVLNT.K.ELSV. S .YRRGN.-------------- V I . CFA
The encoded amino acid sequence of DEN1 virus is shown.Positions where the amino-acid is identical to DEN
sequence are indicated by a dot, amino-acids shown in the alignment indicate differences at that position.
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Chapter 7 Analysis of Modoc Virus Nucleotide Sequence
Figure 7.8 : Dendrogram of phylogenetic relationships between flaviviruses including MOD 
virus based on NS5 gene nucleotide sequence.
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Bootstrap percentage values are shown above the branches and branch lengths are 
shown below the branches.
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Chapter 7 Analysis of Modoc Virus Nucleotide Sequence
viruses.The primers used to produce the upstream NS5 gene fragment included YFNS51 
designed from the sequence of mosquito-borne viruses. Thus it appears that regions in 
the MOD NS5 encoded protein are similar to many flaviviruses, these are interspersed by 
short regions, up to four amino-acids, which contain amino-acids unique to MOD virus.
The phylogenetic analysis confirms the relationship between the viruses which was 
previously demonstrated using the nucleotide sequence of the pan-flavivirus RT/PCR 
fragment (chapter 5). The analysis indicates that MOD virus forms a separate group from 
the tick or mosquito-borne viruses. This group may include all viruses of the MOD 
serocomplex and perhaps all flaviviruses with no arthropod vector.
All of the flavivirus 3’ NO regions sequenced to date lack significant homology except in 
the repeated regions of certain groups of flaviviruses. The nucleotide sequence 
determined from the MOD virus 3’ NC region does not contain any repeated sequences. 
However the anti-sense primer used in the generation of the downstream fragment 
containing this 3’ NC nucleotide sequence was designed from the conserved region CS2 
of mosquito-borne flaviviruses (Hah et al.. 1987) and it can be concluded that MOD 3’ NC 
region contains a sequence homologous to the CS2 sequence suggesting that CS2 may 
have a common role in both mosquito-borne flaviviruses and MOD virus.
The failure to amplify an RT/PCR product using primer FGNS41 or FGNS42 and MNS5R2 
could be because MOD virus does not contain the sequence of the upstream primers. 
However, all other reported flavivirus sequence encodes a homologous region at the 
NS4A/NS4B junction thought to contain the protein cleavage sequences. If MOD uses the 
same mechanism of protein processing as other flaviviruses it is likely that it will also 
encode this homologous region. Thus, the difficulty experienced in amplifying this 
fragment may be due to its predicted size of approx 1800 bases. A shorter predicted 
product may be obtained using an anti-sense primer designed from the nucleotide 
sequence obtained in this study.
The nucleotide sequence presented in this chapter is the first reported sequence from a 
non-arthropod transmitted flavivirus. Despite the lack of sequence data for the 5’ terminal 
end of the gene, the analysis of the sequence has confirmed the conservation of the 
proposed functional motifs and the validity of classification of flaviviruses based on NS5 
nucleotide sequence.
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Though flaviviruses belong to a single genera and share similarities in life-cycle, each virus 
is distinct at a molecular level. It seems that individual flaviviruses have maintained many 
of the same general phenotypic and genotypic characteristics and that some of the 
differences between each flavivirus relate to an adaptation to the particular ecological 
niche each virus occupies. The diseases manifested by flavivirus infections vary from non- 
symptomatic to lethal depending on the virus/host interaction. The RT/PCR method 
developed in this study allowed the study of a wide range of flaviviruses.
A number of E gene primers were designed from two regions of nucleotide sequence 
homology between all flaviviruses. This enabled three sets of RT/PCR primers to be 
designed which amplified fragments from plasmids containing E gene cDNA. One of the 
primer sets, which performed best in a preliminary evaluation, was then tested in RT/PCR 
using a range of flavivirus infected-cell RNA extracts. These primers proved to be of 
limited use as products were produced from only two of the thirteen RNA extracts. Further 
investigation identified the main problem was with the anti-sense primer. The 
heterogenicity of the E gene between flaviviruses of different serocomplexes is reflected 
in the proposed functions of the E gene. All flavivirus E proteins are thought to have fusion 
activity which may be coded in the conserved regions from which the primers were 
designed, but the E protein is also the major viral antigen and it may be advantageous 
for each virus or groups of viruses to have different antigenic motifs. It is likely that this 
inherent variability limited the utility of pan-flavivirus RT/PCR tests.
The flavivirus NS5 genes show a greater degree of homology than the E genes and 
homologous motifs were identified in all flaviviruses for which sequence has been 
determined. These motifs may be conserved because they have an essential role in 
protein function. Therefore it was possible to design a range of primers from different 
regions of this gene. One primer set amplified the predicted cDNA fragment from eighteen 
flavivirus infected-cell RNA extracts including examples from each serocomplex and 
unassigned flaviviruses. A theoretical appraisal of the NS5 primers designed, based on 
sequence homology of primer with target sequence and predicted size of the RT/PCR 
fragment, did not identify the primer set which proved to be the most successful. This is 
probably due to unidentified secondary structure features of the viral RNA which prevent 
primers annealing to target sequences, or the nucleotide sequence of primers which 
enables primers to bind to non-target sequences . Therefore it can be concluded that
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whilst theoretical appraisal and defined primer design criteria are important in producing 
effective primers other undefined factors may influence the successful use of those 
primers.
The nucleotide sequences of the NS5 pan-flavivirus RT/PCR and other NS5 gene 
fragments determined in this study allowed the comparison of a wider range of flavivirus 
NS5 genes than had been previously possible. BAN virus is a member of the Uganda S 
serocomplex,for which no sequence data have previously been reported. The BAN virus 
NS5 gene was most homologous with YF virus sequence which may have implications 
in the study of determinants of flavivirus virulence in both BAN and YF viruses. MOD virus 
represents a group of flaviviruses which are not widely studied and for which nucleotide 
sequence has not previously been reported. The NS5 gene sequence determined in this 
thesis was homologous to this region in other flaviviruses but revealed no significant 
homology with any specific flavivirus or group of flaviviruses previously sequenced. As 
was predicted from the comparisons of the E gene sequence the nucleotide sequence 
of the NS5 RT/PCR fragment of the two CEE viruses (Neudoerfl and Kumlinge) were 
highly similar.
In this thesis previously identified homologous motifs found in flaviviruses NS5 gene 
encoded proteins were also found in BAN, MOD and CEE viruses supporting the proposal 
that these regions have the same functional role in all flaviviruses including the non­
arthropod transmitted flaviviruses. The NS5 protein is thought to be involved in viral 
replication. It has also been proposed, through comparison of conserved motifs with non- 
flavivirus proteins, that the NS5 protein has methyl-transferase and RNA-dependent-RNA- 
polymerase activity. However, the specific role of each NS5 protein motif is unknown. 
Comparisons of proposed secondary structural features of these motifs with similar 
structures of known function in non-flavivirus proteins, has enabled the putative functions 
of these motifs to be suggested. The secondary structure prediction produced in this 
thesis supports previously suggested functions. Analysis of these motifs in different 
flaviviruses shows some residues within the motifs contain a conserved amino-acid and 
in other positions the amino-acids are from the same functional group. Site directed 
mutagenesis of the amino-acids in these positions may allow identification of the specific 
functions of each motif. Determination of NS5 gene sequence of some of the other more 
unusual flaviviruses for which NS5 gene cDNA was amplified would also help in identifying 
positions suitable for site-directed mutagenesis. The effect of such mutagenesis could be
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observed using in-vitro translation systems and also by evaluating infectious cDNA 
clones. Chimeric infectious clones could also allow identification of functional domains 
of the NS5 protein shared by flaviviruses. The determination of a crystallographic structure 
of the NS5 protein would also be useful to relate the protein structure to function.
To date relatively few flaviviruses have been extensively studied, in particular those highly 
pathogenic viruses whose study may lead to a better understanding of the diseases they 
cause in man. However, much can also be learnt from some of the less pathogenic 
flaviviruses. A greater understanding of the molecular biology, in particular mechanisms 
of viral replication, of all flaviviruses will aid in vaccine development and antiviral therapy.
The current flavivirus classification on the basis of serology leaves 17 viruses unassigned 
to any of the eight serocomplexes . The classification of viruses based on nucleotide 
sequence similarities may yield more precise data on the relationships between the 
flaviviruses. Analysis of flavivirus E gene sequence reported to date results in a rational 
method of classification. However, classification on the basis of the E gene nucleotide 
sequences may result in similar problems to that based on serology, and as discussed 
in chapter 5, the E gene may be subjected to greater evolutionary pressures than the NS5 
gene. Thus the E gene sequence is more likely to reflect adaptation to a particular vector 
or host.
Analysis of flaviviruses NS5 nucleotide sequence produces a logical pattern which could 
be used for classification of flaviviruses. Comparison of the entire NS5 gene and the 
sequence of the pan-flavivirus RT/PCR fragment described in chapters 4 and 5 produced 
similar and equally valid results as determined for BAN virus. Comparison of the NS5 
gene sequence determined for MOD virus and the sequence of the MOD virus pan- 
flavivirus RT/PCR fragment also both produced similar results. Thus it can be concluded 
that nucleotide sequencing of the pan-flavivirus RT/PCR fragment of any flavivirus may 
allow classification of flaviviruses; this was exemplified in the case of the CEE virus 
Kumlinge which clusters with the CEE virus Neudoerfl. The NS5 gene sequence 
determined in this study from BAN virus indicates that BAN virus fits into the mosquito- 
borne flavivirus group and is most similar to YF virus. The analysis of MOD virus NS5 
gene sequence shows that MOD virus is not closely related to tick-borne or mosquito- 
borne flaviviruses. The absence of a reported insect vector is borne out by the sequence 
analysis in this thesis.
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All positive-sense RNA viruses contain an RNA polymerase thus the wider classification 
of all these viruses may be performed if the gene encoding the polymerase is considered. 
Future classification of flaviviruses may rely on sequence from both the E and NS5 genes, 
with the NS5 gene sequence analysis playing a more prominent role in classification of 
the more unusual flaviviruses and the wider classification of positive-sense viruses being 
based on RNA polymerase genes. Further flavivirus nucleotide sequence data, particularly 
from the unassigned viruses, are required before this can become possible.
One of the main problems encountered when attempting the classification of viruses 
based on nucleotide sequence is the large amount of data that has to be handled. 
Without powerful computers this would not be possible but as the amount of data 
expands the limits of current systems available to researchers may be reached. If this 
method of classification is to be universally available than this technology must also 
expand.
The nucleotide sequence determined in this study allowed the subsequent study of the 
regions flanking the NS5 gene. The sequence of the 3’ of the NS4B gene and 5’ of the 
3’ NC region of BAN virus was determined. The function of the NS4B protein has not 
been identified but it has also been found associated with viral replication complexes. The 
NS4B encoded sequence of BAN virus, determined in this study, was highly homologous 
to the YF encoded protein. If this is true of the whole of the NS4B protein then it is 
significant as only viruses from the same serocomplex have been seen to share such a 
high degree of similarity in the NS4B protein.
There is little similarity between the nucleotide sequence of 3’ NC region of flaviviruses 
sequenced to date. However related viruses have been shown to contain similar features 
such as conserved repeats. The function of the conserved repeats in the 3’ NC region of 
flaviviruses is not known but they may also be involved in viral replication. The BAN virus 
3’ NC region sequenced in this study has similar features to the 3’ NC region of YF virus. 
The 3’ NC region of YF virus contains three copies of a particular sequence, BAN virus 
also contains three copies of a similar sequence; no other flavivirus sequenced to date 
contains these sequences in their 3’ NC region. Thus it would seem that BAN and YF 
viruses may also have significant similarities in there 3’ NC regions.
Unlike mosquito-borne or tick-borne flaviviruses the part of the 3’ NC region of MOD virus
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which was sequenced in this study appeared to have no repeated features. However this 
virus appears to contain a sequence similar to the CS2 region sequence conserved in 
all mosquito-borne viruses suggesting a common role for the CS2 region in mosquito- 
borne viruses and MOD virus.
The pan-flavivirus RT/PCR method described in this thesis could form the basis of a novel 
method for the detection and identification of flaviviruses. The method reliably amplifies 
a fragment of vRNA from a wide range of flaviviruses but not from other viruses. Further 
work is required to confirm that this product can be amplified from all flavivirus vRNA but 
not from other positive sense RNA viruses. Following initial amplification the nucleotide 
sequence of the product could be determined or further investigated, perhaps by nested- 
PCR, hybridisation of known standards or restriction enzyme mapping, thus the specific 
virus could be identified.
Detection of flaviviruses using RT/PCR methods for has several advantages over the 
traditional immunological techniques. Firstly RT/PCR methods can be developed which 
eliminate un-desired cross-reactions. Also RT/PCR can be developed to detect essential 
regions of the gene not likely to be subject to antigenic variation. Uses of such RT/PCR 
methods include surveillance of reservoirs of virus and other epidemiological studies. 
Mosquito populations detected as carrying flavivirus infections can be sprayed or 
ecologically controlled and in some cases individuals living in areas at risk could be 
vaccinated. Detection of flaviviruses by RT/PCR is also useful in the study of virus 
pathogenesis with in-situ RT/PCR being used to detect virus-infected tissues.
The pan-flavivirus RT/PCR method developed in this thesis has further advantages. It 
provides a single test for detection of a large range of flaviviruses. Including those which 
commonly cause disease in man, to some of the more obscure flaviviruses which 
occasionally infect man and are therefore more difficult to diagnose. This method would 
also identify simultaneous flavivirus infections. The method would also be useful where 
the etiological agent is not obvious or flavivirus infection needs to be ruled out; a single 
test would be much more rapid and simpler than a battery of tests which may not include 
a test for the infectious agent. Finally the method could be used to diagnose infections 
with previously unidentified and new flaviviruses.
The use of this RT/PCR method in surveillance studies would allow identification of the
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flavivirus suspected of being present in an area but would also identify any flavivirus not 
previously seen in that region and could be used to monitor the spread of virus into new 
areas before clinical cases were presented. This type of surveillance may become more 
important with the increasing occurrence of DEN haemhorragic fever.
Lastly this method is a useful tool for the study of many flaviviruses including new and 
emerging viruses. It can yield new information on the relationship of these viruses to 
current flaviviruses and may be important in the further investigation of the function of NS5 
gene. In particular, chimeric viruses with domains or entire NS5 genes from different 
flaviviruses can be constructed using infectious clone technology to study the structure- 
function relationship of the flavivirus NS5 genes.
There are many possible ways in which the work described in this thesis could be 
developed including:
1. Testing a wider range of flavivirus extracted RNA with the NS5 gene pan-flavivirus 
RT/PCR method.
2. Investigate the utility of this method for identifying virus from clinical or vector samples.
3. Complete the MOD NS5 gene sequence.
4. Determine the nucleotide sequnce of the NS5 gene from other flaviviruses.
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APPENDIX A - AMINO-ACID FUNCTIONAL GROUPS
Table A1 : The functional groups of the common amino acids and standard 
abbreviations.
Functional Group/ 
Side Chain
Amino-acid Three-letter
abbreviation
one-letter
abbreviation
aliphatic glycine Gly G
alanine Ala A
valine Val V
leucine Leu L
isoleucine lie 1
secondary amino-group proline Pro P
aliphatic hydroxyl serine Ser S
threonine Thr T
aromatic phenylalanine Phe F
tyrosine Tyr Y
tryptophan Trp W
basic lysine Lys K
arginine Arg R
histidine His H
acidic aspartate Asp D
glutamate Glu E
amide asparagine Asn N
glutamine Gin Q
sulphur containing cysteine Cys C
methionine Met M
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